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Zusammenfassung 
Die Zielsetzung dieses Projektes war die Untersuchung der Rolle von 
Histondeacetylasen (HDACs) in der Neuro- und Gliogenese im embryonalen 
Mausvorderhirn.  
Wir haben gezeigt, dass in sich differenzierenden neuralen Vorläuferzellen eine Reihe 
verschiedener HDACs exprimiert werden, und, dass die pharmakologische Hemmung 
von HDACs der Klassen I und II mittels Trichostatin A zu einer verringerten 
Neurogenese in den Basalganglien und vermehrter Astrogliogenese führt (Shaked et al. 
2008).  
Die Expression der meisten HDACs der Klassen I und II konnte im Cortex, den 
ganglionischen Eminenzen (GE) und im Hippocampus des Embryos nachgewiesen 
werden. Zum Zwecke eines tieferen Verständnisses der den Effekt von HDACs auf 
Neuro- und Astrogliogenese vermittelnden Signaltransduktionswege wurde die 
Expression relevanter Gene in E 15.5 GE-Neurosphärenkulturen untersucht. Dabei habe 
ich festgestellt, dass im Bmp2/4-Signalweg involvierte Gene transkriptionell durch 
HDACs reguliert werden, was zu einer Aktivierung dieses Pathways führt. Die 
astrogliogenen Transkriptionsfaktoren Stat1 und Stat3 wurden nach HDAC-Hemmung 
verstärkt exprimiert, was mit unserer Beobachtung einer erhöhten Astrogliogenese 
konsistent ist. In Zusammenarbeit mit Dr. Catharina Scholl wurden die beteiligten 
Pathways weiter mit Hilfe von Microarray-Genexpressionsanalysen beleuchtet.  
Um die spezifische Rolle einzelner HDACs für die Neurogenese zu untersuchen, 
wurden die entsprechenden Gene mittels RNA-Interferenz reprimiert. Spezifische 
shRNA gegen HDAC1, -2, -4 und -5 wurde über lentivirale Vektoren in neurale 
Vorläuferzellen eingebracht und exprimiert. In allen Fällen fand sich unter den 
getesteten Oligonucleotiden eine Sequenz, die die Transkription um mindestens 50% 
reduzierte. Allerdings zeigte sich durch Real Time RT-PCR, dass die Oligos 
unspezifisch auch die Expression anderer HDACs beeinflussten. HDAC2-Knock-down 
konnte auf der Transkript- und Proteinebene nachgewiesen werden, allerdings ohne 
beobachtbare Auswirkungen auf Neuro- oder Gliogenese.  
6 
 
In jüngerer Vergangenheit erzeugte HDAC-Knockouts in Mäusen bieten vielfältige 
Möglichkeiten zur Untersuchung der Effekte einzelner HDACs auf die Bildung von 
Neuronen und Glia. Die HDACs 4 und 5 werden stark im Gehirn exprimiert, weswegen 
ich dessen Entwicklung und Morphologie in Mausmutanten untersucht habe, die diese 
Enzyme nicht mehr exprimieren.  
Die detaillierte Analyse der subzellulären Lokalisation von HDAC4 zeigte, dass das 
Enzym in den neurogenen Regionen des sich entwickelnden Gehirns vorhanden ist, 
worauf die Zellproliferation in der ventrikulären und subventrikulären Zone (SVZ) von 
HDAC4-Null-Mäusen weiter untersucht wurde. Im rostralen Cortex konnte ein leichter 
Anstieg der Proliferation beobachtet werden, nicht jedoch bei den basalen 
Vorläuferzellen der SVZ.  
Da ich festgestellt habe, dass HDAC5 sowohl in der Kortikal- als auch in der Subplatte 
exprimiert wird, beschloss ich, die kortikale Schichtung der HDAC5-Mutanten zu 
untersuchen. Hierbei zeigten sich keine Unterschiede in der Expression spezifischer 
Schichtmarker zwischen dem Wildtyp und der HDAC5-Null-Mutante. 
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Summary 
In this project the role of histone deacetylases (HDACs) in neuro- and gliogenesis in 
embryonic mouse brain was investigated. We could show that in differentiating neural 
progenitor cells many different HDACs are expressed and that pharmacological 
inhibition of class I and II HDACs with trichostatin A led to a decrease in neurogenesis 
in the basal ganglia and an increase in premature astrogliogenesis (Shaked et al 2008). 
The expression of most class I and II HDACs could be confirmed in embryonic cortex, 
GE and hippocampus.  
To better understand which signaling pathway is mediating the effect of HDACs on 
neuro- and astrogliogenesis, a real time RT-PCR analysis of candidate genes was 
carried out using neurosphere cultures derived from E 15.5 ganglionic eminence (GE). I 
found genes involved in Bmp2/4 signalling to be transcriptionally regulated upon 
HDAC inhibition, hints to the assumption that inhibition of HDACs by TSA releases an 
inhibition of BMP signalling. Stat1 and Stat3, transcription factors known to promote 
astrogliogenesis, were upregulated upon HDAC inhibition which corresponds to our 
observation of an increase in premature astrogliogenesis. The analysis of signaling 
pathways was further complemented by a microarray gene expression study carried out 
in collaboration with Dr. Catharina Scholl.  
In order to understand which HDACs are responsible for the effect on neurogenesis, 
RNA interference was used to inhibit the expression of individual HDAC genes. 
ShRNA against HDAC1, -2, -4, and -5 was generated and expressed in neural precursor 
cultures via lentiviral vectors. For all HDACs examined one shRNA oligo was found 
which knocked down transcription by at least 50%. However, real time RT-PCR 
revealed that the oligos also influenced expression of non-target HDACs. Knock-down 
of HDAC2 could be confirmed on the RNA and protein level, however, no effect on 
neuro- and gliogensis could be observed upon shRNA knock down of HDAC2.  
Recently generated knockout mouse models of individual HDAC genes provide a 
powerful tool to analyze the effect of individual HDACs on neuro- and gliogenesis. 
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HDAC4 and -5 show high expression levels in brain tissue, therefore I investigated 
brain development and morphology in mutant animals deficient in these enzymes.  
A detailed analysis of the subcellular localization of HDAC4 revealed the presence of 
the enzyme in neurogenic regions of the developing brain, therefore proliferation in the 
ventricular zone and basal progenitors in the SVZ were subsequently examined in 
Hdac4-/-. A slight increase in proliferation in rostral cortex could be observed, but no 
change in basal progenitors.  
I found HDAC5 to be expressed in the cortical plate and subplate and decided to 
examine cortical layering in HDAC5 mutants. No difference in the expression of 
specific layer markers could be observed between wildtype and Hdac5 null mouse.  
 
Table of contents 
Zusammenfassung ................................................................................................................................... 5 
Summary ................................................................................................................................................. 7 
Table of contents ..................................................................................................................................... 9 
Table of Figures ..................................................................................................................................... 13 
List of Abbreviations.............................................................................................................................. 17 
1 Introduction ................................................................................................................................. 21 
1.1 Development of the nervous system ......................................................................................... 21 
1.1.1 Cortical neurogenesis ...................................................................................................... 21 
1.1.2 Striatal neurogenesis ...................................................................................................... 24 
1.1.3 Differentiation in cortex and GE ...................................................................................... 26 
1.1.4 Gliogenesis...................................................................................................................... 27 
1.2 Neurosphere cultures as a model system .................................................................................. 29 
1.3 Chromatin Modification ........................................................................................................... 30 
1.3.1 General aspects of chromatin modification ..................................................................... 30 
1.3.2 Classes of mammalian histone deacetylases ................................................................... 34 
1.3.3 Functions of histone deacetylases ................................................................................... 36 
1.3.4 Class IIa HDAC transgenic mice ....................................................................................... 37 
1.3.5 HDAC inhibitors............................................................................................................... 42 
2 Aim of this study .......................................................................................................................... 43 
3 Materials and Methods ................................................................................................................ 45 
3.1 Materials .................................................................................................................................. 45 
3.1.1 Basic Reagents ................................................................................................................ 45 
3.1.2 Cell culture Reagents ...................................................................................................... 47 
3.1.3 Buffer, media and solutions ............................................................................................ 48 
3.1.4 Antibodies....................................................................................................................... 56 
3.1.5 Primers ........................................................................................................................... 59 
3.1.6 TaqMan Gene Expression Assays (Applied Biosystems) ................................................... 61 
3.1.7 Enzymes .......................................................................................................................... 63 
3.1.8 Antibiotics ....................................................................................................................... 63 
10 
 
3.1.9 Cells ................................................................................................................................ 64 
3.1.10 Plasmids ..................................................................................................................... 64 
3.1.11 Mission™  shRNA sequences ....................................................................................... 65 
3.1.12 DNA and Protein standards ........................................................................................ 66 
3.1.13 Kits ............................................................................................................................. 66 
3.1.14 Instruments ................................................................................................................ 67 
3.1.15 Software..................................................................................................................... 70 
3.1.16 Disposables ................................................................................................................ 70 
3.2 Methods ................................................................................................................................... 73 
3.2.1 Cell culture...................................................................................................................... 73 
3.2.2 FACS Analysis .................................................................................................................. 77 
3.2.3 Molecular biology ........................................................................................................... 79 
3.2.4 Biochemistry ................................................................................................................... 88 
3.2.5 Histological techniques ................................................................................................... 92 
3.2.6 Immunological techniques and histochemistry ............................................................... 93 
3.2.7 Mouse strains and genotyping ........................................................................................ 95 
3.2.8 In situ Hybridization ...................................................................................................... 102 
4 Results........................................................................................................................................ 111 
4.1 Analysis of the role of class I and II HDACs in neuro- and gliogenesis in embryonic mouse brain in 
vitro 111 
4.1.1 Class I and II HDACs are expressed in developing mouse brain - analysis through real time 
RT-PCR 111 
4.1.2 In vitro analysis of influence of HDACs on embryonic neuro- and gliogenesis using the 
pharmacological inhibitor TSA .................................................................................................... 115 
4.1.3 RNA interference studies to dissect which HDAC family member(s) influence neuro- and 
astrogliogenesis .......................................................................................................................... 129 
4.2 Developmental phenotype of the CNS of HDAC4 and HDAC5 transgenic mice ........................ 151 
4.2.1 Expression analysis of HDAC4 and HDAC5 in embryonic brain....................................... 151 
4.2.2 Generation and analysis of conditional mutant animals for HDAC4 ............................... 164 
4.2.3 Analysis of HDAC5 mutant mice .................................................................................... 172 
5 Discussion .................................................................................................................................. 179 
5.1 Analysis of the role of class I and II HDACs in neuro- and gliogenesis in embryonic mouse brain in 
vitro 179 
5.2 Inhibition of HDACs in vitro to determine their role in neuro- and gliogenesis ......................... 180 
11 
 
5.2.1 Reduction of neurogenesis in culture upon HDAC inhibition wih TSA ............................ 180 
5.2.2 Quantification of neurogenesis in adherent neurosphere cultures by FACS analysis ..... 181 
5.2.3 HDACs influence neurogenesis on a transcriptional level .............................................. 181 
5.2.4 Protein translation is necessary to upregulate BMP2 expression upon TSA treatment .. 183 
5.2.5 Microarray analysis of pathways potentially involved in HDAC influence on neurogenesis
 183 
5.3 RNA interference to dissect which HDAC family member(s) influence neuro- and astrogliogenesis
 184 
5.3.1 Real time RT-PCR analysis of shRNA-mediated knockdown of HDAC1, -2, -4, and -5 ..... 184 
5.3.2 Confirming HDAC2 knockdown on the protein and the cellular level ............................. 185 
5.3.3 Immunostaining to reveal the progeny of infected precursors ...................................... 187 
5.4 Developmental phenotype of the CNS of HDAC4 and HDAC5 transgenic mice......................... 189 
5.4.1 Embryonic brain phenotype of HDAC4 mutant mice ..................................................... 190 
5.4.2 Embryonic brain phenotype of HDAC5 mutant mice ..................................................... 193 
6 Outlook ...................................................................................................................................... 195 
7 Appendix .................................................................................................................................... 197 
7.1 Plasmid maps ......................................................................................................................... 197 
7.2 Immunoctochemistry of neurosphere cross-sections ............................................................... 200 
Acknowledgements ............................................................................................................................. 203 
References ........................................................................................................................................... 205 
 
12 
 
13 
 
Table of Figures 
Figure 1.1. Neurogenesis in the embryonic brain ................................................................................... 22 
Figure 1.2. Generation of projection neurons in developing mouse cortex in an inside-out-mode ......... 24 
Figure 1.3. Coronal hemisections of E12.5 mouse telencephalon illustrating areas of neurogenesis in the 
ventral telencephalon ................................................................................................................... 25 
Figure 1.4. Signaling pathways and transcription factors involved in gliogenesis .................................... 28 
Figure 1.5. Nucleosome consisting of two copies of each core histone H4, H3, H2B and H2A and 147 bp 
of DNA wrapped around this core ................................................................................................. 31 
Figure 1.6. Specific sites of histone modifications in the amino-termini of core histones ....................... 32 
Figure 1.7. Histone acetylation and deacetylation alters the structure of the chromatin ........................ 33 
Figure 1.8. Acetylation of lysine residues in histone tails ........................................................................ 33 
Figure 1.9. Mammalian classes of HDACs ............................................................................................... 35 
Figure 1.10. Hdac4 null mice .................................................................................................................. 39 
Figure 1.11. Brain phenotype of HDAC -/- mice ...................................................................................... 40 
Figure 1.12. HDAC5 expression in embryos visualized by X-Gal staining ................................................. 41 
Figure 3.1. Scheme of the neurosphere culture and differentiation protocol ......................................... 75 
Figure 3.2: Results of the Gapdh PCR after cDNA transcription .............................................................. 85 
Figure 3.3. Targeting of Cre-REcombinase to the HDAC4 Gene ............................................................... 96 
Figure 3.4. Gene targeting of the HDAC4 locus ....................................................................................... 97 
Figure 3.5. Gene targeting of the HDAC5 locus ....................................................................................... 98 
Figure 4.1. Expression levels of HDACs in embryonic brain tissue at E 13.5 .......................................... 112 
Figure 4.2. Relative expression of HDACs in embryonic brain tissue at E 13.5 ....................................... 113 
Figure 4.3. Expression levels of HDACs in E 15.5 brain tissues .............................................................. 114 
Figure 4.4. Relative expression of HDACs in embryonic brain tissue at E 15.5115 
Figure 4.5. Decrease of neurogenesis in neurosphere-derived progenitor cultures upon treatment with 
TSA. Immunocytochemistry for neurons (TuJ1) and astrocytes (GFAP) in NS cultures ................. 116 
Figure 4.6. FACS analysis of neurosphere-derived cultures plated out to differentiate and treated with 
TSA (B: 10 nM C: 50nM) or vehicle (A: 0 nM) for 12 h between 1.5 DIV to 2.0 DIV ...................... 118 
Figure 4.7. Quantification of neurogenesis determined through FACS analysis .................................... 118 
Figure 4.8. real time RT-PCR analysis of gene expression upon treatment of differentiating neurosphere 
cultures with TSA ........................................................................................................................ 120 
Figure 4.9. Quantitative real time RT-PCR to determine expression of genes involved in neuro- and 
astrogliogenic developmental programs ..................................................................................... 122 
Figure 4.10 Quantitative real time RT-PCR to determine expression of genes involved in neuro- and 
astrogliogeniesis after inhibition of translation ........................................................................... 123 
14 
 
Figure 4.11. Time course of treatment intervals with TSA or BMP2 and subsequent luciferase assay to 
determine levels of BMP2/4 signaling in the cultures. ................................................................ 125 
Figure 4.12. Mission shRNA-Vector pLKO.1-puro (Sigma-Aldrich) with shRNA insert ...........................  129 
Figure 4.13. Relative expression of HDAC1&2 after siRNA-knockdown of HDAC1 ................................. 131 
Figure 4.14. Relative expression of HDAC2 after siRNA-knockdown of HDAC1 ..................................... 132 
Figure 4.15. Relative expression of HDAC2 after siRNA-knockdown of HDAC2 ..................................... 133 
Figure 4.16. Relative expression of HDAC1 after siRNA-knockdown of HDAC2 ..................................... 134 
Figure 4.17. Relative expression of HDAC3 after siRNA-knockdown of HDAC2 ..................................... 134 
Figure 4.18. Relative expression of HDAC4 after shRNA-knockdown of HDAC2 .................................... 135 
Figure 4.19. Relative expression of (A) HDAC5, (B) HDAC7a, (C) HDAC8 after siRNA-knockdown of HDAC2
 ................................................................................................................................................... 137 
Figure 4.20. Relative expression of HDAC4 upon shRNA knockdown of HDAC4 .................................... 138 
Figure 4.21. Relative expression of HDAC2 upon HDAC4 knockdown ................................................... 139 
Figure 4.22. Relative expression of HDAC5 upon HDAC4 knockdown ................................................... 139 
Figure 4.23. Relative expression of HDAC5 upon HDAC5 knockdown ................................................... 140 
Figure 4.24. Relative expression of HDAC2 upon HDAC5 knockdown ................................................... 141 
Figure 4.25. Western blot anaylsis of HDAC2 expression in lentivirus infected neurosphere cultures ... 142 
Figure 4.26. Western blot anaylsis of HDAC2 expression in lentivirus infected neurosphere cultures ... 143 
Figure 4.27. Western blot anaylsis of HDAC2 expression in 293T cells transfected with Mission plasmids 
containing the shRNA sequences generated against HDAC2 ....................................................... 144 
Figure 4.28. Immunostaining of striatal neurosphere derived cells on coverslips ................................. 145 
Figure 4.29. Hippocampal cells (DIV 9) infected with lentivirus carrying shRNAs against HDAC2, fixed 4d 
after infection ............................................................................................................................. 146 
Figure 4.30. Neurosphere cultures infected with lentivirus containing shRNA to knock down HDAC2 .. 148 
Figure 4.31. Neurosphere cultures infected with lentivirus containing shRNA to knock down HDAC2 .. 149 
Figure 4.32. Neurosphere cultures infected with lentivirus containing shRNA to knock down HDAC2 .. 150 
Figure 4.33. In situ hybridization on E 15.5 coronal brain sections........................................................ 152 
Figure 4.34. In situ hybridization of HDAC4 on E 15.5 coronal brain sections ........................................ 154 
Figure 4.35. In situ hybridization of HDAC5 on E 15.5 coronal brain sections  ....................................... 156 
Figure 4.36. LacZ staining on E13.5 coronal brain sections of a HDAC4 mutant embryo ....................... 158 
Figure 4.37. LacZ staining on E15.5 coronal brain sections of a HDAC4 mutant embryo ....................... 160 
Figure 4.38. LacZ staining on E13.5 coronal brain sections of a HDAC5 mutant embryo ....................... 162 
Figure 4.39. LacZ staining on E15.5 coronal brain sections of a HDAC5 mutant embryo ....................... 163 
Figure 4.40. HDAC4 immunoblot of E13.5 brain tissue of the CIMH4 mouse line .................................. 165 
Figure 4.41. HDAC4 immunoblot of E15.5 spinal cord tissue of the CIMH4 mouse line ......................... 166 
Figure 4.42. HDAC4 immunoblot of E15.5 brain tissue of the CIMH4 mouse line .................................. 167 
15 
 
Figure 4.43. Immunostaining for PH3 positive cells on coronal hemisections of HDAC4 mutant mice and 
wt littermates at E 15.5 ............................................................................................................... 168 
Figure 4.44. Hemicoronal sections of E15.5 HDAC4 wildtype and mutant brain ................................... 169 
Figure 4.45. Hemicoronal sections of wildtype and HDAC4 mutant brain stained for Tbr2 (intermediate 
progenitors) and TuJ1 (neurons) ................................................................................................. 170 
Figure 4.46. Hemicoronal sections of wildtype and HDAC4 mutant brain stained for Tbr2 (intermediate 
progenitors) and TuJ1 (neurons) ................................................................................................. 171 
Figure 4.47. X-Gal staining on coronal brain sections of E 15.5 HDAC5 ................................................. 173 
Figure 4.48. Immunostaining for Pax6 in coronal hemisections of HDAC5 heterozygote and mutant mice
 ................................................................................................................................................... 174 
Figure 4.49. Immunostaining of Ctip2 in coronal hemisections of HDAC5 heterozygote and mutant mice
 ................................................................................................................................................... 175 
Figure 4.50. Immunostaining of SatB2 in coronal hemisections of HDAC5 heterozygote and mutant mice
 ................................................................................................................................................... 176 
Figure 4.51. Immunostaining of Reelin in coronal hemisections of HDAC5 heterozygote and mutant mice
 ................................................................................................................................................... 177 
 
16 
 
17 
 
List of Abbreviations 
ΔCT   Difference between the CT-value of the gene of interest and the control  
(housekeeping) gene 
aHDAC1o1  shRNA directed against HDAC1, oligo number 1 
APS   Ammoniumpersulfate 
bHLH   Basic helix-loop-helix (transcription factors) 
bp   Base pairs 
BRE  Bmp-responsive element 
BSA  Bovine serum albumin 
CaMK  Calcium/calmodulin-dependent protein kinase 
CBP   CREB-binding protein, a HAT and coactivator of transcription 
cDNA  Copy DNA 
CHX  Cycloheximide 
CNS   Central nervous system 
CP   Cortical plate 
CT Cycle of threshold: cycle of the real time RT-PCR, in which the enzyme-
substrate curve changes from the linear to the Plateau-phase) 
DAPI 4',6-diamidino-2-phenylindole, fluorescent dye binding AT-rich regions 
of DNA 
DIV  Day in vitro 
DMEM Dulbecco’s  modified  Eagle  medium 
DMSO Dimethylsulfoxide 
dNTP  Deoxyribunucleotide-Triphosphate 
dpc   Days post coitum 
E   Embryonic day 
EDTA  Ethylendiamine-tetraacetate 
EGF   Epidermal growth factor 
EGFP  enhanced green fluorescent protein 
et al.   et alteri 
FCS  Fetal calf serum 
FACS   Fluorescence activated cell sorting 
18 
 
FGF   Fibroblast growth factor 
GABA  Gamma-aminobutyric acid  
GE   Ganglionic emineces 
GFP  Green fluorescent protein 
HAT   Histone acetyltransferase 
HDAC  Histone deacetylase 
HEK  Human embryonic kidney 
HMFM Hogness modified freezing medium 
HRP   Horse radish peroxidise 
IKNM  Interkinetic nuclear migration 
IPC   Intermediate progenitor cell 
LGE   Lateral ganglionic eminence 
M  Mol per liter 
mA  Milliampere 
MEF  Mouse embryonic fibroblast 
MEF2   Myocyte enhancer factor 2 
MGE   Medial ganglionic eminence 
mM  Millimol per liter 
MP   Medial pallium 
mRNA Messenger RNA 
MZ   Marginal zone 
NICD   Intracellular domain of Notch 
NP   Neural precursor 
NS   Neurosphere 
P  Postnatal day 
PBS  Phosphate buffered saline 
PFA  Paraformaldehyde 
PH3  Phospho histone H3 
PKD   Protein kinase D 
PMSF   Phenylmethylsulfonyl fluoride (serine protease inhibitor) 
PP   Preplate 
RG   Radial glia 
19 
 
RIPA   Radio immunoprecipitation assay 
Rpm   Rounds per minute 
RT   Room temperature 
RT-PCR Reverse transcription polymerase chain reaction 
SAHA  Suberoylanilide hydroxamic acid (Vorinostat) 
SDS  Sodium dodecyl sulfate 
shRNA Short hairpin RNA 
SP   Subplate 
SVZ   Subventricular zone 
TBS  Tris buffered saline 
TBST  Tris buffered saline /Tween-20 
TRC   The RNA consortium 
TSA   Trichostatin A 
V  Volt 
VPA   Valproic acid 
VZ   Ventricular zone 
 
20 
 
Kathrin Weißmüller, 2013   1  Introduction 
21 
 
1 Introduction 
The central nervous system (CNS) of mammals is composed of the brain and the spinal 
cord. It is responsible for processing and distributing information, as well as for 
coordinating and maintaining vital functions of the organism.  
The development of the nervous system in mammals is a complex and tightly regulated 
procedure where several processes need to be adjusted to each other and have to take 
place in a coordinated manner. Expression of relevant genes has to occur in a 
coordinated manner. Relevant genes must be expressed in a temporally and spatially 
regulated pattern in order to ensure correct development, positioning and differentiation 
of all the cell types of the nervous system. Epigenetic factors are crucial for the 
regulation of gene expression providing various possibilities to regulate developmental 
processes. 
1.1 Development of the nervous system  
Development of the nervous system begins with neural induction, based on inhibition of 
BMP signals in the ectoderm. Neurulation is induced by signals from the notochord 
ventral of the neural plate and gives rise to the neural folds and eventually neural tube. 
The neural tube is patterned along the anterior-posterior axis of the embryo, which leads 
to establishment of distinct regions with a specific fate: the prosencephalon or forebrain 
(telencephalon and diencephalon), mesencephalon (midbrain) and rhombencephalon 
(hindbrain).  
The cerebral cortex arises from the dorsal telencephalic neuroepithelium (Bayer 1991). 
The striatum develops from the ganglionic eminences which are located ventrally in the 
telencephalic vesicle (Smart 1979).  
1.1.1 Cortical neurogenesis 
The cerebral cortex is the area of consciousness and cognitive functions in the 
mammalian brain. It is the most complex structure of the central nervous system and 
1  Introduction   Kathrin Weißmüller, 2013 
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comprises a large variety of cells organized in a spatially and temporally precisely 
regulated manner.  
Neurons in the neocortex are born by proliferating radial glia cells (Anthony et al 2004, 
Hartfuss et al 2001, Malatesta et al 2003, Malatesta et al 2000), either directly generated 
in asymmetric divisions in the ventricular zone or deriving from symmetrically-dividing 
basal progenitors in the subventricular zone (Figure 1.1).  
 
Figure 1.1. Neurogenesis in the embryonic brain. Neurons are born directly from 
asymmetric cell divisions of radial glia in the ventricular zone of the developing neocortex. 
These also give rise to intermediate progenitor cells (nIPCs) in the subventricularzone 
which then divide symmetrically into new neurons, which is considered the indirect mode 
of neurogenesis. Later in development, radial glia generate macroglial cells (astrocytes and 
oligodendrocytes) (Kriegstein & Alvarez-Buylla 2009) 
The intermediate or basal progenitors (IPs) are also derived from radial glial cells 
(Haubensak et al. 2004; Miyata et al. 2004; Noctor et al. 2004). Most of them only 
divide once, generating 2 neuronal daughter cells, only few IPs undergo up to 3 rounds 
Kathrin Weißmüller, 2013   1  Introduction 
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of proliferation and thereby amplify the output of certain neuron types at specific stages 
of cortical development (Haubensak, Attardo et al. 2004; Miyata, Kawaguchi et al. 
2004; Noctor, Martinez-Cerdeno et al. 2004). 
Radial glia and IPs differ in their profile of transcription factor expression. Radial glia 
express Pax6, which has been shown to be a marker for their neurogenic potential (Gotz 
et al. 1998; Heins et al. 2002) and Hes family transcription factors (Englund et al 2005, 
Ohtsuka et al 2001). Intermediate precursors in contrast express, among others, Tbr2, 
which is considered to be a specific marker for this population (Englund et al 2005), 
Cux1 and Cux2 (Nieto et al 2004), Ngn2 (Miyata et al 2004), Svet1 (Tarabykin et al 
2001) and Insm1 (Farkas et al. 2008). Projection neurons in the cerebral cortex are 
pyramidal neurons which use glutamate as their transmitter. They send axonal 
projections to cortical, subcortical and subcerebral targets.  
In the adult, cortical neurons are arranged in 6 clearly distinguishable layers (Figure 
1.2). The layers are generated in an inside-out manner with the inner cortical layers 
generated first, whereas the neurons of the outer layers are born later and migrate 
through the previously formed layers to their final locations (Nowakowski et al 2002, 
Rakic 1974). 
At around Embyronic day (E) 11.5 in mouse, progenitors assume radial glia 
morphology. In asymmetric division they generate neurons, which migrate to the mantle 
layers guided by radial glia. The first projection neurons settle within the preplate to 
form the nascent cortical plate, which will subsequently become layers 2 to 6 of the 
neocortex. Additional incoming cortical plate neurons then split the preplate into the 
marginal zone and the subplate. Migration of newborn neurons into the cortical plate 
occurs in an inside-first, outside-last manner; early-born neurons form the deep layers, 
whereas later-born neurons migrate past older neurons to form the more superficial 
layers. The cells of the individual cortical layers display discrete molecular and 
functional properties (Arlotta et al 2005, Hevner 2006, Hevner et al 2003). 
At the end of neurogenesis, around E17.5, neural precursor cells become gliogenic, 
generating cortical and subependymal zone astrocytes and giving rise to a layer of 
ependymal cells (Kwan et al. 2012). 
1  Introduction   Kathrin Weißmüller, 2013 
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Figure 1.2. Generation of projection neurons in developing mouse cortex in an inside-
out-mode. The preplate consists of early born neurons and is divided into marginal zone 
and subplate. The cortical plate develops between these two layers and generates most 
layers of the neocortex. Different subtypes of projection neurons are born at different times 
in cortical development (Molyneaux et al 2007). 
1.1.2 Striatal neurogenesis 
The mature striatum shows variability between adults of different mammalian species, 
however, the initial development of the structure is similar. It develops from the 
ganglionic eminences (GE) which are situated in the ventral telencephalon. The 
ganglionic eminences are morphologically divided into the lateral ganglionic eminence 
(LGE) and the medial ganglionic eminence (MGE). 
Kathrin Weißmüller, 2013   1  Introduction 
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The MGE develops earlier and generates cholinergic interneurons of the striatum, 
pallidum and basal forebrain (Olsson et al. 1998; Marin et al. 2000). Most striatal 
interneurons migrate tangentially from the MGE or adjacent preoptic/anterior 
entopeduncular areas and express the NKX2.1 homeodomain protein (Marin, Anderson 
et al. 2000). 
Neurogenesis in the ventral neuroepithelium takes place in the ventricular and the 
subventricular zone (Halliday and Cepko 1992) (Figure 1.3). 
 
Figure 1.3. Coronal hemisections of E12.5 mouse telencephalon illustrating areas of 
neurogenesis in the ventral telencephalon. Progenitor cells migrate radially and 
tangentially from these areas populating their target areas. MGE/LGE: medial/lateral 
ganglionic eminence; MP: medial pallium; DP: dorsal pallium; LP: lateral pallium; VP: 
ventral pallium (Olsson et al 1998) 
Neuroepithelial cells divide asymmetrically into one neuroblast and another 
neuroepithelial cell. Neuroblasts exit the cell cycle and migrate laterally into the mantle 
zone to undergo terminal differentiation. LGE and MGE cells migrate along different 
routes to populate distinct regions in the developing brain.  
Early in development neurons born in the MGE migrate dorsally and invade the 
developing neocortex through the neocortical subventricular zone. They differentiate 
into the transient subpial granule neurons in the marginal zone and into a stable 
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population of GABA-, parvalbumin- or somatostatin-expressing interneurons 
throughout the cortical plate (Anderson et al 2001, Wichterle et al 2001). 
Later in neurogenesis, LGE-derived cells also migrate into the cortex, mainly through 
the subventricular zone. Some of these LGE-derived cells invade the cortical plate and 
express GABA, while others remain within the cortical proliferative zone and appear to 
become mitotically active late in gestation (Anderson et al 2001). LGE neurons also 
migrate ventrally and anteriorly, and give rise to the projecting medium spiny neurons 
in the striatum, nucleus accumbens and olfactory tubercle, and to granule and 
periglomerular cells in the olfactory bulb (Wichterle et al 2001).  
Radial glia also contribute to neurogenesis is the ganglionic eminences (Anthony et al 
2004). Taken together, striatal neurogenesis is crucial not only for the proper 
functioning of the basal ganglia, but also of the cerebral cortex.  
1.1.3 Differentiation in cortex and GE 
The generation of new neurons and macroglial cells (astrocytes and oligodendryocytes) 
by progenitor cells in the developing vertebrate central nervous system requires a 
number of precisely orchestrated steps. As stated before, the neurogenic regions in 
cortex and GE differ in their expression of transcription factors and proneural genes. 
This reflects the specificity of neurogenesis in both regions.  
Progenitors undergo a last cell division and become committed to their post-mitotic fate 
(Edlund & Jessell 1999). This process is influenced by various transcription factors 
leading to regional and time-specific differentiation. Post-mitotic neurons migrate out of 
the neurogenic regions along specific routes and begin to differentiate (reviewed in 
(Edlund & Jessell 1999, Marin et al 2010)). Proneural transcription factors of the bHLH 
family are expressed in proliferating progenitors and play an important role regulating 
the neurogenic differentiation program (Bertrand et al 2002, Powell & Jarman 2008).  
Pax6 and Ngn2 are expressed in the dorsal telencephalon and contribute to a cortical 
differentiation program. Markers for this differentiation are, among others, the 
transcription factors Math2/3, NeuroD1/2, and Tbr1/2. In the ventral telencephalon 
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Mash1 and Nkx2.1 are expressed, steering differentiation towards a striatal pattern 
marked by the expression of the homeobox genes Dlx1/2, Dlx5/6, and Gsh1/2 
(Guillemot et al. 2006).  
1.1.4 Gliogenesis 
There are three types of glial cells in the central nervous system: astrocytes, 
oligodendrocytes and microglia. Astrocytes and oligodendrocytes are also referred to as 
macroglia, both deriving from radial glia precursor cells in development. Microglia, the 
smallest glial cells have a different origin. They are generated by macrophages outside 
the nervous system.  
Astrocytes have a distinct asterisk-like morphology, hence the name. Their processes 
have broad end-feet. Astrocytes provide structural and metabolic support to neurons. 
The cell body of oligodendrocytes is comparatively small; their processes however are 
extensive and form myelin sheaths around axons. 
In mammals, macroglial cells are generated by the same precursors as neurons: radial 
glia. They are first born late in gestation and until after the birth of the animal (Bayer 
1991). During neurogenesis, astrogliogenesis is actively repressed by the proneural 
bHLH transcription factors Ngn2 and Mash1 whose expression is induced by 
neurogenic factors such as BMPs (Tomita et al. 2000; Nieto et al. 2001). 
It is not completely understood how the precursor cell population switches from a 
neurogenic to a gliogenic programme. Several pathways are known to promote 
gliogenesis. Notch signaling (Gaiano and Fishell 2002), as well as JAK/STAT signaling 
(Bhat 1995; Bonni et al. 1997; Barnabe-Heider et al. 2005) are known to induce 
gliogenesis. Both leukemia inhibitory factor (LIF) and ciliary neurotrophic factor 
(CNTF) activate the JAK/STAT pathway. Upon activation of the JAK/STAT pathway, 
Stat proteins are phosphorylated and recruited by transcription factors. The Stat 
complex is then targeted to promoters of genes involved in gliogenesis. 
Another signaling cascade involved in astrogliogenesis is the bone morphogenetic 
protein (BMP) pathway (Bonaguidi et al 2005, Gross et al 1996)). BMPs activate the 
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Smad1/5/8 pathway. They also induce the transcription factors Hes5, Id1 and Id3 which 
antagonize the pro-neurogenic activity of Ngn1 (Nakashima et al 2001). All signaling 
pathways involved act upon the promoter of glial fibrillary acidic protein (GFAP) 
(Nakashima et al. 1999) (Figure 1.4). 
 
Figure 1.4. Signaling pathways and transcription factors involved in gliogenesis 
(adapted from (He & Sun 2007)) 
Just as neurons and astrocytes, oligodendrocytes are generated by multipotent precursor 
cells throughout the CNS (Casper & McCarthy 2006, Fogarty et al 2005). In ventral 
telencephalon the Dlx homeobox transcription factors Dlx1 and Dlx2 were found to 
suppress the generation of Olig2-dependent oliodendrocytes (Petryniak et al 2007) 
The first cortical oligodendrocytes are born from Nkx2.1-expressing precursor cells in 
the ventricular zone of the MGE (Spassky et al 1998, Tekki-Kessaris et al 2001). They 
can be detected in cortex around E16. The second population is derived from cells in the 
LGE and migrates dorsally into the cortex (Kessaris et al. 2006). The third population of 
cortical oligodendrocytes arises within the cortex itself, the cells are detected around 
embryonic day 18 and are derived from Emx1-positive precursors (Gorski et al. 2002; 
Kessaris, Fogarty et al. 2006). These cells, in contrast to the ventrally derived ones, 
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persist until after birth and therefore provide for the majority of cortical 
oligodendrocytes.  
It could be shown that neural progenitors not only generate neurons and microglia in the 
developing brain, but retain properties of neural stem cells in the postnatal brain 
(Alvarez-Buylla et al 1990, Doetsch et al 1999). 
1.2 Neurosphere cultures as a model system 
To determine the influence of histone deacetylases on neuro- and gliogenesis in vitro, 
neurosphere cultures were chosen as a model system to generate a uniform population 
of precursors which can generate neurons and microglia. Neurospheres are derived from 
neural stem and progenitor cells from the adult or fetal central nervous system or 
embryonic stem (ES) cells (Gritti et al. 1996; Tropepe et al. 1999; Tropepe et al. 2001). 
We used a protocol described by Reynolds and Weiss (Gritti et al 2001, Reynolds & 
Weiss 1992, Reynolds & Weiss 1996). The cells are derived from medial and lateral 
ganglionic eminences, dissociated to a single cell suspension and plated in medium 
supplemented with B27, fibroblast growth factor 2 (FGF2) and epidermal growth factor 
(EGF) (Vescovi et al 1993). The cells continue to proliferate in culture and form non-
adherent spherical clusters of cells which are able to generate the major cell types of the 
CNS. They provide a powerful tool to analyze differentiation and lineages. 
 The neurosphere culture system is sensitive to small deviations in the culturing 
methods. Variations in cell density for instance alter the microenvironment in the 
cultures, affecting proliferation capacity and positional cues (Hack et al. 2004). 
Concentrations of the factors in the media and dissociation of the spheres before 
differentiation influence neurosphere composition and properties of the cells. 
One must be aware of those factors capable of causing subtle or pronounced changes in 
the cultures when comparing data generated with different protocols in different groups. 
The neurosphere culture does not completely reflect the situation of the progenitor cells 
in vivo. It could be shown that telencephalic transcription factors are downregulated 
upon treatment with growth factors EGF and FGF2 (Hack et al. 2004). 
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1.3 Chromatin Modification 
1.3.1 General aspects of chromatin modification 
The modification of chromatin is a central aspect of the regulation of gene transcription 
in eukaryotic cells. DNA is wound around histone cores in the nucleus and can assume 
different grades of compaction. Epigenetic modifications influence condensation 
patterns of the chromatin and thereby change accessibility of the DNA for transcription 
factors. There is increasing evidence that genes involved in brain development are not 
only regulated via transcription factors but are subject to regulation on an epigenetic 
level (Jenuwein and Allis 2001). 
Robin Holliday defined epigenetics as "the study of the mechanisms of temporal and 
spatial control of gene activity during the development   of   complex   organisms”  
(Holliday 1990), which includes everything but the DNA sequence itself that can 
influence the development of an organism. Later on, other definitions were proposed; a 
recent one was put forward during a 2008 Cold Spring Harbour meeting. It defines 
epigenetics as a "stably heritable phenotype resulting from changes in a chromosome 
without alterations in the DNA sequence" (Berger et al 2009). Epigenetic modifications 
do not change the DNA sequence, but can modify activity of certain genes, either by 
modifications to the DNA or to nucleosomal proteins. These processes are summarized 
as chromatin remodeling. Epigenetic changes are preserved when cells divide; in the 
case of gene inactivation they can be even transferred to the next generation (Chandler 
2007).  
Eukaryotic DNA is packaged with the help of histones, small basic proteins. The basic 
unit of packaging is called nucleosome. It consists of a disc-like structure containing 2 
copies of each core histone H2A, H2B, H3 and H4 and 147 bp of DNA wrapped around 
the histone core almost two times (Figure 1.5). Histones consist of a globular domain 
and a charged NH2-terminus protruding from the nucleosome. Linker histones H1 and 
H5 bind to the nucleosomes and the linker DNA (20-80 nucleotides) between the 
nucleosomes. The structure formed by DNA wrapped around histone cores interspersed 
with linkers, resembling beads on a string, constitutes the 10 nm fiber. Further 
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compaction arranges the nucleosomes in a helical way in close contact forming the 30 
nm fiber. 
The binding of DNA and histones is achieved through ionic bonds between basic 
residues in the histones and the acidic sugar-phosphate backbone of the DNA (Luger et 
al 1997). 
 
Figure 1.5. Nucleosome consisting of two 
copies of each core histone H4, H3, H2B and 
H2A and 147 bp of DNA wrapped around 
this core. The N-termini of the histones are the 
most important sites for histone modifications. 
Chromatin remodeling is accomplished through two major mechanisms. Firstly, DNA is 
methylated, mostly at CpG sites, converting cytosine to 5-methylcytosine. Highly 
methylated areas of the genome were found to be less transcribed. Methylation is also 
involved in genetic imprinting where alleles are silenced in the germline and genes are 
therefore expressed only from the non-imprinted allele received from one parent.  
The second mechanism of chromatin remodeling is actually an array of different 
posttranslational modifications to the histone proteins. The best known modifications 
include acetylation, methylation, ubiquitylation, phosphorylation and sumoylation 
(Figure 1.6). Histone modifications can be found throughout the protein sequence, 
however the N-termini of the histones are most frequently modified.  
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Figure 1.6. Specific sites of histone modifications in the amino-termini of core 
histones. Histone tails can be subjected to a large number of posttranslational 
modifications. Acetylation, methylation and phosphorylation are probably the most 
commonly known ones. 
It was proposed by Jenuwein and Allis (2001) that different combinations of chromatin 
modifications constitute a code extending the amount of information stored in the 
genetic sequence and providing a mechanism important for gene regulation, DNA 
repair, mitosis and meiosis and on a larger scale for the regulation of cell fate and 
development.  
Acetylation and deacetylation occur on lysine residues in the N-terminal tails of 
histones. Histone acetyltransferases (HATs) add acetyl groups to the –amino groups of 
lysine moieties, histone deacetylases (HDACs) remove these residues (Figure 1.7). Both 
processes are highly regulated.  
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Figure 1.7. Histone acetylation and deacetylation alters the structure of the chromatin. 
Addition of acetyl groups to the histone tails decreases the binding affinity between 
histones and DNA 
The acetyl-group is derived from Acetyl-Coenzyme A and is transferred to Coenzyme 
A (Figure 1.8). Already in 1964, Allfrey et al. found histone acetylation to be related to 
transcription (Allfrey et al 1964). Specific sites of acetylation are associated with 
transcriptional activation or silencing. One example is acetylation of lysines 9 and 14 
(K9 and K14) in histone H3 which is correlated with transcriptional activity. 
 
Figure 1.8. Acetylation of lysine residues in histone tails is carried out by histone 
acetyltransferases (HATs) using acetyl-CoA as the donor of the acetyl moiety. Acetyl 
groups are removed by histone deacetylases (HDACs). 
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Lysine has a positively charged nitrogen atom at the end of the residue, which facilitates 
binding with the negatively charged phosphates in the backbone of DNA. Acetylation 
replaces the positive charge with a neutral amide moiety, which loosens the DNA from 
the histone core (Grunstein 1997, McGhee & Felsenfeld 1980). It was believed that 
acetylation therefore always opens the tightly packed chromatin structure and facilitates 
transcription (Cheung et al 2000), enabling transcription factors to bind more easily to 
the DNA (cis), but this was found not always to be the case (Berger 2007). Acetylation 
can also create a new binding site for chromatin modifying enzymes which can 
themselves act on the state of the chromatin (trans).  
Along the same lines, hypoacetylation of histones was found to correlate closely with 
gene silencing (Lee & Workman 2007). 
There are both nuclear and cytoplasmic HATs. The cytoplasmic enzymes acetylate 
histones before nuclear import and assembly of chromatin. Nuclear HATs acetylate 
histones after the assembly of chromatin and thereby influence chromatin-based 
processes such as gene transcription.  
1.3.2  Classes of mammalian histone deacetylases 
Histone deacetylases are a large family of enzymes present in both prokaryotes and 
eukaryotes. In mammals 11 HDAC genes with a highly conserved deacetylase domain 
are found and categorized as the classical HDACs. Those are grouped in four classes, 
class I, class IIa, class IIb and class IV (Figure 1.9). Another family, the Sir2 (silent 
information regulator)-like family of NAD+-dependent deacetylases or in brief sirtuins, 
are also referred to as class III HDACs. They differ in their structure and mechanism of 
deacetylation from the classical HDACs. Also, the classical HDACs differ in their 
structure, subcellular localization and expression pattern as well as their enzymatic 
function and activity. HDACs deacetylate their substrate by activating a water molecule 
via a divalent zinc ion coupled to a histidine-aspartate charge-relay system (Finnin et al 
1999), whereas sirtuins use a different, NAD+-dependent mechanism. 
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Figure 1.9. Mammalian classes of HDACs. There are four classes of classic HDACs in 
mammals that can be distinguished by their sequence and domain structure. Modified from 
(Haberland et al 2009). 
1.3.2.1 Class I HDACs 
Class I consists of HDAC1, -2, -3 and -8. These HDACs localize to the nucleus where 
HDAC1, -2 and -3 were found to be parts of large transcriptional repressor complexes. 
HDAC1 and -2 for instance are part of the Co-REST complex which inactivates the 
expression of neuronal genes in non-neuronal tissues (Huang et al 1999). HDAC1 also 
associates with the methylCpG-binding protein MeCP2, providing a functional link 
between DNA methylation and histone modification (Tucker 2001). Class I HDACs are 
ubiquitously expressed in many tissues.  
1.3.2.2 Class IIa HDACs 
HDAC class IIa consists of HDAC4, -5, -7 and -9. These enzymes have a large N-
terminal domain with 3-4 binding sites for 14-3-3 proteins which regulates the shuttling 
between nucleus and cytoplasm. Binding of 14-3-3 proteins can, depending on their 
phosphorylation state, either stimulate nuclear export or cytoplasmatic retention. CaM-
kinases (McKinsey et al 2000) as well as several other kinases regulate phosphorylation 
of the 14-3-3 binding sites and thereby influence the subcellular localization. 
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1.3.2.3 Class IIb HDACs 
This class consists of HDAC6 and -10. HDAC6 has two deacetylase domains and a C-
terminal zinc finger domain. It has an important function in the cytoplasm deacetylating 
α-tubulin and Hsp90 (Hubbert et al 2002, Kovacs et al 2005), which regulates cell 
motility and adhesion as well as exhibits chaperone function. The function of HDAC10 
is not well understood. 
1.3.2.4 Class IV HDACs 
Class IV consists of only one enzyme, namely HDAC11. Its expression patterns and 
function are not yet understood.  
1.3.3 Functions of histone deacetylases 
Histone deacetylases do not bind DNA directly. They associate with transcriptional 
activators and repressors and are part of large multiprotein complexes regulating 
transcription (Grunstein 1997, Heinzel et al 1997, Shahbazian & Grunstein 2007). The 
specificity of their activity largely depends on interaction partners in individual cells 
and tissues. Deacetylation of histones in promoters is generally associated with the 
formation of heterochromatin and transcriptional inactivation, yet some genes were 
found to be activated by HDACs (Nusinzon & Horvath 2005).  
Apart from histones, also other proteins in the cytoplasm can be deacetylated by 
HDACs. Inhibition of histone deacetylases has been shown to significantly affect the 
acetylation of various tissue-specific or ubiquitous non-histone proteins such as p53 (Gu 
& Roeder 1997, Juan et al 2000), c-Myb (Tomita et al 2000), PCNA (Naryzhny & Lee 
2004) and -tubulin (Hubbert et al 2002). 
Class IIa HDACs have a very limited deacetylase activity on histones, which might hint 
to a more important function on other, cytoplasmic, substrates (Lahm et al 2007).  
Specific acetylation sites could be found such as lysine 16 of histone H3, which has 
been found to be important for the regulation of chromatin structure (Shogren-Knaak et 
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al 2006). In humans, the loss of H3 lysine 16 acetylation is a hallmark of certain types 
of cancer.  
HDACs of both class I and II have been recently associated with control of neuro- and 
astrogliogenesis. Class I HDACs are believed to act as the main deacetlyases in the 
brain. Class II HDACs bind to class I HDACs and thereby modulate their activity. 
In the brain, HDACs have been shown to be involved in many postnatal functions and 
dysfunctions including the consolidation of memory in the hippocampus (Vecsey et al. 
2007; Miller et al. 2008), epileptic seizures, and depression (Miller et al 2008, Phiel et 
al 2001, Tsankova et al 2006, Vecsey et al 2007). During the development of the 
nervous system, HDACs have been shown to play an important role in neurogenesis in 
motor and retinal neurons in zebrafish (Cunliffe 2004, Yamaguchi et al 2005) and in the 
generation and maturation of oligodendrocytes in the vertebrate brain (Cunliffe & 
Casaccia-Bonnefil 2006, Marin-Husstege et al 2002, Shen et al 2005). 
So far, there is little evidence for the role of HDACs in neurogenesis and 
astrogliogenesis in the developing vertebrate brain. Vega et al. found that Hdac4 null 
mice sometimes show exencephaly (Vega et al 2004b), but no evidence for abnormal 
brain development was found in other gene knockouts of classic HDACs. HDAC1 and 
2 were found to be important for Schwann cell development and myelination. HDAC 
regulated deacetylation of the p65 subunit of NF-κB activates positive regulators of 
Schwann cell development, while at the same time antagonizing inhibitors of their 
differentiation (Chen et al 2011). 
This raises the question of functional redundancy because of the large number of HDAC 
family members being expressed in the developing brain (Shen et al 2005). However, 
studies hint to a rather specific cellular expression pattern and function of individual 
HDACs (MacDonald & Roskams 2008). 
1.3.4 Class IIa HDAC transgenic mice  
In contrast to the ubiquitously expressed class I HDACs, histone deacetylases of class 
IIa exhibit more restricted expression patterns. The in vivo-apporach of this study is 
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focused on HDAC4 and HDAC5, which were found to be expressed in human brain in 
comparatively high levels (Grozinger et al 1999). 
Class II HDACs are comparatively larger than class I HDAC proteins. They do not only 
consist of the deacetylase domain, but have large aminoterminal domains containing 
binding sites for myocyte enhancer factor 2 (MEF2), a transcription factor and the 
chaperone protein 14-3-3. Several kinases, for instance calcium/calmodulin-dependent 
protein kinase (CaMK) and protein kinase D (PKD), can phosphporylate class II 
HDACs and enable them thereby to bind to 14-3-3, which is followed by nuclear export 
(McKinsey et al 2000, Passier et al 2000, Vega et al 2004a). The phosphorylation of 
class II HDACs and their shuttling between cytoplasm and nucleus appears to be a link 
between cell signaling and gene transcription. MEF2 can be rendered from being a 
transcriptional repressor to an activator by dissociating from an HDAC and thereby 
exposing the binding site for the HAT p300 (Lu et al 2000). 
1.3.4.1 HDAC4 transgenic mice 
HDAC4 was shown to be expressed in the brain and growth plates of the skeleton (Vega 
et al 2004b). In this study we examined HDAC4 knockout mice generated by Vega et al 
(Vega et al 2004b). In these mice, HDAC4 expression is abolished because a LacZ-
cassette is knocked into the exon 6 of the HDAC4 gene (see Figure 3.4), resulting in a 
deletion of the MEF2 binding domain, the nuclear localization sequence and the 
complete deacetylase domain. The authors examined skeletogenesis in the mutants and 
found HDAC4 to be crucial for chondrocyte hypertrophy during skeletogenensis. 
HDAC4 was shown to negatively regulate the activity of the Runx2 transcription factor 
and thus influence the Indian hedgehog (Ihh) pathway. Hdac4 null mice did not survive 
to weaning. They were found to be comparatively smaller than wildtype littermates and 
displayed severe skeletal abnormalities, as premature ossification of the skeleton led to 
growth retardation (Figure 1.10). The postnatal phenotype of the brain of the HDAC4 
mutant mice included a 40% reduction in brain size compared to wildtype. Both 
hemispheres as well as the cerebellum were reduced in size as seen in Figure 1.11 
(Majdzadeh et al 2008). 
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It is not clear whether the observed reduction in brain size is a result of the smaller size 
of the skull due to premature ossification. In order to investigate this, we created a 
mouse line deficient in HDAC4 selectively in neural progenitor cells thus 
circumventing the spatial restriction imposed by the skull morphology of the Hdac4 null 
mouse. 
 
Figure 1.10. Hdac4 null mice have a 
drastically reduced body size compared to 
wildtype littermates. They die within 2 
weeks after birth (Vega et al 2004b) 
In 2008 Majdzadeh et al. were able to demonstrate that HDAC4 activity can be 
protective for cerebellar granule neurons in neurotoxic conditions such as low 
potassium concentrations or 6-hydroxydopamine, which otherwise led to apoptosis. 
This has been ascribed the inhibition of the cell cycle progression through repression of 
cyclin-dependent kinase 1 (CDK1) activity (Majdzadeh et al 2008).  
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Figure 1.11. Brain phenotype of HDAC -/- mice. Brains of HDAC4 null mice are up to 
40% smaller than the ones of wildtype littermates. The lower panel shows cresyl violet-
stained coronal and sagittal sections of wildtype and mutant brain at P0. HDAC4 mutants 
have larger ventricles. The cortex, cerebellum, and olfactory bulb are slightly reduced in 
size 
1.3.4.2 HDAC4 conditional knockout mice 
While conventional full knockout of HDAC4 results in perinatal death, conditional 
knockout models allow for functional studies in specific tissues of post-natal animals. In 
this study, we used conditional knockout mice for HDAC4 in order to study the effect 
of the absence of HDAC4 solely on the CNS, isolated from secondary effects which 
might derive from the abnormally sized and shaped skeleton and skull of HDAC4 null 
mice. The mouse line was generated by Potthoff and colleagues (Potthoff et al 2007). 
For their studies, Potthoff et al have generated a conditional knockout of HDAC4 in the 
skeletal musculature of the mouse. This was achieved by mating mice expressing 
Crerecombinase under the control of the myogenin promoter/MEF2 enhancer (Li et al. 
2005) with mice carrying an HDAC4 allele containing a floxed sixth exon, which if 
excised results in a frame shift rendering the protein dysfunctional. 
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We mated this mouse line bearing the HDAC4 allele containing the loxP sites together 
with a transgenic animal harboring a constitutively expressed Crerecombinase 
controlled by the nestin promoter (Tronche et al 1999). This enabled us to selectively 
knock out HDAC4 in the whole developing nervous system, more specifically: in neural 
progenitor cells and their progeny (see Figure 3.3). 
1.3.4.3 HDAC5 mutant mice 
HDAC5 and HDAC9 are highly enriched in muscle, heart and CNS (Chang 2004) as 
well as of HDAC9 (Zhang et al 2002), which like several other HDACs interact with 
the MEF2 transcription factor, results in a hypermyotrophic response upon cardiac 
stress, proving these proteins to be crucial for heart development. 
Although HDAC5 shows a very high sequence homology with HDAC4, whose 
complete knockout leads to perinatal death, HDAC5 null mice are viable and fertile 
(Chang 2004). As HDAC5 is strongly expressed in the brain, it is not surprising that 
knockout leads to neurological abnormalities such as a hypersensitivity to chronic stress 
(Renthal et al 2007) and memory impairment (Agis-Balboa et al 2013). 
In this study we employed mice generated by Chang and colleagues, in which HDAC5 
is knocked out by inserting a LacZ expression cassette into the gene (Figure 3.5). X-Gal 
staining visualizes the expression of HDAC5 in the embryo, which can be detected in 
brain and spinal cord already at 10.5 dpc (Figure 1.12).  
 
 
Figure 1.12. HDAC5 expression in embryos visualized by X-Gal staining. HDAC5 is 
highly expressed in the heart and CNS, expression in CNS can be detected already at E10.5 
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1.3.5 HDAC inhibitors 
Apart from the use HDAC inhibitors serve in laboratory assays for the elucidation of 
HDAC function, they have long proven their therapeutical value for a wide range of 
ailments. Their most prominent are of use are the treatments of cancer (Drummond et al 
2005) and epilepsy (Urdinguio et al 2009). 
Recently, more and more clinical applications have emerged, such as treatment of 
psychological trauma or enhancers of cognitive functions (Graff & Tsai 2013) and 
medication of neurodegenerative disorders (Graff & Mansuy 2009).  
HDAC inhibitors can be classified into six structurally distinct compound groups. They 
act by differential binding to the deacetylase domains of class I and II HDACs. The 
relatively weak HDACi group of the carboxylates includes the widely used sodium 
butyrate and valproic acid, which selectively inhibit class I HDACs.  
Compounds of the hydroxamic acid type include trichostatin A (TSA) and 
subericbishydroxamic acid (SAHA). Benzamide-class inhibitors such as MS-275, which 
target class I HDACs (in particular HDACs 1 and 3) are usually weaker in their effect 
than hydroxamate or cyclic peptide HDACis.  
Trapoxin B and HC-toxin, among others, are members of the epoxyketone-based 
HDACis. Their mechanism of action is not fully understood, but both the ketone as well 
as the epoxy-group are necessary for the compounds to effectively inhibit HDACs 
(Shute et al 1987). 
Pure cyclic peptide HDACis such as apicidin act via the reversible binding of their 
macrocyclic peptide structure to the entrance of the catalytic pit (Miller et al 2003).
Kathrin Weißmüller, 2013   2  Aim of this study 
43 
 
2 Aim of this study 
In this project the role of HDACs in the generation of neurons and astrocytes in 
embryonic mouse brain was under investigation. It was shown that in differentiating 
neural progenitor cells many different HDACs are expressed (Shaked et al 2008). To 
investigate their function in neural development, pharmacological inhibitors of HDACs 
were applied.  
Inhibition of class I and II HDACs with trichostatin A in cultures of in vitro-
differentiating neural precursors from the examined brain regions leads to a 
considerable reduction in neurogenesis in the ganglionic eminences but to a slight 
increase in the cortex. While neurogenesis decreases in cultures from the GE, there is a 
concomitant increase in the production of immature astrocytes. 
The aim of this project was to investigate which HDACs are responsible for this 
phenomenon and to dissect through which signaling pathway HDACs influence neuro- 
and gliogenesis.  
Firstly, the expression of candidate genes which might be involved in controlling 
neurogenesis was examined through real-time RT-PCR. As the BMP2/4 signaling 
pathway had been implicated in the HDAC-mediated control of neurogenesis, genes 
encoding the corresponding growth factors, receptors, and downstream signaling 
proteins were examined. This was further complemented by a microarray analysis in 
collaboration with Dr. Catharina Scholl.  
Secondly, in order to ascertain which HDAC family members are involved in this 
phenomenon, RNA interference was used to inhibit the expression of individual HDAC 
genes. shRNA against several class I and II HDACs was generated and expressed in 
neural precursor cultures via lentiviral vectors. 5 different shRNA oligos were generated 
against each HDAC, which were then tested for knockdown efficiency and potential 
cross-reaction with other, non-target HDACs.  
Since recently generated knockout mouse models of individual HDAC genes have 
shown this family of enzymes to have highly specific roles in development and in adult 
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organisms, I also wanted to investigate the role of HDACs in neuro- and gliogenesis in 
vivo. The mutant mice provide a powerful tool for this experimental question. The class 
II family members HDAC4 and -5 show high expression levels in brain tissue, therefore 
we chose to investigate mutant animals deficient in these enzymes for brain 
development and morphology.  
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3 Materials and Methods 
3.1 Materials 
3.1.1 Basic Reagents 
 
Acetone Zentrallager INF 367 (Heidelberg, 
Germany) 
Acrylamide/Bisacrylamide, 30% (w/v) BioRad (München, Germany) 
Agar Merck (Darmstadt, Germany) 
Agarose (elctrophoresis grade) Roth (Karlsruhe, Germany) 
Ampicillin Sigma-Aldrich (St. Louis, USA) 
Aquatex Mounting Medium Merck (Darmstadt, Germany) 
APS Roth (Karlsruhe, Germany) 
ß-Mercaptoethanol Sigma-Aldrich (St. Louis, USA) 
Boric acid AppliChem (Darmstadt, Germany) 
Bovine serum albumine (BSA) Roth (Karlsruhe, Germany) 
Bromphenol blue 4F057 Division Chroma (Münster, Germany) 
CHAPS Fluka (Buchs, Switzerland) 
Citric acid Sigma-Aldrich (St. Louis, USA) 
Chloroform Fluka (Buchs, Switzerland) 
Coomasie R 250 Serva (Heidelberg, Germany) 
DAB Sigma-Aldrich (St. Louis, USA) 
DMSO Acros Organics (Geel, Belgium) 
DNA Polymerase DreamTaq Fermentas (Waltham, USA) 
DNA Polymerase DreamTaq Mastermix Fermentas (Waltham, USA) 
DTT AppliChem (Darmstadt, Germany) 
EDTA AppliChem (Darmstadt, Germany) 
Entellan Merck (Darmstadt, Germany) 
Ethanol absolut puriss.  Sigma-Aldrich (St. Louis, USA) 
Ethidium bromide Fluka (Buchs, Switzerland) 
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Formaldehyde, 40% (w/v) Carlo Erba Reagents (Arese, Italy) 
Glacial acetic acid Sigma-Aldrich (St. Louis, USA) 
Glutaraldehyde (25% solution) Merck (Darmstadt, Germany) 
Glycerol Sigma-Aldrich (St. Louis, USA) 
Glycine Sigma-Aldrich (St. Louis, USA) 
ImmEdge Pen Vector Laboratories (Burlingame, USA) 
Kanamycin Sigma-Aldrich (St. Louis, USA) 
Methanol Merck (Darmstadt, Germany) 
Methylene blue Merck (Darmstadt, Germany) 
Milk powder Roth (Karlsruhe, Germany) 
MOPS Sigma-Aldrich (St. Louis, USA) 
Nitric acid Mallinckrodt Baker B.V. (Deventer, 
Netherlands) 
NP-40 Fluka (Buchs, Switzerland) 
Paraformaldehyde Sigma-Aldrich  (St. Louis, USA)  
Phenol/Chloroform/Isoamylalcohol,  
pH 7.5-8.0 
Roth (Karlsruhe, Germany) 
PMSF Sigma-Aldrich (St. Louis, USA) 
2-Propanol AppliChem (Darmstadt, Germany) 
Protease inhibitor tablets,  
Complete, EDTA-free 
Roche (Penzberg, Germany) 
Proteinase K Roth (Karlsruhe, Germany) 
Oligo(dT)12 – 18 primer Invitrogen (Carlsbad, USA) 
Orange G Sigma-Aldrich (St. Louis, USA) 
Random hexamer primer Applied Biosystems (Darmstadt, 
Germany) 
Sodium chloride Sigma-Aldrich (St. Louis, USA) 
Sodium citrate dihydrate Sigma-Aldrich (St. Louis, USA) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg, Germany) 
Sodium dihydrogen phosphate 
 NaH2PO4*H2O 
AppliChem (Darmstadt, Germany) 
Disodium hydrogen phosphate AppliChem (Darmstadt, Germany) 
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 Na2HPO4*2H2O 
Sodium tetraborate decahydrate Sigma-Aldrich (St. Louis, USA) 
Sucrose Sigma-Aldrich (St. Louis, USA) 
TEMED Sigma-Aldrich (St. Louis, USA) 
Tissue freezing medium Jung (Nussloch, Germany) 
Trichostatin A Sigma-Aldrich (St. Louis, USA) 
Tris Roth (Karlsruhe, Germany) 
Tris ultrapure Applichem (Darmstadt, Germany) 
Triton X-100 Merck (Darmstadt, Germany) 
Trypan blue Sigma-Aldrich (St. Louis, USA) 
Tween-20 Roth (Karlsruhe, Germany) 
Xylene cyanol Sigma-Aldrich (St. Louis, USA) 
Xylol AppliChem (Darmstadt, Germany) 
3.1.2 Cell culture Reagents 
 
B27 Supplement Invitrogen (Carlsbad, USA) 
Boric Acid J. T. Baker (Deventer, Netherlands) 
Brefeldin A Sigma-Aldrich (St. Louis, USA) 
Cycloheximide Sigma-Aldrich (St. Louis, USA) 
DMEM Gibco (Carlsbad, USA) 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich (St. Louis, USA) 
D-PBS Invitrogen (Carlsbad, USA) 
Foetal Bovine Serum Invitrogen (Carlsbad, USA) 
Ham’s  F12 Medium Sigma-Aldrich (St. Louis, USA) 
HBSS Invitrogen (Carlsbad, USA) 
Human FGF2 Roche or R&D Systems 
Human recombinant EGF Sigma-Aldrich (St. Louis, USA) 
L-Glutamine 100X (200 mM) Gibco (Calsbad, USA) 
OptiMem Invitrogen (Carlsbad, USA) 
Papain 10 U/mg, lyophilized powder Sigma-Aldrich (St. Louis, USA) 
Penicillin-Streptomycin, 100X  Gibco (Carlsbad, USA) 
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Poly-DL-ornithine hydrobromide Sigma-Aldrich (St. Louis, USA) 
Polyethyleneimine Sigma-Aldrich (St. Louis, USA) 
Poly-L-lysine hydrobromide Sigma-Aldrich (St. Louis, USA) 
Saponin  Sigma-Aldrich (St. Louis, USA) 
Trypsin-EDTA Gibco (Carlsbad, USA) 
Versene Invitrogen (Carlsbad, USA) 
3.1.3 Buffer, media and solutions 
3.1.3.1 Cell culture 
 
hFGF2 5 µg/ml in DMEM, 5% (v/v) FCS 
hEGF 20 µg/ml in DMEM/F12 
5x poly-DL-ornithine 500 mg/l in 150 mM H3BO3, pH 8.3 
(use 100 mg/l diluted in D-PBS) 
10x poly-L-lysine 
 
10 mg/ml in H2O, sterile-filtered, use 
1mg/ml für FACS, otherwise 0.1 mg/ml, 
wash 3x with D-PBS 
Trypsin-Papain 0.25% (w/v) trypsin-EDTA, 2.5 U/ml 
papain 
2x Cryomedium 48.75% (v/v) DMEM, 31.25% (v/v) FCS, 
20% (v/v) DMSO, filter-sterilize and keep 
at –20 °C 
FCS Inactivated for 1 h at 57 °C, stored at –20 
°C 
MEF-Medium DMEM, 1 U/ml P/S, 2 mM glutamine, 
10% (v/v) FCS 
Neurosphere (NS) medium 50%  (v/v)  DMEM,  50%  (v/v)  Ham’s  F12 
NS growth medium NS medium, 1 U/ml P/S, 2 mM glutamine, 
10 ng/ml hFGF2, 20 ng/ml hEGF, 2% 
(v/v) B27 
NS differentiation medium w/ FGF2 NS medium, 1 U/ml P/S, 2 mM glutamine, 
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10 ng/ml FGF2, 2% (v/v) B27, 1% (v/v) 
FCS 
NS differentiation medium w/o FGF2 NS medium, 1 U/ml P/S, 2 mM glutamine, 
2% (v/v) B27, 1% (v/v) FCS 
Trichostatin A Stock: 100 µg/ml in 8% ethanol, dilute in 
D-PBS, final concentration 10 nM or 50 
nM 
3.1.3.2 FACS Analysis 
 
Papain 1x PBS, 10 U/ml papain, 10% (v/v) FCS 
PF 1x PBS, 2% (v/v) FCS 
PFS 1x PBS, 2% (v/v) FCS, 0.18% saponin 
Trypsin-papain 0.25% (w/v) trypsin-EDTA, 2.5 U/ml papain 
3.1.3.3 Microbiology 
3.1.3.3.1 General Microbiology 
 
LB medium 10 g NaCl, 10 g tryptone, 5 g yeast extract, H2O (pH 
7.5) ad 1 l; autoclave 
LB agar 
 
10 g NaCl (5 g for low-salt), 10 g tryptone, 5 g yeast 
extract, 15 g agar, H2O ad 1 l (pH 7.5); autoclave 
3.1.3.3.2 Plasmid Minipreparation 
 
Resuspension solution 1 
 
H2O, 50 nM glucose, 25 mM Tris-Cl, 10 mM EDTA 
(pH 8.0); autoclave and store at 4 °C 
Lysis solution 2 H2O, 0.2 N NaOH, 1% (w/v) SDS 
Neutralization solution 3 H2O, 3 M KOAc, 5 M glacial acetic acid 
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3.1.3.3.3 Hogness Modified Freezing Medium for Glycerol Stocks 10x (HMFM) 
 
Solution A H2O, 5 mM MgSO4, 20 mM sodium citrate, 85 mM 
(NH4)2SO4, 45% (v/v) glycerol; autoclave 
Solution B H2O, 0.66 M KH2PO4, 1.3 M K2HPO4; autoclave 
Final 10x HMFM Mix solutions A and B in a 4:1 ratio 
Hogness modified freezing medium was used for storage of cultures at –80 °C. A log 
phase culture (OD 660 nm 0.8) was centrifuged to harvest cells. After pouring off the 
medium, cells were resuspended in sterile HMFM and frozen down.  
3.1.3.4 Molecular Biology 
3.1.3.4.1 General Molecular Biology 
 
Orange G buffer H2O, 0.6% (w/v) Orange G, 50% (v/v) glycerol 
Lysis buffer (tail buffer) H2O, 0.1 M Tris-Cl (pH 8.5), 5mM EDTA (pH 8.0), 
0.2% SDS, 0.2 M NaCl, 100 µg/ml Proteinase K 
1x PBS H2O, 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4 (pH 7.3); adjust pH to 7.4 
10x PBS 
 
H2O, 1.4 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 18 
mM KH2PO4; adjust pH to 7.4 
RLN-Buffer H2O DEPC, 50 mM Tris pH 8.0, 140 mM NaCl, 1.5 mM 
MgCl2, 0.5% NP-40; adjust  pH  to  8.0,  autoclave  for  30’ 
50x TAE 
 
H2O, 2 M Tris base, 50 mM EDTA (pH 8.0), 5.71% 
(v/v) glacial acetic acid 
5x TBE H2O, 0.445 M Tris base, 0.451 M H3BO3, 10 mM 
EDTA (pH 8.0) 
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3.1.3.4.2 Denaturing RNA Gel 
3.1.3.4.2.1 Buffers 
 
5x Formaldehyde gel 
 running buffer 
0.1 M MOPS (pH 7), 40 mM sodium acetate, 5 mM 
EDTA (pH 8.0); filter-sterilize (0.2 µm) 
Loading buffer H2O (DEPC), 50% (v/v) glycerol, 1 mM EDTA (pH 
8.0), 0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol FF 
3.1.3.4.2.2 Denaturing RNA-Gel  
 
Agarose / H2O 1.68 g (2.24 g) for 1.5% (2%), H2O ad 70 ml 
37% (w/v) formaldehyde 20 ml 
5x running buffer 22 ml 
Ethidium bromide 3 µl 
Boil agarose, let cool to 60 °C before adding remaining components 
3.1.3.4.3 In situ Hybridization 
3.1.3.4.3.1 Solutions 
 
0.2% (w/v) Glycine in 
1x PBS 
prepare fresh on the day of the in situ hybridization 
 
Proteinase K 20 µg/ml in 1x PBS, prepared fresh 
PBST 1x PBS, 0.1% (v/v) Tween-20 
NTM H2O Milli-Q, 0.1 M Tris-HCl (pH 9.5), 0.1 M NaCl, 0.05 M 
MgCl2 
10x PBS 
 
H2O, 1.37 M NaCl, 0.027M KCl, 0.015M KH2PO4, 0.065M 
Na2HPO4; pH: 7.2 – 7.4 
20x SSC H2O, 3 M NaCl, 0.3 M trisodium citrate; adjust pH to 4.5 
B-Block 1x PBS, 2% (w/v) Boehringer Block, 0.1% (v/v) Tween-20, 
10% (v/v) NGS; dissolve Boehringer Block in Tween/PBS in 
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water bath at 65 °C (or autoclave w/o Tween and add Tween 
afterwards), add serum after cooling; store at –20 °C 
4% PFA Heat 150 ml H2O to 60 °C, add 8 g PFA with 1 ml 2 N NaOH 
and 20 ml 10x PBS, wait for solution to become clear, filter, 
adjust pH to 7.4, add H2O ad 200 ml; store at –20 °C 
4% PFA + 0.2% 
glutaraldehyde 
0.2% glutaraldehyde in 4% (w/v) PFA/PBS; prepare fresh on 
the day of in situ hybridization 
3.1.3.4.3.2 Hybridization Mix (HYBmix) 
 
Formamide 5 ml 
20x SSC (pH 4.5) 2.5 ml 
Boehringer Block 100 mg 
H2O Milli-Q 2 ml 
Dissolve above reagents in water bath at 65 °C, then add the following: 
0.5 M EDTA (pH 8.0) 100 µl 
10% (v/v) Tween 20  100 µl 
10% (w/v) CHAPS 100 µl 
50 mg/ml Heparin 4 µl 
50 mg/ml tRNa 200  µl,  denature  for  5’  at  95  °C  before  adding 
3.1.3.5 Protein biochemistry 
3.1.3.5.1 Protein extraction from tissues and cells 
3.1.3.5.1.1 Protease inhibitors 
 
Inhibitor  Function Stock Final 
concentration 
PMSF Serine protease inhibitor 0.1 M in 2-
propanol 
0.2 mM 
Benzamidine Reversible competitive 
inhibitor of trypsin, 
0.5 M in H2O 5 mM 
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trypsin-like and serine 
proteases 
ε-Aminocaproic 
acid 
Lysine derivative, 
inhibits lysine-binding 
enzymes 
1 M in H2O  1 mM 
Roche Complete, 
Mini, EDTA-free 
Protease Inhibitor 
Cocktail Tablets 
Inhibits serine and 
cysteine proteases 
1 tablet in 2 ml 
of autoclaved 
H2O Milli-Q 
(7x) 
1x 
3.1.3.5.1.2 Buffers 
 
Buffer H 
 
H2O, 20 mM Tris-HCl (pH 7.4), 1 µg/ml leupeptin, 1 
µg/ml aprotinin, 17 µg/ml PMSF; prepare fresh 
5x Laemmli SDS buffer 
 
H2O, 0.125 M Tris-HCl (pH 6.8), 5% (w/v) SDS 
RIPA buffer H2O, 50 mM Tris-HCl, 1 % (v/v) Triton X-100, 1 % (w/v) 
SDS, 150 mM NaCl, 1 mM EDTA, 1% (w/v) DOC, 
autoclave 
2x SDS sample buffer H2O, 100 mM Tris, 25% (v/v) glycerol, 2% (w/v) SDS, 
0.01% (w/v) bromophenol blue; adjust pH to 6.8, add 10% 
(v/v) β-mercaptoethanol 
2x Urea sample buffer H2O Milli-Q, 20% (v/v) glycerol, 8 M urea, 20 mM DTT, 
125 mM Tris-HCl (pH 6.8), 5% (w/v) SDS, 0.01% (w/v) 
bromophenol  blue;;  heat  5’  at  42  °C 
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3.1.3.5.2 Protein PAGE 
3.1.3.5.2.1 Solutions 
 
10% SDS buffer H2O Milli-Q, 10% (w/v) SDS; heat and filter-sterilize 
10x SDS running buffer H2O, 250 mM Tris base, 1.92 M glycine, 1% (w/v) SDS 
1 M Tris buffer pH 6.8 H2O, 1 M Tris, pH 6.8; filter-sterilize 
1.5 M Tris buffer pH 8.8 H2O, 1.5 M Tris, pH 8.8; filter-sterilize 
3.1.3.5.2.2 SDS-Polyacrylamide Gels 
 
12% Separating gel (2 Biorad Mini-PROTEAN gels, 1.5 mm wide) 
8 ml H2O 
6.6 ml 30% acrylamide / 0.8% bisacrylamide  
5 ml 1.5 M Tris pH 8.8 
200 µl 10% SDS 
200 µl 10% APS 
16 µl TEMED 
 
7.5% Separating gel (2 Biorad Mini-PROTEAN gels, 1.5 mm wide) 
9.6 ml H2O 
5 ml 30% acrylamide / 0.8% bisacrylamide  
5 ml 1.5 M Tris pH 8.8 
200 µl 10% SDS 
200 µl 10% APS 
16 µl TEMED 
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5% Stacking gel (2 Biorad Mini-PROTEAN gels, 1.5 mm wide) 
5.4 ml H2O 
1.34 ml 30% acrylamide / 0.8% bisacrylamide 
1 ml 1.5 M Tris pH 8.8 
80 µl 10% SDS 
80 µl 10% APS 
16 µl TEMED 
The gel solutions were prepared and poured immediately. After pouring the separation 
gel was immediately covered with a thin layer of 2-propanol until it was completely 
polymerized. Then the 2-propanol was removed, the stacking gel poured on top and the 
comb inserted.  
3.1.3.5.3 Western blot 
3.1.3.5.3.1 Buffers 
 
Blocking buffer 5 % milk powder in TBS-T 
10x TBS H2O Milli-Q, 1.5 M NaCl, 1.18 % (w/v) Tris-base, 6.35 % 
(w/v) Tris-acid 
TBS-T 0.05 % (v/v) Tween-20 in 1xTBS 
10x TBS H2O, 1.5 M NaCl, 500 mM Tris base (pH 7.5) 
TBS-T 1x TBS, 0.05% (v/v) Tween 20 
Transfer Buffer H2O Milli-Q, 0.381 % (w/v) Na2B4O7*10H2O 
3.1.3.6 Immunologic analyses 
3.1.3.6.1 Sera 
 
Bovine serum albumine 
(BSA) 
Roth (Karlsruhe, Germany) 
Native goat serum (NGS) Sigma-Aldrich (St. Louis, USA) 
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3.1.3.6.2 Dyes 
 
DAPI Sigma-Aldrich (St. Louis, USA) 
3.1.3.6.3 Solutions 
 
Antibody buffer 1x PBS, 5% (v/v) NGS , 1% (w/v) BSA in PBS 
Blocking buffer 1x PBS, 0.5% (v/v) NGS, 1% BSA, 0.5% (v/v) Triton X-
100 
Coverslip storing solution 1% (w/v) NaN3 in 1x PBS 
DAPI stock solution  0.5% (w/v) DAPI in DMF 
DAPI working solution 0.0004% (w/v) DAPI stock in PBS  
3.1.4 Antibodies 
3.1.4.1 Antibodies for Western Blotting 
 
Primary 
antibodies 
Description Dilution Reference 
α-Tubulin Mouse, monoclonal IgG 
against α-tubulin of 
microtubules 
1:20 000 Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
ß-Actin Mouse; monoclonal IgG1, 
HRP-(horse radish 
peroxidase)-conjugated 
1:200 000 Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
ß-Actin Mouse; monoclonal antibody 
against N-terminal epitope of 
ß-actin 
1:1000 Santa Cruz 
Biotechnol. Inc.  
GFP Rabbit; polyclonal antibody 
against GFP 
1:1000 Clontech 
GFP Rabbit; polyclonal antibody 1:3000 Novus Biological 
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against GFP 
HDAC2 Rabbit; polyclonal antibody 
against histone deacetylase 2 
1:500 Zymed Laboratories 
Inc. 
HDAC4 Rabbit; polyclonal IgG 
against amino acids 530-632 
of HDAC4 of human origin 
1:1000 Santa Cruz 
Biotechnol Inc.  
 
Secondary 
antibodies 
Description Dilution Reference 
Goat  α-rabbit HRP-conjugated rabbit IgG 
antibody 
1:5000 Jackson Immuno-
Research 
Laboratories Inc. 
Goat  α-mouse HRP-conjugated AffiniPure 
mouse IgG antibody 
1:10 000 Jackson 
ImmunoResearch 
Laboratories Inc. 
3.1.4.2 Antibodies for Immunohistochemistry 
 
Primary 
antibodies 
Description Dilution Reference 
BLPB Rabbit, polyclonal antibody 
against BLBP 
1:1500 Chemicon 
Brn-2 Goat polyclonal antibody 
against C-terminus of human 
Brn-2 
1:250 Santa Cruz 
Ctip Rat, monoclonal IgG for 
Ctip2 
1:500 Abcam 
GFAP Rabbit, IgG fraction of 
antiserum cow Glial 
Fibrillary Acidic Protein 
(GFAP); strong reaction 
1:500 DAKO 
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against mouse GFAP 
GFP Rabbit, polyclonal antibody 
against GFP 
1:1000 Ulrich Mueller, 
Cripps Research 
Inst., San Diego, CA 
HDAC2 Rabbit, Polyclonal antibody 
against histone deacetylase 2 
1:1000 Zymed Laboratories 
Inc. 
KI-67 Rat anti-mouse Ki67 antigen 1:25 – 1:50  
Nestin Mouse anti-rat, monoclonal 
antibody IgG1 labeling 
neural stem cells 
1:1000 BD Bioscience 
O4 Mouse monoclonal antibody 
against O4 
1:400 Millipore 
Pax6 Mouse, monoclonal IgG 
against Pax6 
1:1000 Chemicon 
Pax6 Rabbit polyclonal antibody 
against C-terminus of mouse 
Pax6 
1:1000 Chemicon 
PH3 Rabbit, polyclonal antibody 
against phospho-histone H3 
(Ser10) 
1:1000 Upstate/Millipore 
RC2 Rat anti mouse IgM against 
RC2 
1:1000 Developmental 
Studies Hybridoma, 
(Iowa, USA) 
Reelin Mouse monoclonal IgG1 
against reelin 
1:1000 Calbiochem 
S100ß Monoclonal antibody against 
S100ß 
1:1000 Sigma 
Sox2 Goat, antibody against 
mouse Sox 2 
1:1000 Abcam 
Tbr2 Rabbit, polyclonal antibody 
against Tbr2 
1:3000 Chemicon/Millipore 
TuJ1 Mouse, monoclonal antibody 1:500 – 1:1000 HISS Diagnostics 
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IgG2a against neuronal β-
tubulin III 
GmbH/COVANCE 
TuJ1 Mouse, monoclonal antibody 
IgG2a antibody against ß-
tubulin III 
1:1000 R&D systems 
 
Secondary antibodies Description Dilution Reference 
Alexa Fluor 488 goat α-
mouse IgG conjugate 
Fluorescent α-
mouse IgG 
(green) 
1:1000 Invitrogen 
(Carlsbad, USA) 
Alexa Fluor 488 goat α-
rabbit conjugate 
Fluorescent  α-
rabbit (green)  
1:1000 Molecular Probes 
Alexa Fluor 546, goat α-
mouse conjugate 
Fluorescent α-
mouse IgG (red) 
1:1000 Molecular Probes 
Alexa Fluor 546 goat α-
rabbit IgG conjugate 
Fluorescent α-
rabbit IgG (red) 
1:1000 Invitrogen 
3.1.5 Primers 
All primers were purchased from Thermo Electron GmbH.  
3.1.5.1 Genotyping 
3.1.5.1.1 tau::EGFP 
Wildtype 
WT-F 5'-CTC AGC ATC CCA CCT GTA AC-3' 
WT-R 5'-CCA GTT GTG TAT GTC CAC CC-3' 
Product 187 bp  
Mutant 
KO-F 5'-CAG GCT TTG AAC CAG TAT GG-3'
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KO-R 5'-TGA ACT TGT GGC CGT TTA CG-3' 
Product 218 bp  
3.1.5.1.2 Nestin::Cre 
 
NesCre+  5'-GCC GAA ATT GCC AGG ATC AG-3' 
NesCre- 5'-AGC CAC CAG CTT GCA TGA TC-3' 
Product 500 bp  
3.1.5.1.3 HDAC4 
 
HDAC4-fwd 5'-ATC TGC CCA CCA GAG TAT GTG-3' 
HDAC4-rev 5'-CTT GTT GAG AAC AAA CTC CTG CAG CT-3' 
nLacZ-rev 5’-GAT TGA CCG TAA TGG GAT AGG TTA CG-3’ 
Product wildtype 480 bp 
 floxed 620 bp 
 LacZ 810 bp 
3.1.5.1.4 HDAC5 
 
gt-HD5-fwd 5’-CAA GGC CTT GTG CAT GCT GGG CTG G-3’ 
gt-HD5-rev 5’-CTG CTC CCG TAG CGC AGG GTC CAT G-3’ 
gt-HD5-lacZ-rev 5’  GCC  AGT  TTG  AGG  GGA  CGA  CGA  CAG  TAT  CG-3’ 
Product wildtype 300 bp 
 mutant 500 bp 
3.1.5.2 PCR to control cDNA-synthesis 
3.1.5.2.1 Gapdh-PCR 
A PCR for the housekeeping gene Gapdh was run to test the quality of cDNA after in 
vitro translation.  
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G3PDH F 5´-AAC ACA GTC CAT GCC ATC AC-3´ 
G3PDH R 5´-TCC ACC ACC CTG TTG CTG TA-3´ 
3.1.6 TaqMan Gene Expression Assays (Applied Biosystems) 
3.1.6.1 Endogenous controls 
 
Name Assay number Gene Species Amplicon 
length 
 
Gapdh Mm99999915_g1 glyceraldehyde
-3-phosphate 
dehydrogenase 
mouse 107 Inventoried 
Hprt1 Mm00446968_m1 hypoxanthine 
guanine 
phosphoribosyl 
transferase 1 
mouse 65 Inventoried 
3.1.6.2 Genes of interest 
 
Name Assay number Gene Species Amplicon 
length 
 
Bmpr1a Mm00477650_m1 bone 
morphogenetic 
protein 
receptor, type 
1A 
mouse 64 Inventoried 
Bmpr1b Mm00432117_m1 bone 
morphogenetic 
protein 
receptor, type 
1B 
mouse 84 Inventoried 
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Bmpr2 Mm00432134_m1 bone 
morphogenic 
protein 
receptor, type II 
(serine/threonin
e kinase) 
mouse 81 Inventoried 
Bmp2 Mm01340178_m1 bone 
morphogenetic 
protein 2 
mouse 58 Inventoried 
Bmp4 Mm00432087_m1 bone 
morphogenetic 
protein 4 
mouse 61 Inventoried 
Hdac1 Mm01351188_m1 histone 
deacetylase 1 
mouse 121 Made to 
Order 
Hdac2 Mm00515108_m1 histone 
deacetylase 2 
mouse 62 Inventoried 
Hdac3 Mm00515916_m1 histone 
deacetylase 3 
mouse 71 Inventoried 
Hdac4 Mm01299557_m1 histone 
deacetylase 4 
mouse 110 Inventoried 
Hdac5 Mm00515917_m1 histone 
deacetylase 5 
mouse 82 Inventoried 
Hdac7a Mm00469520_m1 histone 
deacetylase 7A 
mouse 65 Inventoried 
Hdac8 Mm01224986_m1 histone 
deacetylase 8 
mouse 57 Made to 
Order 
Ngn1 Mm00440466_s1 neurogenin 1 mouse 82 Inventoried 
Ngn2 Mm00437603_g1 neurogenin 2 mouse 64 Inventoried 
Smad1 Mm00484721_m1 MAD homolog 
1 (Drosophila) 
mouse 63 Inventoried 
Smad7 Mm00484741_m1 MAD homolog 
7 (Drosophila) 
mouse 138 Inventoried 
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Stat1 Mm00439518_m1 signal 
transducer and 
activator of 
transcription 1 
mouse 144 Inventoried 
Stat3 Mm00456961_m1 signal 
transducer and 
activator of 
transcription 3 
mouse 93 Inventoried 
3.1.7 Enzymes 
3.1.7.1 Polymerases and Ligase 
 
DreamTaq DNA-Polymerase Fermentas (Waltham, USA) 
SuperScript II Reverse Transcriptase Invitrogen (Carlsbad, USA) 
SP6 RNA-Polymerase Fermentas (Waltham, USA) 
T3 RNA-Polymerase Fermentas (Waltham, USA) 
T7 RNA-Polymerase Fermentas (Waltham, USA) 
T4 DNA-Ligase NEB (Ipswich, USA) 
3.1.7.2 Restriction Enzymes 
 
All restriction enzymes were were obtained from Fermentas or NEB.  
3.1.8 Antibiotics 
 
Antibiotic Dilution 
Ampicillin 1:1000 from stock (150 mg/ml in H2O) 
Kanamycin 1:1000 from stock (30 mg/ml in H2O) 
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3.1.9 Cells 
3.1.9.1 Bacteria 
 
DH5 competent E. coli Invitrogen (Carlsbad, USA) 
XL-1 blue competent E. coli Stratagene (La Jolla, USA) 
TOP10 competent E. coli Invitrogen (Carlsbad, USA) 
3.1.9.2 Permanent cell lines 
 
HEK293T ATCC 
3.1.10 Plasmids 
 
Plasmid Insert Reference 
pBluescript II KS (+/-) Ampicillin resistance gene Genbank 
pLKO.1-puro 
 
shRNA against HDACs  
puromycin resistance gene 
Sigma-Aldrich Chemie 
GmbH (Steinheim, 
Germany) 
pLentiLox 3.6 EGFP, ampicillin resistance 
gene 
Didier Trono, unpublished 
N1-EGFP EGFP Clontech (Mountain View, 
USA) 
AAV hRluc Synthetic Renilla luciferase, 
ampicillin resistance 
David Lau 
pBREx4-luc BMP responsive elements, 
four copies 
Hata et al. (2000) 
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3.1.11 Mission™  shRNA  sequences 
 
HDAC Oligo# TRCN shRNA sequence 
HDAC1 Oligo 1 TRCN0000039399 CCGGGCTTGGGTAATAGCAGCCATTCTCG
AGAATGGCTGCTATTACCCAAGCTTTTTG 
 Oligo 2 TRCN0000039400 CCGGCCGGTATTTGATGGCTTGTTTCTCGA
GAAACAAGCCATCAAATACCGGTTTTTG 
 Oligo 3 TRCN0000039401 CCGGCCCTACAATGACTACTTTGAACTCG
AGTTCAAAGTAGTCATTGTAGGGTTTTTG 
 Oligo 4 TRCN0000039402 CCGGGCCAGTCATGTCCAAAGTAATCTCG
AGATTACTTTGGACATGACTGGCTTTTTG 
 Oligo 5 TRCN0000039403 CCGGGCGTTCTATTCGCCCAGATAACTCG
AGTTATCTGGGCGAATAGAACGCTTTTTG 
HDAC2 Oligo 1 TRCN0000039398 CCGGCGATCAATAAGACCAGATAATCTCG
AGATTATCTGGTCTTATTGATCGTTTTTG 
 Oligo 2 TRCN0000039396 CCGGCCTGTGAAATTAAACCGGCAACTCG
AGTTGCCGGTTTAATTTCACAGCTTTTTG 
 Oligo 3 TRCN0000039395 CCGGCCCAATGAGTTGCCATATAATCCGA
GATTATATGGCA ACTCATTGGGTTTTTG 
 Oligo 4 TRCN0000039397 CCGGCGAGCATCAGACAAACGGATACTCG
AGTATCCGTTTGTCTGATGCTCGTTTTTG 
HDAC4 Oligo 1 TRCN0000039249 CCGGCCTCAGCAAGATAATCTCCAACTCG
AGTTGGAGATTATCTTGCTGAGGTTTTTG 
 Oligo 2 TRCN0000039250 CCGGCATGGGTTTCTGCTACTTTAACTCGA
GTTAAAGTAGCAGAAACCCATCTTTTTG 
 Oligo 3 TRCN0000039251 CCGGGTTCTACATCAGAGACCCAATCTCG
AGATTGGGTCTCTGATGTAGAACTTTTTG 
 Oligo 4 TRCN0000039252 CCGGGAGGCACAGTTGCATGAACATCTCG
AGATGTTCATGCAACTGTGCCTCTTTTTG 
 Oligo 5 TRCN0000039253 CCGGACTCTCTGATTGAGGCGCAAACTCG
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AGTTTGCGCCTCAATCAGAGAGTTTTTTG 
HDAC5 Oligo 1 TRCN0000039384 CCGGCTGGGCAAGATCCTTACCAAACTCG
AGTTTGGTAAGGATCTTGCCCAGTTTTTG 
 Oligo 2 TRCN0000039385 CCGGCCAAACCAGTTCAGCCTCTATCTCG
AGATAGAGGCTGAACTGGTTTGGTTTTTG 
 Oligo 3 TRCN0000039386 CCGGGCTCAAGAATGGATTTGCTATCTCG
AGATAGCAAATCCATTCTTGAGCTTTTTG 
 Oligo 4 TRCN0000039387 CCGGGCACCAGTGTATGTGCGGAAACTCG
AGTTTCCGCACATACACTGGTGCTTTTTG 
 Oligo 5 TRCN0000039388 CCGGCCAGGAATTCCTGTTGTCCAACTCG
AGTTGGACAACAGGAATTCCTGGTTTTTG 
SHC002   CCGGCAACAAGATGAAGAGCACCAACTC
GAGTTGGTGCTCTTCATCTTGTTGTTTTTG 
3.1.12 DNA and Protein standards 
 
25 bp DNA ladder Promega (Madison, USA) 
50 bp DNA ladder Promega (Madison, USA) 
GeneRulerTM100 bp DNA Ladder, ready-
to-use 
Fermentas (Waltham, USA) 
1 kb DNA Ladder NEB (Ipswich, USA) 
peqGOLD Prestained Protein-Marker III peqLab (Erlangen, Germany) 
Spectra Multicolor Broad Range Protein 
Ladder 
Fermentas (Waltham, USA) 
3.1.13 Kits 
 
Applied Biosystems (Darmstadt, 
Germany) 
TaqMan® Universal PCR Master Mix, No 
AmpErase® UNG 
Amaxa Biosystems (Gaithersburg, USA) Rat Neuron Nucleofactor Kit 
BioRad (München, Germany) Bradford-Assay 
GE Healthcare Amersham™ (Little ECL™  Plus  Western Blotting Detection 
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Chalfont, UK) System 
Invitrogen (Carlsbad, USA) SuperScript® II First-Strand Synthesis 
System 
 TOPO TA Cloning Kit for subcloning 
 Zero Blunt TOPO PCR cloning Kit 
Genomed (Löhne, Germany) NoEndo Jetstar Endotoxin-Free Maxi Kit 
Macherey and Nagel (Düren, Germany) Nucleospin Extract II QIAEX II 
Promega (Fitchburg, USA) Dual Luciferase Assay System 
Qiagen (Hilden, Germany) RNeasy Mini-Kit 
 QIAquick Gel Extraction Kit 
Roth (Karlsruhe, Germany) Gel Drying Frames 
Sigma-Aldrich (St. Louis, USA) GenElute HP Plasmid Midiprep Kit 
 GenElute Plasmid Maxiprep Kit 
Thermo Scientific (Waltham, USA) BCA Protein Assay Kit 
3.1.14 Instruments 
 
AGFA-Gevaert (Mortsel, Belgium) Curix 60 Developing Machine 
Amaxa Biosystems/Lonza (Basel 
Switzerland) 
Nucleofector I 
Amersham Bioscences (Amersham, UK) 
 
Ultrospec 3100 pro UV/Visible 
Spectrophotometer with DPU-414 thermal 
printer 
Applied Biosystems (Foster City, USA) ABI Prism 7000 Sequence Detection 
System 
Beckman Coulter (Brea, USA) Avanti J-25 Centrifuge 
Avanti J-26 Centrifuge 
Optima LE-80K Ultracentrifuge 
SW32 Ti Ultracentrifuge Rotor 
JA-10 Ultracentrifuge Rotor 
Becton Dickinson (Franklin Lakes, 
USA) 
FACSCalibur 
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Bender & Hobein (Zurich, Switzerland) Vortex Genie 2 G-560E Mixer 
Biometra (Goettingen, Germany) TPersonal Thermal Cycler, 
Bio-Rad (Hercules, USA) GS-800 Calibrated Densitometer 
Icycler 582BR Thermocycler 
Mini-PROTEAN II Electrophoresis Gel 
System 
Mini Trans-Blot Electrophoretic Transfer 
Cell 
PowerPac 200 Power Supply 
Trans-Blot SD Electrophoretic Transfer 
Cell 
Carl Roth (Karlsruhe, Germany)  IR Microcentrifuge 
CAT Ingenieurbüro M. Zipperer 
(Staufen, Germany) 
ST5 Shaker 
Dr. Goos-Suprema (Heidelberg, 
Germany) 
X-Ray Casette 
Edmund Bühler (Hechingen, Germany) TH 15 heating cover 
KS-15 control shaker 
Eppendorf (Hamburg, Germany) Microcentrifuge 5415 D 
Thermomixer compact 
GFL Gesellschaft für Labortechnik 
(Burgwedel, Germany) 
Water Bath Type 1008 
Hybridisation Incubator 7601 
Heidolph Instruments (Schwabach, 
Germany) 
MR 2002 Magnetic Stirrer 
Hettich (Tuttlingen, Germany) Mikro 20 Tabletop Centrifuge 
Mikro 200R Tabletop Centrifuge 
Heraeus (Hanau, Germany) HERAcell 150 Incubator 
HERAsafe HS 9-18 Safety Cabinet 
UT 12P Heating and Drying Oven 
Herolab (Wiesloch, Germany) Gel Documentation System 
ICU-1  
UVT-20 SL UV Transilluminator with 
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Panasonic Video Monitor WV-CM 1020 
Hirschmann Laborgeräte (Eberstadt, 
Germany) 
Pipetus Pipette Filler 
Holten (Allerød, Denmark) LaminAir Safety Cabinet Model 1.2 
Incucell Medcenter (München, 
Germany) 
Incubator for Microbiological Cultures 
Integra Biosciences (Fernwald, 
Germany) 
Fedegari FVA3 Autoclave 
Kern und Sohn (Balingen, Germany) Precision Balance 440-33N 
Leica Microsystems (Wetzlar, 
Germany) 
DM LB Light Microscope 
DFC320 Microscope Camera 
BioMed Microscope 
CM3050 S Cryosat 
Rotary Microtome Leica RM 2235 
S6E Dissecting Microscope with 
Fiber Optic Illuminator KL 1500 LCD 
membraPure (Bodenheim, Germany) Astacus Water Purification System 
Memmert (Schwabach, Germany) Waterbath 
Mettler-Toledo (Greifensee, 
Switzerland) 
SevenEasy pH-Meter 
Nikon (Tokyo, Japan) Eclipse 90i upright automated microscope 
DS-QiMc black and white CCD camera 
Nikon DS Ri1 color CCD camera 
Plan Apo 4x NA 0.2 objective 
Plan Apo 10x NA 0.45 objective 
Plan Apo 20x NA 0.75 objective 
Plan Apo 40x NA 0.95 objective 
Olympus Germany (Hamburg, 
Germany) 
BX61WI Fluorescence Microscope 
CKX41 Fluorescence microscope 
Paul Marienfeld & Co. (Lauda-
Königshofen, Germany) 
Neubauer Counting Chamber 
Sartorius (Göttingen, Germany) Potter S Homogeniser 
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Schott (Mainz, Germany) KL 1500 LCD Light Source 
Sigma Laborzentrifugen (Osterode am 
Harz, Germany) 
2-5 Tabletop Centrifuge 
Starlab (Hamburg, Germany) RM Multi-1 Programmable Rotator-Mixer 
Tecan (Männedorf, Switzerland) SunriseTM microplate reader 
Techne (Staffordshire, UK) Hybridiser HB-1D Incubator 
Visitron Systems (Puchheim, Germany) SpoRT CCD Camera 
Zeiss (Oberkochen, Germany) 
  
Axiovert 200 M Microscope 
FluoArc Light Source 
Plan NeoFLUAR 40x/1.3 Oil Objective 
Plan Apochromat 63x/1.4 Oil Objective 
Plan FLUAR 100x/1.45 Oil Objective 
3.1.15 Software 
 
4D (San Jose, USA) 4D Client 
Applied Biosystems (Darmstadt, 
Germany) 
ABI Prism 7000 
Adobe Systems (San Jose, USA) Adobe Acrobat 
 Adobe Photoshop 
 Adobe Illustrator 
Biorad (München, Germany) Quantity One 1-D Analysis Software 
Wayne Rasband (NIH) ImageJ 
Microsoft (Redmond, USA) MS Office 2007 
Soft Imaging Systems GmbH (Münster, 
Germany) 
AnalysisSIS 
Tecan (Männedorf, Switzerland) Magellan Data Analysis Software 
Visitron Systems (Puchheim, Germany) Metamorph Software (Version 6.2r6) 
3.1.16 Disposables 
 
Autoclave bags CPP clear Nerbe Plus (Winsen/Luhe, Germany) 
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Bacteriological petri dishes, 10 cm Zentrallager (INF 367, Heidelberg, 
Germany) 
Cell scraper 1.9 cm long Covance (Princeton, USA) 
Cell scraper Greiner Bio-One GmbH (Kremsmünster, 
Austria) 
Cell strainer 100 µm Millipore (Billerica, USA) 
Conical tubes, 15 ml and 50 ml Greiner Bio-One GmbH (Kremsmünster, 
Austria) 
Cryo vials, CryoS, PP, with screw cap Greiner Bio-One GmbH (Kremsmünster, 
Austria) 
Embedding Medium Aqua Poly Mount Polysciences Europe GmbH (Eppelheim, 
Germany) 
Embedding molds Peel-A-Way 
truncated / T12 
Polysciences Europe GmbH (Eppelheim, 
Germany) 
FACS tubes Polystylene Round Bottom 
Tubes 5 ml 
BD Falcon (San José, USA) 
Filter pipette tips (10 µl, 20 µl, 200 µl 
and 1000 µl) 
Sarstedt (Nümbrecht, Germany) or Starlab 
(Hamburg, Germany) 
Glass cover slips 13 mm, 15 mm Marienfeld (Lauda-Königshofen, 
Germany) 
Gloves Nitril S VWR (Radnor, USA) 
Gloves Peha-soft S Hartmann (Heidenheim,Germany) 
Hyperfilm ECL GE Healthcare/Amersham™ (Little 
Chalfont, UK) 
Injection needles (21  G  x  1  ½  “  Nr.  2,  25  
G  x  1”  Nr.  18,  24  G,  30  G  x  ½”) 
BD Microlance (San José, USA) 
Kimwipes Kimberly Clark (Roswell, USA) 
Microscope glass slides Superfrost Roth (Karlsruhe, Germany) 
Microtome Blades 819 Low Profile Leica Microsystems (Wetzlar, Germany) 
Microtome blades S35 Feather (Osaka, Japan) 
Parafilm Pechiney (Akron, USA) 
Pasteur Capillary Pipettes (150 mm/ Wilhelm Ulbrich (Bamberg, Germany) 
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230 mm) 
PCR tubes with attached lids Kisker (Steinfurt, Germany) 
Pipette tips (10 µl, 20 µl, 200 µl and 
1000 µl) 
Greiner Bio-One GmbH (Kremsmünster, 
Austria) 
Plastic cuvettes 1 ml Sarstedt (Nümbrecht, Germany) 
PVDF-Membrane Millipore (Billerica, USA) 
Real Time RT-PCR MicroAmp Optical 
96well reaction plate 
Applied Biosystems (Darmstadt, Germany) 
Real Time RT-PCR Optical adhesive 
films 
Applied Biosystems (Darmstadt, Germany) 
Reaction tubes (1.5 ml, 2.0 ml) Greiner bio-one (Kremsmünster, Austria) 
Safe-Lock reaction tubes (1.5 ml, 2.0 
ml) 
Eppendorf (Hamburg, Germany)  
Sterile filter (Steritop-GP 0.45 µm 150 
ml 45 mm width) 
Millipore (Billerica, USA) 
Syringes (1 ml) BD Plastipak (Franklin Lakes, USA) 
Syringe  driven  filter  unit  0.22  μm  /  0.45  
μm 
Millipore (Billerica, USA) 
Tissue culture Flasks (25 cm2, 50 cm2) Nalgene Nunc (Penfield, USA) 
Tissue culture petri dishes 3.5 cm Greiner Bio-One (Kremsmünster, Austria) 
Tissue culture petri dishes 6 cm  Nalgene Nunc (Penfield, USA) 
Tissue culture petri dishes 10 cm Greiner Bio-One (Kremsmünster, Austria) 
Tissue culture petri dishes 15 cm BD Falcon (Franklin Lakes, USA) 
Tissue culture pipettes (2 ml, 5 ml, 10 
ml)  
Greiner Bio-One (Kremsmünster, Austria) 
Ultracentrifuge  tubes  „Polyallomer  
Röhrchen,  38,5  ml,  PA,  dünnwandig“ 
Beranek (Weinheim, Germany) 
 
Whatman paper Schleicher und Schuell Bioscience (GE 
Healthcare, Little Chalfont, UK) 
 
Kathrin Weißmüller, 2013   3  Materials and Methods 
73 
 
3.2 Methods 
3.2.1 Cell culture 
3.2.1.1 Permanent cell lines 
3.2.1.1.1 Culture and passaging of HEK293 and HEK293T cells 
 
HEK293 and HEK 293T cells were grown in either 10- or 15 cm cell culture petri 
dishes. The cells were grown to exponential growth at 70 – 80% confluency. The cells 
were passaged three times a week as follows: cells were rinsed very carefully with D-
PBS and incubated with 0.5 ml (10 cm dishes) or 1.5 ml (15 cm dishes) Trypsin/EDTA 
for 1 minute at 37 °C. They were resuspended in fresh medium and centrifuged for 5 min at 800 x g. After centrifugation, the medium was aspirated, the cells resuspended in fresh culture medium and plated out in dilutions of 1:5 or 1:10 in 
fresh culture dishes.  
For the production of lentivirus, cells were counted and 19 million cells plated on a 15 
cm culture dish coated with 0.001% poly-L-lysine. Those were then grown for another 
day before being transfected.  
3.2.1.2 Primary cultures  
3.2.1.2.1 Neurosphere cultures 
 
Culture medium was supplemented just before preparation and warmed to 37 °C in an 
incubator. The mice employed for neurosphere cultures were of the inbred background 
C57BL/6. Neurospheres were prepared from E15.5 embryonic brain tissue as described 
(Gritti et al 2001, Reynolds & Weiss 1996). The pregnant female was sacrificed, the 
embryos removed from the uterus and decapitated. The dissection was carried out in 
petri dishes with PBS.  
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The heads were opened using fine forceps and the brains removed. The hemispheres 
were separated carefully and the meninges removed. From the hemispheres either the 
lateral and medial ganglionic eminences or for cortical cultures, respectively, a part of 
the frontal cortex, were dissected out. The tissue was collected in PBS during the 
dissection and cooled on ice.  
The tissue was then triturated with a fire-polished Pasteur pipette in order to obtain a 
single cell solution. The cells were counted and plated out in culture flasks in a density 
of 100 000 cells/ml in NS growth medium (striatal cells) or 150 000 cells/ml (cortical 
cells). The neurospheres were incubated in suspension at 37 °C, 5% CO2 for one week. 
After 5 days they were fed with an equal volume of NS growth medium. The cells were 
plated out on polyornithine-coated culture dishes or cover slips for differentiation after 
7 days in culture. Cryosections of neurospheres stained with developmental markers 
after 7 das in culture can be found in the Appendix. 
3.2.1.2.2 Hippocampal cultures 
 
Primary hippocampal cultures were obtained from Stefanie Schumacher.  
3.2.1.3 Differentiation of neurosphere-derived cells 
 
Differentiation medium containing FGF2 was prepared freshly and warmed to 37 °C in 
an incubator. Neurospheres were collected in 50 ml conical tubes. Upon centrifugation 
for 4 min at 100 x g, the medium was removed and a small amount of fresh 
differentiation medium added to the cells, 2 – 5 ml depending on the amount of 
neurospheres collected. The neurospheres were then triturated with a fire-polished 
Pasteur pipette and the single-cell suspension plated out on polyornithine-coated (200 
mg/ml) petri dishes in differentiation medium without EGF and with 1% fetal calf 
serum (FCS, Invitrogen), a medium that supports the differentiation of both neurons and 
astrocytes.  
For virus infections the cells are plated out on petri dishes coated with poly-L-Lysine in 
the following densities:  
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Plating density of striatal cells 
Cell culture vessel Regular cultures   
12 well plate, per well 200 000 300 000 – 400 000 
6 cm petri dish 1 million 1.5 – 2 million 
10 cm petri dish (for RNA or protein 
isolation) 
3 millon 4 – 5 million 
 
For FACS Analysis, the cells were plated out on dishes coated with 1 mg/ml poly-L-
lysine. For lentivirus infection cells were plated out on coverslips coated with 
polyornithine (washed 2x with PBS) and 1 µg/ml Laminin (2 h, washed 3x with PBS). 
2.5 days after plating, the medium was changed to differentiation medium without 
FGF2 and EGF, but containing 1% FCS.  
During the differentiation protocol cells were either infected with lentivirus or adeno-
associated virus or treated pharmacologically to examine the effects of HDAC 
inhibition. Thereupon they were lysed for either RNA or protein analysis, fixed for 
immunostainings or examined with FACS Analysis.  
 
Figure 3.1. Scheme of the neurosphere culture and differentiation protocol 
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3.2.1.4 Amaxa nucleofection and Dual-Luciferase Reporter Assay 
 
150 000 cells were used for one well of a 24-well plate. The cells were counted and 
aliqouted. They were spun down and the medium aspirated. Afterwards the cells were 
resuspended in Amaxa nucleofection medium.  
Plasmids containing firefly luciferase and Renilla luciferase as a reporter (BREx4-luc) 
are added, everything pipetted into the Amaxa nucleofection cuvette which is then 
placed   into   the   nucleofection   device   and   transfected   according   to   manufacturer’s  
specifications (programme A-33). Afterwards, the cells are immediately resuspended in 
pre-warmed medium and plated in 24 well plates. They were treated with 10 nm, 25 nm 
or 50 nM TSA or 10 ng/ml BMP2 for different durations and after the incubation they 
were lysed with passive lysis buffer and the lysates stored at –80 °C.  
3.2.1.4.1 Measurement 
 
In the Dual-Luciferase Reporter Assay, the activities of firefly (Photinus pyralis) and 
Renilla (Renilla reniformis) luciferases are measured as reporters sequentially from a 
single sample. First, the firefly luciferase reporter is measured by adding Luciferase 
Assay Reagent II (LAR II) to generate the luminescent signal. After measuring the 
evoked luminescence, the reaction is quenched, and simultaneously the Renilla 
luciferase reaction initiated by adding Stop & Glo® Reagent. The Renilla luciferase 
signal decays slowly over the course of the measurement. The Dual-Luciferase Reporter 
Assay is constructed in a way that both reporters yield linear readouts.  
The BRE(2243/2191)x4-luc construct was generated by cloning four copies of the BRE 
sequence upstream of the E1b TATA box in the pE1b-luc vector (Hata et al 2000).  
The lysates were removed from –80 °C and allowed to adjust to room temperature. 200 
µl of lysate were transferred from each well to a 96-well microtitre plate. In the 
software Glomax 2.4 the delay was set to 10 sec and integration time to 10 sec. 2 
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measurements were made with a delay of 5 sec to determine the decay of the 
fluorescence signal.  
75 µl Luciferase II solution were added to each well and lysates and mixed. Then the 
firefly luciferase fluorescence is measured. For Renilla fluorescence integration time 
was set to 3 sec. Stop & Glo® solution was supplemented with 50x Renilla substrate to 
a final concentration of 1x. 75 µl of this mixture were added to each well and mixed 
briefly. The Renilla fluorescence was measured.  
The average fluorescence value of all empty wells was considered as a blank and 
subtracted from each firefly fluorescence value. The lowest fluorescence value of the 
Renilla measurement was used to normalize all values (Renilla fluorescence/lowest 
Renilla fluorescence value). All firefly luciferase values were normalized with the 
Renilla fluorescence from the respective well. An average of all wells with the same 
sample was calculated and all averages normalized to control.  
3.2.1.5 Pharmacological treatments 
 
The following pharmacological reagents were added in different experiments: 
trichostatin A (Sigma, Calbiochem) 10 nM, 25 nM, or 50 nM or human recombinant 
bone morphogenetic protein 2 (BMP2) (1 ng/ml; prepared and provided by Dr. Peter 
Hortschansky, Jena).  
3.2.1.6 Fixation 
 
Cells were rinsed with 1x PBS, then fixed with 4% PFA in PBS for 10 minutes at 4 °C 
and rinsed again 3 times with 1x PBS. They were then either stored in PBS at 4 °C or 
immediately processed for immunofluorescence stainings.  
3.2.2 FACS Analysis 
Neurospheres were grown in suspension culture as described above for 7 days. Tissue 
culture petri dishes were freshly coated with poly-L-lysine (1 mg/ml in water) for either 
2 h or overnight at 37 °C in the incubator.  
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Neurospheres were dissociated with a fire-polished Pasteur pipette and plated out in a 
density of 3.5x106 cells on the poly-L-lysine coated 6-cm cell culture dishes. They were 
cultured according to the standard differentiation protocol described above. 
At DIV 7 cells were dissociated from the plates. First, the medium was discarded, the 
cells were then washed with 1x PBS and incubated with 1 ml Versene for 1 min at 
37°C. After this, Versene was removed and 1 ml of a trypsin-papain-mixture [0.25% 
Trypsin; 2.5 U/ml papain] added for 6 min at 37 °C.  
The cells were then dissociated by gently tapping the culture dish and repeated 
trituration by pipetting. The cell suspension was diluted in 1x PBS with 10% FCS, 
transferred to a fresh tube and centrifuged for 2 min at 4000 rpm. After discarding the 
supernatant, the cells were fixed in 4% PFA in 1x PBS for 20 min at 4 °C, then washed 
3 times in 1x PBS with 2% FCS (PF) by centrifugation for 2 min at 4000 rpm  and 
subsequent resuspension in PF. Eventually the cells were resuspended in PF with 0.18% 
saponin (PFS).  
The cell suspension was divided according to the different antibody stainings and 
controls. 
3.2.2.1 Antibody stainings – Neurogenesis 
 
To assess the extent of neurogenesis in the cultures, stainings with TuJ1 antibody were 
carried out in order to label and subsequently quantify newborn neurons. Primary TuJ1 
antibody was prediluted in PFS and applied to the cells at a concentration of 1:1000 for 
30 min at 4 °C (100 µl per sample). The cells were washed three times with PFS, each 
time centrifuged for 2 min at 4000 rpm and resuspended in PFS. They were incubated 
with secondary antibodies conjugated with Alexa546 at a dilution of 1:1000 in PFS for 
30 min at 4 °C. Afterwards, the cells were washed with PFS twice, once with PF and 
resuspended 200 µl of in PF. 
The stained cells were then analyzed using a Becton Dickinson FACSCalibur flow 
cytometer.  
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3.2.3 Molecular biology  
3.2.3.1 Transformation of bacteria  
 
Chemically competent E. coli cells were stored in aliquots at –80 °C. For each 
transformation one vial of competent cells was gently thawed on ice. 50 μl of the cell 
suspension was mixed with 0.5 μl of DNA and incubated on ice for 30 min. Following a 
heat shock of 30 s in a 42 °C water bath, 450 µl of LB-medium without antibiotics was 
immediately added to the cells. The bacteria were incubated on a bacterial shaker at 37 
°C and 180 rpm for 45 min. 50 – 100 µl of the bacteria suspension were plated on agar 
plates containing the appropriate antibiotic for selection.  
3.2.3.2 Minipreparation of plasmid DNA 
 
Plasmid DNA was isolated from bacteria in an alkaline lysis essentially as described by 
Birnboim and Doly and Ish.Horowicz and Burke (Birnboim & Doly 1979, Ish-
Horowicz & Burke 1981). Solutions 1 and 3 were stored at 4 °C and put on ice before 
starting the protocol. From an agar plate a single colony was picked with an autoclaved 
pipette tip and incubated in 5 ml of LB-medium containing the appropriate selection 
antibiotic. The culture was incubated overnight in a bacterial shaker at 37 °C. 4 ml of 
the culture were centrifuged for 1 min at 12 000 x g and 4 °C to pellet the bacteria and 
remove the medium. The bacterial pellet was thoroughly resuspended in 100 µl solution 
1 by pipetting up and down and vortexing. To lyse the cells, 200 µl lysis solution 2 were 
added.  The tubes were closed firmly, rapidly inverted five times and placed on ice. 150 
µl ice-cold solution 3 was added to neutralize the lysis buffer. Each tube was vortexed 
gently for 10 s and incubated on ice for 3 – 5 s. Afterwards, the samples were 
centrifuged at 12 000 x g and 4 °C. Supernatants were transferred into new tubes and 
the volume measured for subsequent DNA extraction.  
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3.2.3.3 Plasmid isolate purification 
3.2.3.3.1 Phenol-chloroform extraction 
 
In order to purify the DNA sample, phenol-chloroform extraction was perfomed. An 
equal volume of phenol-chloroform was added to the supernatant and the sample 
vortexed. The sample was then centrifuged for 2 min at 12 000 x g and 4 °C and the 
supernatant transferred into a new tube.  
3.2.3.3.2 DNA ethanol precipitation 
 
In order to precipitate the DNA upon phenol-chloroform extraction, ethanol 
precipitation was performed. Two volumes of 100% ethanol were added to the 
supernatant and vortexed briefly. After 2 min at room temperature, the solution was 
centrifuged for 5 min at 12 000 x g and 4 °C. The supernatant was removed, the pellet 
washed once with 1 ml 70% ethanol, centrifuged 5 min at 12 000 x g and 4 °C. The 
supernatant was removed again, the DNA pellet dried for approximately 10 min and 
resuspended in 50 µl Tris-HCl, pH 8.0. The Plasmid-DNA was stored at –20 °C.  
Alternatively, plasmid minipreparations were carried out with the QIAgen QIAprep 
Spin Miniprep Kit according to  manufacturer’s  instructions.   
3.2.3.4 Plasmid midipreparation 
 
Plasmid midipreparations were carried out with Sigma GenElute Plasmid Midiprep Kit 
according  to  manufacturer’s  instructions.   
3.2.3.5 Plasmid maxipreparation 
 
To amplify plasmid DNA on a larger scale, an overday culture was prepared. From an 
agar plate one bacterial colony was picked and incubated in 5 ml LB-medium in a 
bacterial shaker at 37 °C. In the evening, 2 ml of this culture were used to inoculate 500 
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ml of LB-medium containing the appropriate selection antibiotic which was incubated 
overnight in a bacterial shaker at 37 °C and 250 rpm.  
The plasmids were then isolated using the GenElute Plasmid Maxiprep Kit (Sigma) 
according  to  manufacturer’s  specifications.  The  plasmid  DNA  was  eluted  in  the  elution 
buffer provided and then precipitated to increase the purity of the preparation.  
The plasmid eluate was supplemented with 1/10 of its volume of 3 M sodium acetate 
(pH 5.3) and a volume of ethanol twice as large as the volume of the eluate was added 
and everything mixed. To precipitate, the mixture was incubated for 30 min at –80 °C, 
then centrifuged for 10 min at 4 °C and 13 000 rpm, the DNA pellet washed with 70% 
ethanol and again centrifuged for 10 min at 4 °C and 13 000 rpm. The pellet was air-
dried and subsequently resuspended in 200 µl 10 mM Tris (pH 8.0). After determining 
concentration and purity by measuring the OD260/280 the plasmid DNA was stored at –20 
°C.  
3.2.3.6 Plasmid maxipreparation for lentivirus production 
 
For lentivirus production plasmid DNA was prepared using the NoEndo Jetstar 
Endotoxin Free Maxi Kit,   Genomed   (Löhne,   Germany)   according   to   manufacturer’s  
instructions. Overday and overnight cultures were set up as described above. Plasmid 
DNA was eluted using the buffer provided, concentration and purity determined 
measuring the OD260/280 and DNA stored at –20 °C.  
3.2.3.7 Agarose gel electrophoresis 
 
To analyze DNA samples on an agarose gel, the samples were supplemented with a 10x 
Orange G loading dye to a final concentration of 1x. The samples were then loaded on 
an agarose gel (1 – 2% agarose in TAE (w/v) with ethidiumbromide at a concentration 
of 7 µl per 120 ml Gel) and electrophoresis carried out at 100 V – 130 V. After 
separation the DNA was visualized on a UV table and the bands photographed for 
documentation.  
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3.2.3.8 Gel extraction  
 
For the extraction of DNA from the agarose gels, the QIAquick Gel Extraction Kit was 
used. The bands were visualized on a UV table, cut out of the gel with a scalpel, 
weighed  and  then  processed  with  the  kit  according  to  manufacturer’s  instructions.   
3.2.3.9 Restriction digest  
 
Restriction enzymes and buffers were used both from NEB and Fermentas. The buffer 
compositions   and   restriction   times   were   adapted   to   manufacturer’s   suggestions.   For  
double digestion reactions, optimal conditions were determined according to 
manufacturer’s  specifications.   
3.2.3.10 RNA isolation 
3.2.3.10.1 RNA isolation using Trizol 
 
Cells were grown in a monolayer in 6 cm petri dishes. The cells were lysed within the 
dishes by adding 1 ml of Trizol to a 3.5 cm petri dish (1 ml/10 cm2). The lysate was 
pipetted up and down two or three times and was then either further processed 
immediately or stored at –80 °C.  
The lysate was incubated 5 min at RT to ensure dissociation of nucleoprotein 
complexes. 200 µl Chloroform were added per 1 ml of Trizol, the tube shaken for 15 
sec and incubated at RT for 2 – 3 min. The lysate was centrifuged for 15 min at 4 °C 
and 12 000 x g which resulted in a colourless upper aqeous phase containing the RNA, 
an interphase and a lower red phenol-chloroform phase.  
To precipitate the RNA, the upper phase was transferred to a fresh tube, 500 µl 
isopropyl alcohol per ml of Trizol reagent were added and incubated for 10 min at RT. 
The mixture was then centrifuged for 10 min at 4 °C and 12 000 x g, the supernatant 
removed and the RNA pellet washed with at least 1 ml 75% ethanol per ml of Trizol 
reagent used. The mixture was vortexed and centrifuged for 5 min at 4 °C and 7500 x g. 
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The RNA pellet was air-dried for 5 – 10 min, resuspended in RNAse-free water and 
incubated for 10 min at 55 °C.  
3.2.3.10.2 RNA isolation with QIAgen RNA Mini-Kit 
 
RNA from tissues and cell cultures was isolated using the QIAGEN RNeasy Mini Kit 
according  to  the  manufacturer’s  instructions.  RNA  was  eluted  with  30   μl of water. To 
further increase the concentration, the eluate was used to elute remaining RNA from the 
membrane a second time. The concentration was determined by UV spectrophotometry 
at 260 nm. The RNA was stored at –80 °C.  
3.2.3.10.3 RNA isolation from embryonic brain tissue 
 
RNA was isolated from E13.5 or E15.5 brain tissue. The brains were dissected in PBS 
and the tissue collected in Eppedorf tubes cooled in a mixture of liquid nitrogen and dry 
ice. 600 µl RLT buffer were applied to each sample. With a rotor-stator-homogenizer 
the tissue is homogenized immediately upon adding the lysis buffer for two minutes at a 
medium speed. Afterwards the RNA is isolated using the QIAquick RNA isolation Kit 
according  to  manufacturer’s  specifications. 
3.2.3.11 cDNA work 
3.2.3.11.1 cDNA synthesis 
 
Reverse transcription of RNA was carried out using the SuperScript® II Reverse 
Transcriptase from Invitrogen. The DNA polymerase synthesizes a complementary 
DNA strand from single-stranded RNA.  
Reaction setup for 1 – 5 µg of total RNA 
2 µg RNA (volume 13 µl, diluted with Millipore water if necessary) 
1 µl random hexamer primers (100 μM, Fermentas) 
1 µl oligo(dT)18 primer (0.5 mg/ml, Fermentas) 
1 µl dNTP-Mix 
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This mixture was incubated for 5 min at 65 °C on a Biorad iCycler thermocycler and 
subsequently put on ice. After collecting the liquid at the bottom of the tube by 
centrifugation, the following reagents were added:  
5 µl 5x First Strand buffer (Invitrogen) 
2.5 µl 0.1 M DTT 
1.25 µl Ribolock RNase Inhibitor (Fermentas, 40u/µl) 
Everything was mixed carefully by pipetting up and down and incubated for 2 min at 42 
°C. After this 1 µl Super Script II reverse transcriptase was added, the reaction mixed 
carefully and incubated for 1.5 h at 42 °C. The cDNA was diluted 1:5 for real time RT-
PCR.  
3.2.3.11.2 Gapdh-PCR to control cDNA quality 
 
To control for the quality of the cDNA, a PCR reaction with primers for Gapdh was 
performed. As Gapdh is a housekeeping gene, equal amounts of its PCR product 
(expected size 500 bp) were expected in each cDNA preparation.  
Mastermix for 1 sample    
H20 15.3 µl 
10x PCR buffer 2.0 µl 
50 mM MgCl2 0.8 µl 
10 mM dNTPs 0.4 µl 
GAPDH  3’  primer 0.4 µl 
GAPDH  5’  primer 0.4 µl 
Taq polymerase 0.2 µl 
Total 19.5 µl 
To the mastermix, 0.5 µl DNA were added per sample. The PCR reaction was 
performed according to the following programme on a Biometra PCR Cycler TPersonal. 
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Temperature Time  n cycles 
94 °C 5 min  1 
94 °C 30 s 
 
 
 
60 °C 30 s 32  
72 °C 30 s  
72 °C 5 min  1 
The PCR products were separated on a 1.2% agarose gel at 100 V for about 30 min and 
visualized with ethidium bromide and  UV light. When all samples showed the same 
amount of Gapdh PCR product, cDNA was used for quantitative real time RT-PCR.  
 
Figure 3.2: Results of the 
Gapdh PCR after cDNA 
transcription. The expected 
size of the PCR product is at 
500 bp. 100 bp molecular size 
marker. Gelelectrophoresis 
was carried out for 45 min on 
a 1.2% agarose gel. 
3.2.3.11.3 Real Time RT-PCR  
 
To perform quantitative real time RT-PCR, equal amounts of cDNA (1 – 5 µg) of each 
sample were diluted in water to a final volume of 13.5 µl. The reaction mix was 
prepared by mixing 15 µl TagMan Master Mix per sample with 1.5 µl of the respective 
TaqMan Gene Expression Assay. This mixture was then pipetted into the relevant wells 
of a 96 well reaction plate and the DNA dilution added. Each sample was assayed in 
triplets. The plate was sealed with an adhesive cover and centrifuged for 2 min at 1500 
rpm to remove bubbles from the reaction volumes and collect the liquid at the bottom of 
the tubes. Sterile-filtered water (Sigma) served as negative control.  
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Amplification was performed on an Applied Biosystems AbiPrism 7000 Cycler. The 
program used was the following: 
50 °C 2 min 
95 °C 10 s 
95 °C 15 s 
60 °C 1 min 
A total of 50 cycles were run. Analysis of the data was carried out using the provided 
software. The data were analyzed using the ΔΔCt method which assumes a duplication 
of DNA during one cycle. For all analyzed genes, an auto-baseline was set in order to 
eliminate background noise. The threshold is determined as the region in which 
amplification progresses in a linear fashion. The cycle of threshold is also automatically 
determined.  
3.2.3.12 Production and harvest of lentiviral particles 
3.2.3.12.1 PEI-Transfection of HEK293T cells 
 
Plasmids containing shRNAs to knock-down individual HDACs were purchased from 
Sigma Aldrich. shRNA sequences were generated by Sigma algorithms. To select 
infected cells, the Sigma plasmids contain a sequence for puromycin resistance. 
However, they did not contain a reporter sequence for a fluorescent protein. Therefore, 
for the production of lentiviral particles, the knock-down construct was cloned into a 
pLentiLox3.6 plasmid vector.  
Plasmids for Lentivirus production were isolated using the GenoMed NoEndo Maxiprep 
Kit as described above. The HEK293T cells used to produce virus were cultured in low 
passage numbers and split the day before transfection. 19 million cells were plated on 
one 15 cm culture dish and grown until the next day to about 70 – 80% confluency.  
Lentivirus production was based on three plasmids (Lois et al. 2002; Naldini et al. 
1996): the transfer vector plasmid pLKO1.puro or pLL3.6 containing the gene of 
interest, the HIV-1 packaging vector ΔR8.9 and the VSVG envelope encoding vector. 
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Equimolar amounts of all three plasmids were transfected into HEK293T cells using 
PEI (polyethyleneimine, Sigma). 22 µg pΔR8.9, 15 µg pVSVG and 30 µg of the 
respective plasmid containing the shRNA sequence were used. The plasmids were 
pipetted into a vial containing 2.2 ml OptiMem medium, while the PEI was pipetted 
into a vial containing 2.4 ml OptiMem medium. The mixtures were incubated at room 
temperature for 5 min and then the DNA solution pipetted into the PEI solution. After 
incubation of 1 h at RT, DNA and PEI have formed complexes which are able to 
penetrate the cells and to deliver DNA to the cells. Prior to transfection 10 ml medium 
were removed from the cells and kept at 37 °C. Then, the transfection mix was carefully 
and dropwise added to the cells. 4 h after transfection the medium was changed.  Transfection efficiency was estimated after 48 h visually by determining the rate of GFP-expressing cells in the cultures. Transfection efficiency was usually between 60 and 70%. After 48 to 72 h the medium was removed from the cells, pooled and subjected to low speed centrifugation for 5 min at 800 x g at RT to remove cell debris. The supernatant was sterile filtered through 0.45 µm filters and transferred to ultracentrifuge vials. It was then centrifuged at 25 300 rpm in an ultracentrifuge with a SW32Ti rotor at 4 °C for 90 min. The supernatant was carefully decanted and the pellet of viral particles resuspended in 200 µl PBS and layered on a sucrose cushion (1.5 ml 20% Sucrose in HBSS). It was then purified through the sucrose cushion by centrifugation in a SW50.1 rotor for 2 h at 21 000 rpm. The pellets were then resuspended in 200 µl HBSS, aliquoted into eppendorf tubes, deep frozen in liquid nitrogen and stored at –80 °C.  
Transfection mixture for virus production, per 15 cm dish HEK293T cells 
Plasmid Amount per 15 cm dish  
pCMV  ΔR8.9 7.5  μg   
pVSVG  5  μg   
pLentilox3.6 (shRNA) 10  μg   
PEI  75  μl   
OptiMem  925  μl   
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3.2.3.12.2 Infection of neurosphere-derived precursor cells to knock down 
HDACs 
 
Neurosphere cells were plated out in a monolayer without FGF2 and with serum and 
infected one day after plating or on the same day. One virus aliquot was gently thawed 
on ice. The virus was added to the medium of the cells, the plates were gently shaken to 
distribute the virus and incubated between 1 and 7 days before preparation of RNA 
lysates. 
Volumes of lentivirus used for infection 12-well (per well) 6-cm petri dish 
Striatal cells 1.5 µl 7 µl 
Cortical cells 2 µl 10 µl 
3.2.4 Biochemistry  
3.2.4.1 Protein extracts 
3.2.4.1.1 Protein extracts from cells 
 
Cells were grown in cell culture petri dishes and subjected to treatment. To obtain 
lysates for immunoblotting, the medium was removed from the dishes and the cells 
were washed once with PBS. The plates were put on ice. For 3 million cells, 200 μl 
RIPA buffer complemented with the following protease inhibitors: 1 mM ε-
aminocaproic acid (stock 1 M), 0.2 mM PMSF (stock 0.1 M in 2-propanol), 5 mM 
benzamidine (stock 0.5 M). The lysis buffer was applied to the cells and the cells 
scraped off in the buffer. The cell lysate was then transferred to a 1.5 ml reaction tube. 
To shear genomic DNA, the lysate was slowly passed through a 21 G needle 10 – 15 
times and then centrifuged at 4 °C and 13 000 rpm to remove debris. The cleared lysate 
was then aliquoted into new reaction tubes and stored at –80 °C or subjected to SDS-
PAGE and immunoblotting immediately. 
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3.2.4.1.2 Protein lysates from embryonic brain tissue 
 
Brain tissue from brain and spinal cord tissue were prepared as follows. The tissue was 
dissected out of the embryos. From each embryo, the tail was removed for extraction of 
genomic DNA and genotyping. The brain or spinal cord was then weighed and 
according to the weight homogenizing buffer added.  
To 1 mg of tissue, 20 µl of buffer were added. A glass homogenizer was inserted into a 
Potter, the tissue and homogenizing buffer put into the glass tube and homogenized for 
2 min at 900 rpm. The homogenizer tube was kept in a beaker with ice throughout this 
procedure. The lysate was then transferred to a reaction tube on ice. The volume was 
measured and 5x Lämmli buffer added. The lysate was sheared subsequently with 
needles of decreasing diameter: 21G, 25G, and 30 G.  
The lysates were incubated at 95 °C for 5 min, subsequently centrifuged at 13 000 rpm 
and 4 °C for 10 min, the cleared supernatant removed. 40 µl were frozen down for 
assessment of protein concentration and the lysate volume measured. They were 
eventually complemented with ß-mercaptoethanol to a final concentration of 5%.  
3.2.4.2 Bradford-Assay 
 
To determine protein concentrations of cell lysates, Bradford Protein Assay was 
applied. Protein standards were generated by dissolving BSA in water and adding RIPA 
according to the volume of the diluted protein samples . The measurement was carried 
out in a TECAN Sunrise Reader using Magellan Software.  
3.2.4.3 BCA-Assay  
 
The concentration of protein samples derived from embryonic tissue was determined in 
a BCA assay according to manufacturer’s  instructions.   
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3.2.4.4 Polyacrylamide-gel-based work 
3.2.4.4.1 Polyacrylamide Gels  
 
Acrylamide gels for the polyacrylamide gel electrophoresis (PAGE) and subsequent 
immunoblot analysis were prepared prior to electrophoresis according to the molecular 
weight of the protein of interest. For HDAC2 and BMP2 western blots, 12.5% 
acrylamide gels were poured. For HDAC4 western blot, 7.5% polyacrylamide gels were 
prepared.  
Protein Molecular weight % Acrylamide  
ß-Actin 42 kDa         12% 
BMP2 precursor 
           heterodimer 
           monomer 
60 kDa 
30 kDa 
18 kDa 
12% 
GFP   
HDAC2 56 kDa 12% 
HDAC4 140 kDa 7.5% 
Once the gels were fully polymerized, the electrophoresis was set up and the gel loaded 
immersed in electrophoresis buffer.  
3.2.4.4.2 SDS-PAGE  
 
Protein extracts were thawed on ice and complemented with 2x urea loading buffer. The 
samples were heated for 5 min at 42 °C and cooled to room temperature. 15 – 60 μg of 
protein per lane were separated on an acrylamide gel using the Bio-Rad Mini Protean III 
Gel System at a current of 35 mA.  
3.2.4.4.3 Western Blot 
 
After gel electrophoresis the separated proteins were transferred from the gel to a PVDF 
membrane. The membrane was activated in methanol for 15 s followed by 2 minutes in 
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double-distilled water and then kept in transfer buffer. The blot sandwich was 
assembled in a bowl filled with transfer buffer. The membrane was put onto three sheets 
of whatman paper with the water-repelling side facing away from the paper. The gel 
was carefully removed from the chamber and placed onto the membrane. This 
construction was covered by two more sheets of Whatman paper. The transfer was 
carried out using a Bio-Rad tank blot system, either for 3 h at 400 mA or overnight at 
180 mA and 4 °C. Alternatively a semi-dry blot system was used for 1 – 1.5 h at 150 – 
200 mA.  
After blocking for 1 h in blocking buffer (5% milk/TBST) at RT on a rocker, the 
membrane was incubated with primary antibody diluted in blocking buffer for 1 h at RT 
or overnight at 4 °C. The membrane was washed 3 x 15 min with TBS-T and 
subsequently incubated with secondary antibody diluted in blocking buffer for 30 – 60 
min at RT. Afterwards, it is again washed 3 x 15 min in TBS-T and once in TBS. For 
detection, ECL plus solution (GE) was applied to the membrane according to 
manufacturer’s   instructions.   The   membrane   was   then   very   shortly   rinsed   in   TBS.  
Subsequently it was dried, put into a cassette, and Hyperfilm (GE) exposed to the 
signal. Development of the films was carried out using a Curix developing machine. As 
controls, housekeeping proteins like ß-actin or tubulin were detected in the samples 
using the described detection procedure a second time on the same membranes.  
3.2.4.4.3.1 Quantification 
 
For semi-quantitative analysis, films were scanned with a BioRad GS-800 Calibrated 
Densitometer and analyzed using QuantityOne software. Protein bands of interest were 
encircled and subsequently measured. Actin or tubulin bands were used as a reference 
for analysis.  
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3.2.5 Histological techniques  
3.2.5.1 Fixation of cells on coverslips  
 
Cells grown and treated on coverslips were fixed in order to be immunostained later on. 
The cells were washed once with pre-warmed D-PBS (37 °C). Subsequently 4 % PFA 
(RT) was added to the cells followed by incubation for 10 min at RT. The PFA was 
removed and the cells were washed three times with D-PBS at RT.  
3.2.5.2 Fixation of embryonic brains for immunohistochemistry 
 
13.5 or 15.5dpc timed-pregnant females were sacrificed, the embryos dissected from the 
mother and collected in cold 1x PBS. A tail sample was collected from the mother and 
from each embyo and processed in tail buffer.  
The embryos were treated one by one to ensure that the genotyping results could be 
matched to the individual embryo samples later on. The embryo was decapitated and the 
heads placed in individual tubes with 10 ml 4% PFA and fixed overnight on a shaker at 
4 °C. The next day, the heads were washed 2 times for 1 h in 1x PBS to remove residual 
PFA before embedding.  
3.2.5.3 Embedding of embryos for cryosections 
 
The heads were incubated in a series of sucrose solutions at increasing concentrations: 
10%, 20% and 30% sucrose in 1x PBS. Each incubation was carried out on a shaker at 4 
°C  overnight.  “Peel-Away”  mounting  moulds  were  labelled  with  the  sample  name  and  
line, the date, the intended orientation of the head and filled with Jung tissue freezing 
medium and the heads placed carefully inside. After 30 min incubation at RT, the heads 
are carefully orientated as intended and the mould dipped into liquid nitrogen several 
times to keep the samples in position. Then the moulds are placed on dry ice to freeze 
through. The samples were stored in cryoboxes at –80 °C.  
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3.2.5.4 Cryosectioning 
 
Cryosections were prepared on a Leica Cryostat. The chamber and sample temperatures 
had to be adapted according to the temperatures and conditions of the day the sections 
were prepared. Usually a chamber temperature of –21 °C and an object temperature of –
19 °C was intended.  
The sections were cut, collected on superfrost slides and examined with a microscope. 
For each slide a note was taken about in which region of the brain the sections were 
located, using an atlas of the developing mouse brain for comparison.  
3.2.6 Immunological techniques and histochemistry 
3.2.6.1 Immunofluorescence staining of fixed cells  
 
Coverslips carrying the fixed cells were placed on a layer of parafilm into a humid 
chamber. The cells were incubated for 1 h with blocking buffer and subsequently with 
primary antibody diluted in antibody buffer, either for 1 h at RT or overnight at 4 °C. 
After incubation, the cover slips were washed in 1x PBS three times for 10 min and then 
incubated for 1 h at RT with the secondary antibody diluted in antibody buffer. If the 
nuclei were to be visualized the cover slips were then incubated for 10 min at RT with 
DAPI in PBS (0.0004% w/v) The cells were then washed again three times for 10 min 
in 1x PBS, the coverslips then dipped briefly into Millipore water and mounted with 
Aqua-Poly/Mount on a previously cleaned glass slide. The mounted cells were kept at 4 
°C until they were examined by fluorescence microscopy.  
3.2.6.2 Immunofluorescence staining of cryosections 
 
Slides with cryosections were removed from –80 °C and allowed to adjust to RT. The 
sections were encircled with Roti-Liquid Barrier marker to contain the buffers on the 
sections. After the Roti-Liquid barrier marker was dried the sections were rehydrated in 
1x PBS for 15 min at RT. Excessive 1x PBS was carefully removed using Kimwipes. 
200 μ
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wet chamber. The blocking buffer was subsequently removed and 200 μl of antibody 
buffer with the appropriate primary antibodies were added to the slides. The sections 
were incubated with the primary antibody in a wet chamber at 4 °C overnight. The next 
day the primary antibody was removed and the sections were washed 4 x 10 min with 
1x PBS at RT in glass cuvettes. Then the appropriate secondary antibodies diluted in 
antibody buffer were added to the slides and incubated in a wet chamber in darkness for 
one hour at RT. Afterwards, the secondary antibodies were removed and the sections 
were washed 1 x with DAPI in 1x PBS for 10 min at RT and 3 x in 1x PBS for 10 min 
at RT. The sections were briefly dipped in MilliQ H2O which was then removed using a 
Kimwipe. The sections were mounted with coverslips using Aqua-Poly/Mount and 
stored at 4 °C in the dark. 
3.2.6.3 ß-Galactosidase staining 
 
ß-Galactosidase was used as a reporter gene in transgenic mice deficient for HDAC4 
and HDAC5. HDAC4-/- mice were generated by knock-in of a nuclear-localized LacZ 
cassette into exon 6 of HDAC4 such that LacZ was in-frame with amino acid 162 (Rick 
B. Vega 2004). In HDAC5-deficient mice expression of the enzyme takes place in cells 
with a perturbation of the endogenous HDAC-expression. ß-Galactosidase staining can 
therefore be used to assess the tissue distribution of HDAC5 expression.  
The pregnant female was sacrificed and E13.5 or E15.5 embryos removed from the 
uterus. The embryos were incubated in ß-galactosidase fixation solution for 60 minutes 
at 4 °C. They were washed three times for 20 min in wash buffer and three times for 20 
min in 1x PBS. The embryos were then incubated in 15% sucrose in PBS at 4 °C 
overnight. Then they were incubated in 30% sucrose overnight at 4 °C and eventually 
embedded in Jung tissue freezing medium and stored at –80 °C.  
From the embedded embryos 10 µm sections were prepared using a Leica CM1850 
cryostat and collected on slides. The slides were stored at –80 °C. 
Before staining the sections on glass slides were encircled with clear nail polish. The 
sections were then encircled re-fixed in 0.2% glutaraldehyde in PBS for 10 min at 4 °C 
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and washed three times for 5 min in wash buffer and subsequently incubated with ß-
galactosidase staining solution at 37 °C overnight. The next day they were washed for 
10 min with PBS. A part of the stained sections on each slide was counterstained with 
nuclear fast red by incubating the two separate brain slices in a 1:4 dilution of Nuclear 
Fast Red for 1 min. The sections were then incubated in dilutions of ethanol of 
increasing concentrations: 50% ethanol for 5 min, 70% ethanol for 5 min, 80% ethanol 
for 5 min, 90% ethanol for 5 min and pure ethanol for 5 min. They were incubated in 
xylol for 5 min in a fume hood and eventually mounted in Entellan.  
3.2.7 Mouse strains and genotyping  
3.2.7.1 Mouse Strains 
 
All animal experiments were carried out according to the guidelines of the University of 
Heidelberg and the State of Baden-Württemberg. 
The mouse lines were kept in the animal facility of the University of Heidelberg (IBF). 
They were exposed to light between 6:00 AM to 6:00 PM. For the administration of the 
colonies the software 4D Client (TierBase) was used.  
To obtain timed-pregnant females, one male and two female mice were set up per cage 
on a certain day and the females controlled each day for the rest of the week for a 
vaginal plug. Once a plug was detected, the animals were separated. E0.5 was assumed 
to be at noon of the day when the vaginal plug was detected.  
3.2.7.1.1 C57BL/6 mice 
 
C57BL/6 is a substrain of C57BL which was created by Clarence Cook Little in 1921 at 
the Bussey Institute for Research in Applied Biology. The subline C57BL/6 became the 
inbred strain which is most extensively used for creating transgenic lines today (Bult et 
al 2008). In 2002, the genome of the substrain C57BL/6J was sequenced (Waterston et 
al 2002). 
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3.2.7.1.2 HDAC4 conditional knock-out mice  
 
In order to allow for a conditional knock-out of HDAC4 in specific tissues, Potthoff et 
al inserted two loxP sites into the HDAC4 gene, which are flanking exon 6. This 
insertion leads to an out-of-frame mutation of the HDAC4 open reading frame (Potthoff 
et al 2007).  
 
Figure 3.3. Targeting of Cre-REcombinase to the HDAC4 Gene (modified from (Potthoff 
et al 2007)) 
3.2.7.1.3 HDAC4 LacZ knock-in mice  
 
HDAC4 LacZ knock-in mice were generated by Vega et al via gene targeting. Genomic 
sequences between exons 5 and 6 and between 6 and 7 were cloned into a targeting 
vector encoding nuclear LacZ and a neomycin resistance cassette. The vector was 
linearized and electroporated into ES cells. This insertion led to in-frame knock-in of 
those elements into exon 6 by homologous recombination. Generation of chimeric mice 
from successfully targeted ES clones and subsequent breeding of the offspring to obtain 
germline transmission were carried out using C57BL/6/129 mixed background mice 
(Vega et al 2004b).  
HDAC4 LacZ knock-in mice were mated to C57BL/6 mice to enable for screening of 
HDAC4 expression in the embryonic brain. 
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Figure 3.4. Gene targeting of the HDAC4 locus (modified from (Vega et al 2004b)) 
3.2.7.1.4 HDAC5 LacZ knock-in mice 
 
HDAC5 LacZ knock-in mice were generated by Cheng et al. similarly to the HDAC4 
LacZ knock-in strain by gene targeting. The HDAC5 targeting construct was generated 
with the pN-Z-TK2 vector, containing a nuclear LacZ cassette and a neomycin 
resistance gene. The LacZ cDNA and neomycin resistance cassette controlled by a PGK 
promoter were fused in-frame  with  the  5’  region  of  exon  3,  placing the ß-galactosidase 
reporter gene under the control of the endogenous HDAC5 promoter. The targeting 
vector was linearized and electroporated into mouse D3 embryonic stem (ES) cells. 
Correctly targeted ES cell clones were identified by Southern blotting and injected into 
3.5-day mouse C57BL/6 blastocystst to generate chimeric males. Those were then bred 
to C57BL/6 females to achieve germ line transmission of the mutant allele.  
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Figure 3.5. Gene targeting of the HDAC5 locus (modified from Chang et al. 2004) 
3.2.7.1.5 Nes::cre mice  
 
Tronche et al. generated this line expressing the cre-recombinase via injection of the 
nestin::cre DNA construct into oocytes from strain mouse BL6/SJF2 (Tronche et al 
1999). Nestin is an intermediate filament protein expressed in neural stem cells of the 
developing central nervous system (Chang 2004). Although its expression is claimed to 
be restricted to the central nervous system, it has also been detected in the peripheral 
nervous system (PNS) (Tucker et al 2001). The targeting vector encoded for cre under 
the control of the nestin promoter. Downstream of the polyadenylation signal (human 
growth hormone polyadenylation signal) (Tronche et al 1999) the vector also contained 
a nervous system-specific enhancer present in the second intron of the rat nestin gene 
(Zimmerman et al 1994).  
HDAC4 conditional mice were mated to Nes::Cre mice in order to achieve conditional 
knock-out of HDAC4 in the developing central nervous system. 
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3.2.7.2 Genotyping 
 
In order to genotype transgenic animals, DNA was extracted from tail tissue of 
embryos, newborn or adult mice according to a modified protocol of Laird et al. (1991). 
Tails were digested overnight with 500 µl lysis buffer supplemented with 5 µl 
proteinase K each at 55 °C in a hybridization oven in a rotating glass tube. After 
digestion DNA was precipitated by adding 500 µl 2-propanol to each sample, the 
mixture vortexed and incubated at –80 °C for 30 minutes. Afterwards, the samples were 
centrifuged for 15 minutes at 13 000 rpm and 4 °C. The supernatant was discarded; the 
DNA pellet was washed with 300 μl of 70% ethanol and centrifuged for another 10 min 
at 13 000 rpm and 4 °C. Ethanol was removed and the pellets were allowed to dry. The 
dried pellets were redissolved in 70 μl of TE buffer overnight at 55 °C.  
Genotypes of transgenic animals were determined by polymerase chain reaction (PCR). 
All genotyping experiments were carried out with both negative and positive controls. 
In negative controls water was added instead of DNA to exclude unspecific 
amplification. As a positive control, a sample from a either heterozygous or 
homozygous mutant animal was used.  
3.2.7.2.1 HDAC4 conditional knock-out mice and HDAC4 LacZ knock-in mice 
 
The expected PCR product for wildtype animals was 480 bp, the one for the floxed 
allele 620 bp and the product for the LacZ knock-in allele 810 bp.  
The reaction mix for the PCR reaction was as follows 
Reagent HDAC4 cond. knock-out HDAC4 LacZ knock-in 
 Volume [µl] Volume [µl] 
10 mM HDAC4 fw 0.4  
10 mM HDAC4 rev 0.4  1.5 (primer mix*) 
10 mM HDAC4 LacZ rev -  
10 mM dNTPs 0.4 0.4 
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50 mM MgCl2 0.8 0.8 
1 x reaction buffer 2.0 2.0 
dd H2O 15.7 15.0 
Taq polymerase 0.1 0.1 
DNA 0.5 0.5 
* The primer mix consisted of HDAC4 fw, HDAC4 rev and HDAC4 LacZ rev in a ratio 
of 2:1:1.  
The PCR reaction was carried out in either a Biometra Tpersonal cycler or a BioRad 
iCycler. The programme used was the following:  
94 °C 2 min  
96 °C 15 sec  
58 °C 30 sec 35 cycles 
72 °C 2 min  
72 °C 10 min  
3.2.7.2.2 NesCre mice 
 
To test for the presence of the cre allele in animals, a PCR reaction was carried out. The 
expected PCR product was 500 bp long, if there was no cre allele, there would not be 
any product. This set-up does not allow discriminating in cre positive animals, whether 
there are one or two copies present. The reaction mix is as follows: 
Reagent Volume [µl] 
10 mM Nes::Cre fw 0.4 
10 mM Nes::Cre rev 0.4  
10 mM dNTPs 0.4 
50 mM MgCl2 0.8 
10x reaction buffer 2.0 
dd H2O 15.7 
Taq polymerase 0.1 
DNA 0.5 
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The PCR was carried out in a Biometra Tpersonal cycler according to the following 
programme:  
95 °C 5 min  
95 °C 30 sec  
60 °C 30 sec 40 cycles 
72 °C 37 sec  
72 °C 5 min  
3.2.7.2.3 HDAC5 LacZ knock-in mice 
 
The expected size for the PCR product of a wildtype allele is 300 bp, the size of the 
LacZ knock-in allele 500 bp.  
Reagent Volume [µl] 
10 mM gt-HDAC5-fw  
10 mM gt-HDAC5-rev 1.5 (primer mix*) 
10 mM gt-HDAC5-LacZ-rev  
10 mM dNTPs 0.4 
50 mM MgCl2 0.8 
10x reaction buffer 2.0 
dd H2O 15.0 
Taq polymerase 0.1 
DNA 0.5 
* The primer mix consisted of HDAC4 fw, HDAC4 rev and HDAC4 LacZ rev in a ratio 
of 2:1:1.  
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The PCR reaction was carried out in a BioRad iCycler according to the following 
programme:  
95 °C 4 min  
95 °C 30 sec  
62 °C 30 sec 35 cycles 
72 °C 45 sec  
72 °C 5 min  
The PCR product was either applied on an agarose gel or stored at –20 °C until 
electrophoresis. The product is separated via agarose gelelectrophoresis in an 1.5% 
agarose gel. Each sample is supplemented with 10x Orange G marker. 10 µl of PCR 
product and Orange G are applied to each lane of the gel. Electrophoresis is run at 120 
V. After the run, the gel is stained in ethidium bromide for 15 min and eventually 
photographed on an UV transilluminator. 
3.2.8 In situ Hybridization 
3.2.8.1 Preparation of tissue samples 
3.2.8.1.1 Fixation 
 
The pregnant female was sacrificed, the embryos dissected out of the uterus and 
decapitated. The heads were collected in cold 1 x PBS and then fixed overnight on a 
rocker in 4% PFA at 4 °C, pH 7.4. The PFA was filtered after preparation and 
adjustment of pH. Fixed tissue was either processed further for embedding or stored for 
a short period of time at 1% PFA at 4 °C.  
The heads were dehydrated in a series of ethanol solutions with ascending 
concentrations and subsequently acetone. In order to be penetrated completely, tissues 
should not exceed 5 mm in length. The heads were placed in ethanol solutions and 
incubated on a laboratory rocker at room temperature. Afterwards, they were incubated 
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in acetone and eventually in liquid paraffin in and incubation oven. The incubation 
protocol is as follows:  
repetitions time solution temperature 
3 30 min 1x PBS RT 
3 1 h 50% ethanol RT 
2 1 h 70% ethanol RT 
1 over night 70% ethanol 4 °C 
2 30 min 80% ethanol RT 
2 30 min 90% ethanol RT 
2 30 min 96% ethanol RT 
2 30 min absolute ethanol RT 
1 1 h aboslute ethanol RT 
1 1 h ethanol:acetone (1:1) RT 
2 1 h acetone RT 
1 over night paraffin 65 °C 
2 2 h paraffin 65 °C 
The paraffin was melted in the incubation oven at 65 °C before use. Also the embedding 
moulds were pre-heated in the oven prior to embedding. They were then placed on a 
heater and about half of each mould filled with liquid paraffin. The heads were placed 
in the moulds, oriented as desired for coronal sectioning and afterwards the heater 
turned off and the paraffin allowed to cool down and harden. The blocks with the heads 
were removed from the moulds, labelled with laboratory tape and kept in Ziploc bags at 
room temperature until sectioning.  
3.2.8.1.2 Paraffin sectioning 
 
The embedded embryo heads were cut with a Leica microtome and Feather blades to 10 
– 12 μm thick paraffin sections. The sections are collected with a small water bath just 
behind the blade, transferred with a paintbrush to another water bath at 50 – 52°C. The 
sections flattened on the surface of the warm water and were immediately picked up and 
mounted on a superfrost ultra plus microscopy glass slide. The sections were dried 
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overnight at 37 °C and subsequently stored at 4 °C until in situ hybridization is carried 
out on them.  
3.2.8.2 Generation of in situ probes 
 
For in situ probes for HDAC4 and HDAC5 we used sequences that had been published 
within the Allen brain atlas.  
3.2.8.2.1 HDAC4 
 
Length: 598 
GC Percent: 56.6890 
Reverse Primer Tag: SP6 
Forward Primer: CCTCTGCCAGAAAAGGTTCTAC 
Reverse Primer: CAACTTGATTCAGCAACTCTGC 
Sequence: 
CCTCTGCCAGAAAAGGTTCTACATCAGAGACCCAATGCCAATGCTGTCCACTCC
ATGGAGAAAGTGATGGACATCCACAGCAAGTACTGGCGCTGCCTGCAGCGTCT
GTCCTCCACGGTGGGGCACTCTCTGATTGAGGCGCAAAAGTGTGAGAAGGAAG
AAGCTGAGACAGTCACCGCCATGGCCTCGCTGTCTGTAGGCGTCAAACCTGCTG
AGAAGAGATCTGAGGAGGAGCCCATGGAGGAGGAACCACCACTGTAGCCCGA
AGCTGCTGTTCTCTCCTTTGTTTGTCTGTCTTGAAGCTCAGCCAAGAAACTTACC
CGTATCACTCCTGCGTCCTGCCTTGGTGCTCTCTTGAGTACAAAGGGACAGCAG
GCGTGCAGCAGCAACGGGAAGCCTTTCTGCCGCCCTGGACCACAGGTCTGGAG
ACGCACACGGAACACCGGGTGTGGCAGATCACATGGAACACAGGACAGCGCG
CAACACACGGGCACACAGACATGTGGAAGCCAAGCACACGCTGGTGGCTCCCC
CTCCCCCTGGGAAGCCTCGAAGGAAGAAGCTTGTGGCAACTTGGGCAGAGTTG
CTGAATCAAGTT 
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3.2.8.2.2 HDAC5 
 
Length: 684 
GC Percent: 62.8655 
Reverse Primer Tag: SP6 
Forward Primer: CTATACGTCTCCTTCTCTGCCC 
Reverse Primer: CTCCTCCTCCTCCTCTTCTAGG 
Sequence: 
CTATACGTCTCCTTCTCTGCCCAACATCTCCCTAGGGCTGCAGGCCACTGTCACT
GTCACCAACTCGCACCTCACCGCCTCCCCGAAGCTGTCAACACAGCAGGAGGC
TGAGAGGCAGGCCCTTCAGTCCCTGCGGCAGGGCGGCACACTGACCGGCAAGT
TCATGAGCACATCCTCCATCCCTGGCTGCCTGTTGGGAGTGGCACTGGAGGGTG
ACACAAGCCCCCACGGGCACGCTTCCCTGCTGCAGCACGTTTGCTCCTGGACAG
GCCGGCAACAGAGCACGCTCATAGCAGTGCCGCTTCATGGGCAGTCCCCACTG
GTGACGGGTGAACGTGTGGCCACCAGCATGAGGACGGTGGGTAAGCTCCCGAG
GCACCGACCTCTGAGCCGCACTCAGTCCTCCCCGCTGCCGCAGAGTCCCCAGGC
CCTGCAGCAGCTGGTCATGCAGCAGCAGCACCAGCAGTTCCTGGAGAAGCAGA
AGCAGCAGCAGATGCAGCTGGGCAAGATCCTTACCAAAACTGGGGAGCTGTCA
AGGCAGCCCACCACTCACCCGGAGGAGACAGAAGAGGAGCTGACGGAGCAGC
AGGAGGCCTTGCTGGGAGAGGGGGCCCTGACCATTCCCCGGGAAGGCTCTACA
GAAAGTGAGAGCACCCAGGAAGACCTAGAAGAGGAGGAGGAGGA 
The plasmids containing the desired sequence are linearized using appropriate 
restriction enzymes according to the following reaction setup: 20 µg plasmid DNA, 1 µl 
restriction enzyme, 3 µl 10 x restriction buffer, dd H2O ad 30 µl. The reaction mixture 
was incubated for 2 h at 37 °C or RT, depending on the reaction temperature of the 
enzyme. Linearization was controlled by gel electrophoresis, 1 – 2 µl of the reaction 
mix was loaded on a 0.75 or 1% agarose gel together with one lane of the original 
circular plasmid.  
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In case that the plasmid was not completely linearized yet, another volume of enzyme 
was added and the mix incubated again at the appropriate temperature.  
After linearization the plasmid was purified using the Nucleospin Extract II Kit 
according to manufacturer´s instructions. The concentration of the purified plasmid was 
measured by spectrophotometry and the DNA stored at –20 °C.  
3.2.8.2.3 Probe synthesis 
 
To synthesize the probe the following reaction was set up:  
Reagent volume [µl] 
5x transcription buffer 2 
10x DIG nucleaotide mix 1 
linearized plasmid [1 µg/µl] 1 
RiboLock RNase Inhibitor 0.25 
T3, T7 or Sp6 RNA polymerase 1 
dd H2O 4.75 
The RNA synthesis reaction was incubated overnight in a water bath at 37 °C. 
Subsequently, to precipitate the probe, 5 µl of 10 M Ammonium acetate and 40 µl 
ethanol were added and the reaction mix incubated at -80°C for one hour. It was then 
centrifuged for 45 min at 4 °C and 13 000 rpm in a benchtop centrifuge. After removing 
the supernatant, the probe pellet was washed with 300 µl 70% ethanol and centrifuged 
for 10 min at 13 000 rpm and 4 °C: The supernatant was removed and the pellet air 
dried. Afterwards, the probe was dissolved in 30 µl of hybridization mix and stored at –
20 °C. To control for the probe synthesis, 2 µl of the probe were analyzed via 
electrophoresis in a 2% agarose gel in TBE buffer.  
3.2.8.3 Denaturing RNA gel 
 
The gel chamber was cleaned with water before using. It was filled with water which 
was left in the chamber for about 20 minutes. The Gel comb was incubated with 0.5 
NaOH and also the gel tray cleaned with 0.5 N NaOH.   
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The gel was prepared as follows 2.2 M formaldehyde and 1.5% or 2.0% agarose in 
formaldehyde gel running buffer. Ethidiumbromide (0.5 µg/ml) was added to the gel.  
As controls total-RNA from heads was used, in which 18 S and 28 S RNA are readily 
visible. Those samples were obtained from Marc Willaredt.  
3.2.8.3.1 Sample preparation 
 
2 µl in situ probes are supplemented as follows to be analyzed in a gel: 
RNA (probe) 2.25 µl 
5x formaldehyde gel-running buffer 1.0 µl 
Formaldehyde 1.75 µl 
Formamide 5 µl 
RNA, 5x formaldehyde gel running buffer, formaldehyde, and formamide were mixed, 
incubated 15 min at 65 °C and then chilled on ice. The samples were briefly centrifuged 
to collect the liquid and supplemented with 1 µl sterile, DEPC treated formaldehyde 
gel-loading buffer.  
Before loading the samples the gel was run without any sample for 5 minutes at 5 V/cm. 
To prevent the samples from floating up out of the gel pockets, the gel was loaded 
without buffer and the 1 x formaldehyde gel running buffer only filled into the gel 
chamber exactly until the upper edge of the gel.  
The gel was run at 60 V (3 V/cm) for 4.5 h. Every hour, the buffer from the two gel 
chamber reservoirs was collected, mixed and returned to the gel apparatus.  
After running the entire gel was fluorescing strongly in UV-light. To decrease the 
background fluorescence, the gel was washed in DEPC treated water for 2.5 h up to 
overnight. After the washing the background was sufficiently decreased and the bands 
clearly visible. 
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3.2.8.3.2 Hybridization protocol 
 
Paraffin sections of embryo heads were allowed to adjust to RT. At first, paraffin was 
removed and the sections re-hydrated. The sections were therefore incubated in the 
following solutions:  
Repetitions Time Solution Temperature 
3 7 min 100% xylene RT 
1 2 min ethanol:xylene (1:1) RT 
1 1 min Absolute ethanol RT 
1 1 min 96% ethanol RT 
1 1 min 90% ethanol RT 
1 1 min 70% ethanol RT 
1 1 min 50% ethanol RT 
2 5 min 1x PBS RT 
1 5 min 20 µg/ml proteinase K in PBS RT 
1 5 min 0.2% glycine in PBS RT 
2 5 min 1x PBS RT 
1 20 min 4% PFA/0.2% glutaraldehyde in PBS RT 
2 5 1x PBS RT 
After the last wash as much liquid as possible was removed from the sections. The slide 
was dried a little with a laboratory tissue around the sections. The sections were 
encircled with a barrier pen (ImmEdge, Vector Laboratories). The microscope slides 
were placed on metal slide supports in a moist chamber with 50% formamide/ 2x SSC, 
pH 4.5. Hybridization mix was incubated for 5 min at 95 °C and subsequently 7.5 µl of 
hybmix were carefully pipetted on each section. The sections were prehybridized in the 
moist chamber for one hour at 70 °C. The in situ probes were diluted in hybmix to a 
final concentration of 1 ng/µl and incubated for 5 min at 95°C. After prehybridization 
hybmix was removed from the sections and 7.5 µl of probe diluted in hybmix added to 
the appropriate sections. Hybridization was carried out overnight in the moist chamber 
in the hybridization oven at 70°C. The chamber had to be sealed well to prevent drying 
of the sections.  
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After hybridization, slides underwent the following incubation or washing steps:  
Repetitions Time Solution Temperature 
1 15 2x SSC, pH 4.5 RT 
2 15 50% formamide/2 x SSC, pH 4.5 65 °C 
3 10 1x PBST RT 
After washing with PBST liquid was removed as much as possible from the slides and 
they were placed on metal slide supports in a moist chamber with water. 100 µl B-block 
were pipetted onto each slide to cover the sections. Incubation was carried out in the 
moist chamber for one hour at RT. After removing B-Block, slides were incubated for 
two hours at 37 °C with anti-digoxygenin antibody diluted 1:1000 in B-Block. The 
sections were washed three times for 5 min with 1x PBST and then for 10 min with 
NTM on a shaker at RT. The slides were placed back on metal slide supports in a dark 
moist chamber. To start the colour development, 400 µl NBT/BCIP diluted 1:50 in 
NTM were added onto each slide. Incubation took place at RT and the progress of the 
colour reaction was controlled every half an hour using a microscope. Sense and 
antisense probes were developed the same amount of time. To stop the enzymatic 
reaction, slides were washed once with PBST and then post-fixed with 4% PFA for 10 – 
20 min. After the fixation they were washed twice with 1x PBS for 5 min at RT. The 
sections were mounted with aquatex and stored at 4 °C. 
The sections were examined with a Leica DM LB microscope and photographed with a 
Leica DFC320 microscope camera.  
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4 Results 
4.1 Analysis of the role of class I and II HDACs in 
neuro- and gliogenesis in embryonic mouse 
brain in vitro 
4.1.1 Class I and II HDACs are expressed in developing mouse 
brain - analysis through real time RT-PCR 
Expression of HDACs in embryonic mouse brain was examined using real time RT-
PCR on total RNA lysates of embryonic brain tissue at embryonic days E 13.5 and E 
15.5.  
4.1.1.1 HDAC1, -2, -3, -4, -5, 7a, and -8 are present in embryonic mouse 
brain at 13.5 dpc 
In order to determine whether class I and II HDACs are expressed in the developing 
brain in vivo, quantitavtive real time RT-PCR analysis was performed on total RNA 
lysates from embryonic brain regions dissected at two different developmental ages. 
Cortex, developing basal ganglia and hippocampus were dissected from E13.5 and 
E15.5 brains as carefully as possible and RNA extracted from the samples. After reverse 
transcription, real time RT_PCR was performed with TaqMan Assays to detect 
individual HDACs.  
The real time RT-PCR analysis confirmed expression of all examined HDACs at both 
13.5 dpc and 15.5 dpc, however not all HDACs showed the same levels of expression. 
At 13.5 dpc the expression of HDAC1, -2, -3, -4, -5, -7a, and -8 was examined in 
cortex, striatum and hippocampus. HDAC2 showed the highest expression in all 
examined brain tissues, cortex striatum and hippocampus (Figure 4.1), HDAC3 the 
second highest. HDAC1 showed the lowest expression levels, HDAC4, -5, -7a and -8 
intermediate levels, however all very similar to each other.  
4  Results   Kathrin Weißmüller, 2013 
112 
 
 
Figure 4.1. Expression levels of HDACs in embryonic brain tissue at E 13.5 determined 
via real time RT-PCR using TaqMan Assays for HDAC1, -2, -3, -4, -5, -7 and -8 
To compare expression levels not only compared within one brain area, but to compare 
respective expression levels between brain areas, relative expression of the individual 
HDACs is was normalized to the level in hippocampus as a standard.  
Here HDAC1 was found to have a much higher expression in hippocampus compared to 
the other regions, which might hint to a specific role there.  
On the other hand, expression of HDAC5 is more than 3-fold higher in striatum and 
almost 3-fold higher in cortex than in hippocampus. I am reluctant to conclude that 
HDAC5 expression levels are higher in these areas because the standard deviation is 
comparably high. Expression levels of all other HDACs are similar to each other in the 
different brain tissues (Figure 4.2).  
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Figure 4.2. Relative expression of HDACs in embryonic brain tissue at E 13.5 
normalized to hippocampus. Relative  expression  levels  calculated  with  ΔΔCt  method.  SEM 
4.1.1.2 HDAC1, -2, -3, -4, -5, 7a, -8, and -9 are present in embryonic 
mouse brain at 15.5 dpc. 
The expression of HDAC1, -2, -3, -4, -5, 7a, -8 and -9 was also examined in 15.5 dpc in 
striatum, cortex, hippocampus and liver as a non-brain tissue for comparison. 
Differently to 13.5 dpc tissue, HDAC3 showed the highest expression in all tissues, 
except from striatum, where both HDAC2 and HDAC3 had highest expression levels.  
HDAC2 had the second highest expression levels in brain, whereas HDAC7a was 
second highest in liver. Expression levels of HDAC 4 and 5 respectively were similar to 
each other and also similar in the different tissues (Figure 4.3). 
4  Results   Kathrin Weißmüller, 2013 
114 
 
  
Figure 4.3. Expression levels of HDACs in E 15.5 brain tissues determined by real-time 
RT-PCR using TaqMan Assays for HDAC1, -2, -3, -4, -5, -7 and -8 
Looking at relative expression levels in cortex and striatum compared to those levels in 
hippocampus again, HDAC1- and HDAC2-expression were lower in striatum and 
cortex. This corresponds to the result of the E 13.5 tissue. HDAC5 expression was more 
than 2.5-fold higher in cortex than in hippocampus (Figure 4.4). Also this result 
corresponds to the results of the E 13.5 brain tissue analysis. A relatively high 
expression of HDAC5 in cortex could hint to a specific role of this HDAC in this area in 
development.  
Taken together, all examined HDACs were expressed both at 13.5 and 15.5 dpc in all 
examined brain tissues. However, some prominent differences in expression levels 
could be observed. HDAC1 and -2 expression levels are relatively high in hippocampus 
compared to the other brain areas, whereas HDAC5 expression is high in those brain 
areas compared to hippocampus. These differences might hint to specific functions of 
different HDACs in the respective brain areas.  
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Figure 4.4. Relative expression of HDACs in embryonic brain tissue at E 15.5 
normalized to hippocampus for comparison. Relative expression levels calculated with 
ΔΔCt  method.  SEM 
4.1.2 In vitro analysis of influence of HDACs on embryonic 
neuro- and gliogenesis using the pharmacological 
inhibitor TSA 
4.1.2.1 Pharmacological inhibition of all class I and II HDACs in 
neurosphere cultures 
To test the influence of HDACs on neurogensis in vitro, we used neurosphere cultures 
to generate a uniform population of neural precursors from the medial and lateral 
ganglionic eminences of E15.5 dpc C57BL/6 mice (Reynolds & Weiss 1996). After 7 
days in suspension culture, neurospheres were dissociated and plated out to differentiate 
according to standard protocol (Gritti et al 2001). TSA was applied to the cultures 
during different time windows; it was however always applied immediately prior to 
withdrawal of FGF2 at 2.5 DIV after plating. An addition of TSA in a time window of 3 
h before withdrawal of FGF2 proved to be sufficient to inhibit neurogenesis in the 
cultures.  
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In order to analyze the signalling mechanisms involved in differentiation, RNA samples 
and protein lysates were prepared 6, 12, and 24 hours after treatment. RNA samples 
were examined by Real Time RT-PCR and Affymetrix GenChip 420 2.0. Protein 
samples were analyzed with western blot analysis.  
4.1.2.1.1 HDAC promotes neurogensis in ganglionic eminences in vitro – HDAC 
inhibition decreases neurogenesis in GE 
To assess the outcome of differentiation, neurosphere cultures were plated out for 
differentiation and cells fixed after 7 days in vitro and stained with appropriate 
antibodies. Staining with TuJ1 revealed that after 12 h of treatment with TSA or 
vehicle, neurogenesis was reduced to less than 50% in the TSA-cultures compared to 
controls (Figure 4.5). No change in astrogliogensis could be observed in this 
experiment.  
 
Figure 4.5. Decrease of neurogenesis in neurosphere-derived progenitor cultures upon 
treatment with TSA. Immunocytochemistry for neurons (TuJ1) and astrocytes (GFAP) in 
NS cultures differentiated for 7 days. Cells were treated with TSA or vehicle from DIV 1.5 
to 2.5. Quantification of TuJ1 and GFAP positive cells in the cultures. Scalebar 100 µm 
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4.1.2.1.2 Establishing FACS analysis to quantify neurogenesis reliably and 
efficiently 
As the method to quantify neurogenesis described above seemed to be tedious and 
prone to be biased by the individual round of immunostaining and counting, I intended 
to establish a more reliable method which would be less biased by the individual 
counting the cells in the microscopy images. FACS analysis seemed to be a very 
efficient and experimentally unbiased approach. After plating out neurosphere cultures 
to differentiate and treating the cells with TSA or vehicle as described, the cells were 
detached from the culture dishes, fixed and stained with TuJ1 antibody to determine the 
amount of newborn neurons in the cultures. The cultures were stained either with TuJ1 
antibody and secondary antibody or with secondary antibody alone to determine the 
background fluorescence. The forward (FSC-H) and sideward scatter (SHC-H) plot 
shows counting events within the first gate that are considered to be actual cells and not 
debris. Counting events outside the gates are not taken into analysis. The plot displaying 
fluorescent channels shows two gates with cells. In R1, cells are not stained as they can 
also be found with secondary antibody only. In R2 the cells positive for TuJ1 are 
depicted. In the control cultures (0 nM TSA), the amount of TuJ1 stained cells is the 
largest; it decreases with increasing TSA concentration.  
The FACS protocol confirmed the results of the conventional immunostainings and 
subsequent counting of stained cells on coverslips. Also with FACS, a dose dependent 
effect of TSA treatment on neurogenesis could be observed. Treatment with TSA led to 
a decrease in neurogenesis to almost 50% (Figure 4.7) 
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Figure 4.6. FACS analysis of neurosphere-
derived cultures plated out to differentiate and 
treated with TSA (B: 10 nM C: 50nM) or 
vehicle (A: 0 nM) for 12 h between 1.5 DIV to 
2.0 DIV. In the FSC and SSC plot, the gate R1 
contains counting events considered to be cells. 
Those are further displayed in the fluorescence 
plot. R2 contains unstained cells, R3 cell positive 
for TuJ1 and considered to be newborn neurons. 
 
 
Figure 4.7. Quantification of neurogenesis 
determined through FACS analysis. Cultures 
were plated out to differentiate and treated with 
TSA or vehicle for 12 h between 1.5 DIV to 2.0 
DIV. The percentage of TuJ1 positive cells is 
decreased by 50% upon treatment with 50 nM 
TSA. The effect is dose-dependent. 
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4.1.2.2 HDACs influence neurogenesis on a transcriptional level 
To better understand by which mechanism HADCs influence the generation of neurons 
and glia in embryonic brain, we turned towards examining signalling pathways known 
to be involved in these processes. First, we investigated the expression of several genes 
involved in BMP2/4 signalling because BMPs had been shown to promote astroglial 
lineage commitment in vitro (Gross et al 1996) and in vivo (Bonaguidi et al 2005).  
Since we expected HDACs to influence neuro- and gliogenesis on a transcriptional 
level, I performed Real Time RT-analysis to examine transcription of genes known to 
be involved in neuro- and astrogliogenic developmental programs. Neurospheres were 
prepared from E15.5 GE and cultured for 7 days. Subsequently, the cells were 
dissociated and plated out on polyornithine-coated coverslips. The cells were treated 
with TSA or vehicle in different time intervals, all of them ending at 2.5 dpc when 
FGF2 was removed from the cultures. Total RNA was collected and real time RT PCR 
carried out to examine transcription levels of potential target genes in TSA treated cells 
compared to controls.  
Especially when TSA was applied for 12 h 2 days after plating out, several changes in 
transcription levels of potential target genes could be observed (Figure 4.8).  
Upon inhibition of HDACs Bmp2 was transcriptionally upregulated, whereas Bmp4 
showed a downregulation (Figure 4.8a). No change was observed in transcription levels 
of Bmp receptors 1a, 1b and 2 (Figure 4.8b). Interestingly, Smad7, a negative regulator 
of Bmp2/4 signaling was downregulated (Figure 4.8e), which together with the 
upregulation of Bmp2 hints to the idea that inhibition of HDACs by TSA releases an 
inhibition of BMP signalling.  
Stat1 and Stat3, transcription factors known to promote astrogliogenesis, were 
upregulated 2- respectively 3-fold upon HDAC inhibition (Figure 4.8d).  
Ngn1 is known to promote neurogenesis in cortex. Expression of Ngn1 in GE is 
upregulated up to 3fold upon treatment of the cultures with TSA. The increase seems to 
be dose-dependent. Ngn2 expression however does not change significantly upon 
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pharmacological inhibition of HDACs (Shaked et al 2008). The up- and downregulation 
of all genes examined happened in a dose-dependent manner. 
 
Figure 4.8. real time RT-PCR analysis of gene expression upon treatment of 
differentiating neurosphere cultures with TSA to inhibit all class I and II HDACs. 
Relative expression of a. Bmp2 and Bmp4, b. BmpR1a, BmpR1b, and BmpR2, c. Ngn1 and 
Ngn2, d. Stat 1 and Stat3, e. Smad7. All results were normalized to Gapdh expression. 
Values   represent   the   mean   (+/−   SEM)   of   3   individual   experiments.   *   =   p<0.05,   **   =  
p<0.01, *** = p<0.001, Student’s  T-test. 
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In a second line of real time RT-PCR experiments we aimed to confirm the results 
obtained in the meantime with gene expression analysis through Affymetrix chips and 
also to look at the time course of gene expression upon HDAC inhibition in neurosphere 
cultures. In order to determine the influence of Bmp2 signalling on a transcriptional 
level, additional to TSA treatment, we also treated differentiating neurosphere cultures 
with 10 ng/ml BMP2.  
We had previously observed that treatment of the differentiating neurosphere cultures 
with 10 ng/ml BMP2 (10 ng/ml) from DIV1.5 to DIV 2.5 led to an almost 50% increase 
in astrocytes in the cultures (Shaked et al 2008). When inhibitors of BMP2/4 signalling 
(Noggin and Alk3-ECD) were added to the cultures, they had no effect on neurogenesis. 
However, in the TSA treated cultures, these inhibitors restored normal levels of neuro- 
and astrogliogenesis (Shaked et al 2008). 
RNA was isolated from the cells 6 h, 12 h and 24 h after the beginning of treatment at 
DIV 1.5. The observed dose-dependent increase of Bmp2 upon TSA-treatment 
corresponded to the previous experiments. The increase was transient; after 12 h the 
increase was less prominent and not detectable any more after 24 h. Bmp2 treatment did 
not change its own expression at all (Figure 4.9a). Bmp4 expression was decreased, 
especially after 6 hours of treatment in a dose-dependent manner, confirming the result 
of the previous experiments. Also adding Bmp2 to the cultures reduced the expression 
of Bmp4 (Figure 4.9b). Stat3 expression was upregulated in a dose-dependent manner 
at all three time points, with a slight increase from 6 h to 24 h. Treatment with Bmp2 
increased Stat3 expression 6 h and 12 h as well. Smad7 was downregulated in a dose-
dependent manner after TSA treatment. The downregulation was stronger at later time 
points than after 6 h. Treatment with Bmp2 however led to a strong upregulation of 
Smad7 expression, which would be expected.  
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Figure 4.9. Quantitative real time RT-PCR to determine expression of genes involved 
in neuro- and astrogliogenic developmental programs. RNA isolated from NS cultures 
differentiated for 2.5 days, treated with TSA, BMP2 or vehicle for 6 h, 12 h or 24 h (DIV 
1.5 – 2.0). TaqMan assays for the following genes were applied: a. Bmp2, b. Bmp4, c. 
Smad7 and d. Stat3. All results were normalized to Gapdh expression. Values represent the 
mean  (+/−  SEM)  of  3  individual  experiments  (6  h  and  24  h) or 2 individual experiments (12 
h). *  =  p<0.05,  **  =  p<0.01,  ***  =  p<0.001,  Student’s  T-test. 
4.1.2.3 Protein translation is necessary to upregulate BMP2 expression 
upon TSA treatment 
In order to determine whether expression of BMP2 is directly or indirectly regulated by 
Stat3, the HDAC inhibition experiment was carried out with additional samples which 
were treated not only with TSA, but with cycloheximide (5 µg/ml). Cycloheximide 
(CHX) inhibits protein biosynthesis in eukaryotes. It blocks translational elongation by 
interfering with the translocation step of tRNA and mRNA in relation to the ribosome. 
The effect is reversible. CHX was added to the cultures 1 h before TSA treatment was 
started.  
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In the presence of both TSA and CHX for 3 hours, the upregulation of BMP2 
expression did not take place as observed with only TSA treatment of the cultures. 
BMP2 expression is not upregulated in the presence of a translational inhibitor (Figure 
4.10a). Moreover, the downregulation of Bmp4 expression did not occur as observed 
before without inhibition of translation (Figure 4.10b). We considered this finding as a 
hint that after treatment of the cultures with HDAC inhibitors a specific factor is 
expressed which then in turn upregulates BMP2 expression and the same applies for 
Bmp4 downregulation. One of the potential candidates to regulate the Bmp expression 
could be Stat3. The expression of Stat3 in striatal neurosphere cultures increases with 
HDAC inhibition through TSA treatment. When cultures were treated with CHX 
additionally, the increase in Stat3 expression was slightly lower than with TSA 
treatment only but still visible (Figure 4.10c). The expression of Stat3 does not seem to 
depend on the previous translation of other factors as it seems to be the case for BMP2.  
  
 
Figure 4.10 Quantitative real time RT-PCR to 
determine expression of genes involved in 
neuro- and astrogliogeniesis after inhibition of 
translation. RNA isolated from NS cultures 
differentiated for 2.5 days, treated with TSA or 
vehicle for 3 h and CHX. TaqMan assays for the 
following genes were applied: a. Bmp2, b. Bmp4, 
c. Stat3. All results were normalized to Gapdh 
expression.  Values  represent   the  mean  (+/−  SEM)  
of 3 individual experiments. * = p<0.05, ** = 
p<0.01,  ***  =  p<0.001,  Student’s  T-test..  
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4.1.2.4 TSA and BMP2 treatment elicit similar responses of BMP2/ 
signaling in different time frames 
The reporter assays with cells treated with TSA or BMP2 also confirmed our finding, 
that Bmp2/4 signaling is regulated in both treatment protocols, but following a different 
timely order. Bmp2 treatment elicits a response in BMP2/4 signalling already after few 
hours of treatment. The expression of firefly luciferase is driven by consecutively 
aligned BMP-responsive elements (BRE) which are binding motifs for Smads and 
therefore reporters for Bmp signalling. BMP2 treatment led to a strong increase in 
luciferase fluorescence intensity. TSA treatment, however, first led to a downregulation 
of BMP2/4 signaling and subsequently, after a longer time of treatment, to an 
upregulation. The effect of TSA on BMP2/4 signaling might be indirect. The directional 
change in the reaction should be investigated further.  
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Figure 4.11. Time course of treatment intervals with TSA or BMP2 and subsequent 
luciferase assay to determine levels of BMP2/4 signaling in the cultures. 
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4.1.2.5 Microarray analysis of pathways potentially involved in HDAC 
influence on neurogenesis 
Which pathways and genes are involved in TSA and BMP2-mediated regulation of 
neuro- and astrogliogenesis was addressed in a Microarray study with neurosphere-
derived cultures treated with 10 nM or 50 nM TSA for 12 h before withdrawal of FGF2. 
RNA was collected 6h and 24 h after the end of the treatment window. Gene expressing 
profiling with Affymetrix GenChip 420 2.0 of samples after 6 h and 24 h. Genes were 
considered significantly regulated if their expression had changed more than 2-fold and 
exceeded a minimal difference of 100 comparing treated and mock-treated cells with a 
confidence greater than 90%. Since these experiments were carried out in collaboration 
and have been published previously (Scholl et al 2012),   I   don’t   want   to   present   all  
results here and instead give a short overview.  
220 genes were significantly different in expression in cells treated with BMP2 for 6 h, 
573 in cells treated for 24 h. TSA treatment led to an expression change in 917 genes 
after 6h and in 982 genes after 24 h.  
In order to identify an overlap of regulated genes within TSA and BMP2 treatments 
Venn analyses were carried out intersecting TSA 6 h and 24 h, BMP2 6 h and 24 h 
respectively. This analysis showed that a majority of regulated genes was unique to 
each treatment condition, only small numbers of genes occurred in the intersections. 
The largest intersection was found between TSA 6 h and 24 h; expression of more than 
half of the BMP2 6 h genes overlapped with the one of BMP2 24 h genes. More genes 
were in common between the two treatments after 24 h than after 6 h, but only eight 
genes were common to both treatments at all-time points: Gpr17 (G protein-coupled 
receptor 17), Lims2 (LIM and senescent cell antigen like domains 2), Bcas1 (breast 
carcinoma amplified sequence 1), Ptpre (protein tyrosine phosphatase, receptor type, E), 
Afap1l2 (actin filament associated protein 1-like 2), Dll3 (delta-like 3), G0s2 (G0/G1 
switch gene 2), and Gpd1 (glycerol-3-phosphatase dehydrogenase1).  
65 genes were regulated in three out of four experimental groups, most of them 
regulated in the same direction. Few genes showed opposed expression: Smad7, Papss2, 
Fam19a2, Cadps, Car8 and Efhd1.  
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Among the genes regulated by BMP2 6h and 24h and TSA 24h several genes involved 
in BMP2/4 signalling were detected (Bmp4, Smad7, Fst and Bambi) 
Hierarchical clustering of the microarray data with the clustering option of dChip was 
carried out to illustrate the overall relationship between regulated genes. All genes 
regulated in at least one of the conditions were clustered using the same conditions 
mentioned above (twofold change, Euclidean distance 100).  
The clustered genes were functionally annotated with the DAVID Database which 
allows classification of regulated genes according to their functional relevance. Each of 
the six sub-clusters was annotated separately; strong differences in the functional 
categories were detected.  
Genes upregulated in TSA treated cells were annotated to the following groups: antigen 
processing, metabolism, cell membrane and cell adhesion. Genes downregulated upon 
TSA treatment belong to the functional groups chromosome organization, 
transcriptional processes, metabolism, and posttranslational processes. 
Genes upregulated by BMP2 treatment were annotated in functional groups cell 
communication, cell membrane, extracellular matrix, and differentiation and 
development. Genes downregulated by BMP2 treatment belonged to the functional 
groups cell communication, signal transduction. Genes annotated to the functional 
groups extracellular matrix and cell adhesion were upregulated by both treatments, 
genes annotated to differentiation and development were downregulated by both 
treatments.  
BMP2 and TSA treatment resulted in independent gene expression profiles, the 
downregulation of genes seems to reflect the similar phenotype seen after both 
treatments.  
Only few primary target genes of TSA and BMP2 clustered together, but many genes 
involved in neural development were present: Mag (myelin-associated gly-protein), Mal 
(myelin and lymphocyte protein), Mog (myelin oligodendrocyte glycoprotein), Omg 
(oligodendrocyte myelin glycoprotein), Mbp (myelin basic protein), Mobp (myelin-
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associated oligodendrocytic basic protein) were downregulated in one or both 
treatments 
The functional annotation clustering did not reveal an enrichment of direct target genes 
of TSA or BMP2, therefore an additional DAVID analysis including genes regulated 
significantly after different times of treatment was carried out. After 6 h of BMP2 
treatment genes annotated to developmental processes were regulated, after 24 h of 
BMP2 treatment groups like plasma membrane, cell adhesion, antigen-presenting, and 
developmental processes appeared in the annotation analysis. After 6 h of TSA 
treatment, genes could be annotated to the functional groups histone modification, 
chromatin organization, transcriptional regulation, cell cycle control. The functional 
groups of genes regulated after 24 h of TSA treatment were plasma membrane, cell 
adhesion, cell communication, as well as developmental processes. Thereby the 
treatments of TSA and BMP2 of 24 h showed the greatest similarity.  
This suggests that genes regulated after 6 h directly reflected the well-established 
activity on gene regulation mediated by histone deacetylase inhibition, but that after 24 
h already a secondary biological effect may have been observed. 
The microarray data was further verified with mRNA expression and protein analysis.  
Quantitative RT-PCR of selected genes was carried out. Gpr17, Bambi, Smad7 and 
Bmp4 were regulated in TSA and BMP2 treatments. All selected genes showed 
consistent expression patterns to the microarray. Stat3, Wnt5a and Wisp1 (both 
involved in Wnt signalling and upstream of BMP2 signalling) were found to be 
upregulated upon TSA treatment.  
Western Blots were carried out, based on the upregulation of Stat3 expression and its 
well-established role in BMP2-triggered astrogliogenesis. Smad1/5/8 was 
phosphorylated in the BMP2 treated samples, but not in TSA treated ones. Stat3 was 
found to be phosphorylated upon TSA treatment, not in BMP2 treatment. TSA reduces 
phosphorylation of Gsk-3ß after TSA 24 h.  
The stronger correlation in the 24 h gene expression data set between TSA- and BMP2-
treated cultures reveals that even if the early gene expression response to the treatment 
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differs dramatically, similar downstream processes are induced, resulting in a 
comparable cell fate phenotype 
4.1.3 RNA interference studies to dissect which HDAC family 
member(s) influence neuro- and astrogliogenesis 
In order to ascertain which HDAC family members are involved in neuro- and 
astrogliogenesis, inhibition of the expression of individual HDAC genes using RNA 
interference was applied. Effective knockdown of the expression of HDACs 1, 2, 4 and 
5 was observed at the mRNA level.  
The consequences of these RNA interference experiments at the level of protein 
expression and effect upon neurogenesis were examined.  
Five short hairpin RNA oligos had been generated against HDAC1, 2, 4 and 5 and were 
expressed from pLKO.1-puro-Vectors, as purchased from Sigma-Aldrich (Figure 4.12).  
 
Figure 4.12. Mission shRNA-Vector pLKO.1-puro (Sigma-Aldrich) with shRNA 
insert. The vector contains a puromycin resistance sequence to select transfected or 
infected cells but no fluorescent reporter. 
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The shRNAs were expressed in neurosphere cultures prepared from embryonic GE via 
lentivirus infection. In the beginning, we used the pLKO.1-puro-Vectors to generate 
viral particles in HEK293T cells.  
Since the pLKO1-puro vectors unfortunately lack a reporter protein being expressed 
together with the shRNA, to be able to determine infection rates at all, I cloned the 
shRNA oligos into a new vector containing EGFP as a fluorescent reporter protein.  
As a first step, the different oligos were tested for knockdown of the respective target 
HDAC. Neurosphere cells prepared from embryonic mouse striatum taken at 15.5 dpc. 
were infected with Lentivirus containing the five different shRNA oligos. After 
different time periods, cells were lysed and RNA collected or protein. Gene knockdown 
was tested on the transcriptional level via real time RT PCR, on translational levels 
using western blot analysis and using immmunocytochemistry on infected cell cultures.  
Moreover it was tested whether the oligos have an influence on other non-target 
HDACs to determine whether other HDAC genes than the specific target HDAC are 
influenced by the knockdown.  
4.1.3.1 Analysis of shRNA knockdown of HDACs on the transcriptional 
level 
4.1.3.1.1 SiRNA-knockdown of HDAC1 
Neurosphere cultures were plated out to differentiate and infected with lentivirus 
expressing shRNA against HDAC1 or GFP as a transfection control. RNA was 
collected, reverse transcribed and subjected to quantitative real time RT-PCR. A 
TaqMan Assay specific for mouse HDAC1 was used for the quantification of the 
knockdown.  
A knockdown of HDAC1 expression could be observed with oligo1, 2 and 5. Oligo 3 
and 4 however led to an upregulation of HDAC1 expression, an effect contrary to the 
one intended. HDAC1 led to a decrease in expression of about 50%, oligo 5 of about 
40% and oligo2 of about 35% (Figure 4.13). 
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Figure 4.13. Relative expression of HDAC1&2 after siRNA-knockdown of HDAC1. 
GFP-infected cells as control. TaqMan assays for HDAC1 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression. n=1 
To control for potential cross-reactions of the oligos with other HDACs, HDAC2 
expression was also examined after siRNA knockdown of HDAC1 (Figure 4.14). 
Oligo1 led to a reduction in HDAC2 expression of about 20%, as well as oligo 5. Oligo 
3 led to an increase in HDAC2 expression of about 20%, oligo 2 and 4 decrease 
HDAC2 expression with more than 40 percent. The shRNAs generated to knock down 
HDAC1 expression show cross reactions with at least one non-target HDAC. To 
determine specificity of the oligos, more experiments should be carried out.  
Since oligo1 led to the largest knockdown of HDAC1 and has does not change HDAC2 
expression as strongly as the other oligos, it would probably the oligo to choose for 
further experiments. 
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Figure 4.14. Relative expression of HDAC2 after siRNA-knockdown of HDAC1, GFP-
infected cells as control. TaqMan assays for HDAC2 and Gapdh were applied. Relative 
expression was calculated through the ΔΔCt method. Results were normalized to Gapdh 
expression. n=1 
4.1.3.1.2 SiRNA-knockdown of HDAC2 
Neurosphere cultures were plated out to differentiate and infected with lentivirus 
expressing shRNA against HDAC2, GFP or a scambled sequence as control. Since the 
oligos against HDAC2 had already been tested previously, only 2 oligos were used for 
virus production. Since the virus is harvested in two rounds, virus from each harvesting 
day was used to infect cultures. RNA was collected, reverse transcribed and subjected to 
quantitative real time RT-PCR. A TaqMan Assay specific for mouse HDAC2 was used 
to quantify the degree of knockdown.  
Knockdown of HDAC2 could be shown with both oligo 3 and 4, which had previously 
been selected from the initial 5 oligos generated against HDAC2. Lentivirus, harvested 
at two different time points after transfection of 293T cells were tested, virus collected 
after 48 h and 72 h respectively. The most effective knockdown could be seen with 
oligo 4 where virus was harvested 72 h after transfection. Oligo 3 led to a reduction in 
HDAC2 expression level of more than 50%, virus harvested after 72 h of about 50%. 
Oligo 4 reduces expression of HDAC2 to 20% (Figure 4.15).  
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However, the expression of HDAC2 seems to vary dramatically even in cultures which 
were not infected with any virus. I chose cells infected with SHC002 (a nonsense 
shRNA) as a control in real time RT-PCR, but the variation even in non-infected 
cultures should be kept in mind.  
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
SHC002 aH2O3 72h aH2O4 72h
 
Figure 4.15. Relative expression of HDAC2 after siRNA-knockdown of HDAC2, 
SHC002-infected cells as control. TaqMan assays for HDAC2 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression.  n=4 
To exclude cross-reactions with other HDACs, relative expressions of HDAC1, 3, 4, 5, 
7 and 8 were also determined after siRNA knockdown of HDAC2 in cell cultures. 
HDAC1 expression seems to be influenced by HDAC2 knockdown. aHDAC2 oligo 3 
causes down- or upregulation of HDAC1 expression, oligo 4 reduces HDAC1 
expression to almost 50%. The variation within the experiments was however quite 
large, therefore drawing a consistent conclusion from these findings appears difficult 
(Figure 4.16).  
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Figure 4.16. Relative expression of HDAC1 after siRNA-knockdown of HDAC2, 
SHC002-infected cells as control. TaqMan assays for HDAC1 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression. n=4 
aHDAC2 oligo 3 and -4 both seem to elevate expression levels of HDAC3, oligo4 even 
more than doubled HDAC3 expression (Figure 4.17). Here it is difficult to draw a 
conclusion because the quantification was only performed once and should be repeated.  
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Figure 4.17. Relative expression of HDAC3 after siRNA-knockdown of HDAC2, 
SHC002-infected cells as control. TaqMan assays for HDAC3 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression. n=1 
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HDAC4 expression was also influenced by both oligos directed against HDAC2 in 
individual experiments. Summarizing different experiments, the change in HDAC4 
expression was not detectable any more (Figure 4.18), which might even hint to the fact 
that if there were further experiments carried out concerning expression changes of 
other HDACs, the influences might show to be weaker as seen in these initial studies.  
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1,6
uninfected SHC002 aH2O3 48h aH2O4 24h
 
Figure 4.18. Relative expression of HDAC4 after shRNA-knockdown of HDAC2, 
SHC002-infected cells as control. TaqMan assays for HDAC4 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression.  n= 2 
Expression of HDAC5 was influenced upon knockdown of HDAC2, but should also be 
investigated further because it has only been quantified once (Figure 4.19a). The 
expression seemed to increase with both oligo 3 and 4. Again, since the variations 
between individual experiments were relatively high, these quantifications should be 
repeated to make a sound statement about cross-reactions.  
The same holds true for HDAC7a and HDAC8, both showed changes in expression 
levels upon knockdown of HDAC2 in differentiating neurosphere cultures. Expression 
of HDAC7a seemed to be downregulated by aHDAC2 oligo 3 and upregulated by oligo 
4 (Figure 4.19b). Considering the fact that also the detected expression levels in two 
independent non-virus infected cultures differed by about 25%, these quantifications 
have to be repeated.  
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HDAC8 expression was downregulated by aHDAC2 oligo 3 48 h and ahDAC2 oligo 4 
72 h upregulated by aHDAC2 oligo 3 72h and aHDAC2 oligo 4 48 h (Figure 4.19c). 
Since the individual virus preparations are expected to be identical on both days; they 
were derived from the same plasmids being transfected into the same HEK293T cells, 
the changes cannot be explained by the shRNA knockdown of HDAC2 in the cultures. 
Perhaps, there are changes in expression level of an HDAC that are multiplied by the 
detection method which is very sensitive. The differences in expression levels in 
identical, untreated cultures would also support this thought. Also the procedure of 
infecting the cells might bring modifications along or have side effects that are difficult 
to control for.  
Kathrin Weißmüller, 2013   4  Results 
137 
 
 
A 
0,0
0,5
1,0
1,5
2,0
2,5
3,0
un
inf
ect
ed
un
inf
ect
ed
*
SH
C0
02
aH
2O
3 4
8h
aH
2O
3 7
2h
aH
2O
4 2
4h
aH
2O
4 7
2h
 
Figure 4.19. Relative 
expression of (A) HDAC5, (B) 
HDAC7a, (C) HDAC8 after 
siRNA-knockdown of 
HDAC2, SHC002-infected 
cells as control, TaqMan 
assays for the different HDAC 
genes and Gapdh were applied. 
Relative expression was 
calculated through the ΔΔCt 
method. Results were 
normalized to Gapdh 
expression.n=1 
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4.1.3.1.3 SiRNA-knockdown of HDAC4 
In an initial experiment, five oligos generated against HDAC4 were tested for their 
effect on HDAC4 expression. Oligo1 decreased HDAC4 expression to less than 50%, 
oligo 3 by 20% and oligo 4 by about 30%. Oligos 2 and 5 did not change HDAC4 
expression. Oligo 1 was chosen to carry out further experiments because it showed the 
highest degree of knockdown for HDAC4. In three experiments, oligo 1 reduced 
HDAC4 expression by 30% (Figure 4.20).  
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Figure 4.20. Relative expression of HDAC4 upon shRNA knockdown of HDAC4, 
SHC002-infected cells as control. TaqMan assays for HDAC4 and Gapdh were applied. 
Relative expression was calculated through the ΔΔCt method. Results were normalized to 
Gapdh expression. n=3 
Again, to examine cross-reactions with other HDACs, expression of HDAC2 and 5 
were examined upon shRNA knockdown of HDAC4. HDAC2 expression was not 
changed dramatically, but slightly reduced by about 10% (Figure 4.21).  
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Figure 4.21. Relative expression of HDAC2 upon HDAC4 knockdown, SHC002-
infected cells as control. TaqMan assays for HDAC2 and Gapdh were applied. Relative 
expression was calculated through the ΔΔCt method. Results were normalized to Gapdh 
expression. n=3 
HDAC5 expression was not changed upon knockdown of HDAC4. aHDAC4oligo1 
does not cross-react at least with HDAC2 and -5 and could therefore be used for further 
knockdown experiments (Figure 4.22).  
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Figure 4.22. Relative expression of HDAC5 upon HDAC4 knockdown, SHC002-
infected cells as control. TaqMan assays for HDAC5 and Gapdh were applied. Relative 
expression was calculated through the ΔΔCt method. Results were normalized to Gapdh 
expression. n=2 
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4.1.3.1.4 SiRNA-knockdown of HDAC5 
All oligos generated against HDAC5 knocked down its expression, oligo1 by 20%, 
oligo2 to less than 20%, oligo3 to about 22%, oligo4 to almost 40% and oligo5 to less 
than 20%. Oligo4 does not show the strongest knockdown effect of all oligos, but was 
chosen for further experiments (Figure 4.23) because it was found to influence HDAC2 
expression least of all oligos. HDAC2 expression upon HDAC5 knockdown was 
analyzed to investigate potential cross-reactions (Figure 4.24). However, also potential 
influences on other class II HDACs with a higher sequence similarity should also be 
examined.  
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Figure 4.23. Relative expression of HDAC5 upon HDAC5 knockdown, SHC002-
infected cells as control. TaqMan assays for HDAC5 and Gapdh were applied. Relative 
expression was calculated through the ΔΔCt method. Results were normalized to Gapdh 
expression. n=3 
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Figure 4.24. Relative expression of HDAC2 upon HDAC5 knockdown, SHC002-
infected cells as control. TaqMan assays for HDAC2 and Gapdh were applied. Relative 
expression was calculated through the ΔΔCt method. Results were normalized to Gapdh 
expression. n=1 
In general, many experiments were carried out only once and need to be repeated in 
order to draw sound conclusions. The lentivirus knockdown project was not continued 
so far because of the availablility of mouse models and the high variability between 
individual experiments.  
4.1.3.2 Analysis of HDAC2 knockdown on the protein and the cellular 
level 
We analyzed knockdown of HDAC2 because we knew HDAC2 to be ubiquitously 
expressed in brain, especially in GE and cortex, and since it was shown to play a role in 
several brain functions. It negatively regulates memory formation (Guan et al 2009) and 
can be found in higher levels in the brain and spinal cord of patients suffering from 
amyotrophic lateral sclerosis (ALS) (Janssen et al 2010).  
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4.1.3.2.1 Analysis of the knockdown of HDAC2 in cell cultures on protein level: 
Western Blot analysis 
Knockdown of HDAC2 was examined both in neurosphere cultures and in a permanent 
cell line (293T) to determine the efficiency of the shRNA oligos for knocking down 
HDAC2.  
4.1.3.2.1.1 Knockdown of endogenous HDAC2 in Neurospheres – analysis 4 days after 
infection 
Lysates of the infected neurosphere cells were prepared 4 days after infection. The 
protein was separated in a PAGE and subsequently analyzed though western blotting. 
According to the quantification of the protein bands through the pixel intensity, HDAC2 
protein levels were decreased in cultures infected with virus containing aHDAC2 oligo 
3 in a dose-dependent manner. Compared to the control cultures infected with a 
scrambled shRNA virus, HDAC2 protein level was much higher in uninfected cultures 
(Figure 4.25). According to this result, knockdown of HDAC2 in neurosphere cultures 
leads to a reduction of protein levels to about 50%. This would support the idea that the 
infection rate of the cells on coverslips was too low to detect the change in 
immunostaining of the entire culture.  
 
Figure 4.25. Western blot anaylsis of HDAC2 expression in lentivirus infected 
neurosphere cultures. A dose-dependet reduction of HDAC2 protein levels could be 
observed in cultures infected with aHDACs oligo 3 after 4 days of infection. 
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4.1.3.2.1.2 Knockdown of endogenous HDAC2 in Neurospheres – analysis 7 days after 
infection 
After 7 days of infection, the same effect could be observed. A dose dependent decrease 
of HDAC2 protein levels upon infection with lentivirus containing shRNA against 
HDAC2. The downregulation was even more pronounced in the sample with the highest 
virus concentration than after 4 days of infection (Figure 4.26).  
 
Figure 4.26. Western blot anaylsis of HDAC2 expression in lentivirus infected 
neurosphere cultures. A dose-dependet reduction of HDAC2 protein levels could be 
observed in cultures infected with aHDACs oligo 3 after 7 days of infection. 
4.1.3.2.1.3 Knockdown of endogenous HDAC2 in 293T cells 
To test the original plasmids bought from Sigma for their knockdown capacity, they 
were transfected into HEK293T cells. The cells were cultured for 4 d respectively 6 
days after transfection. Lysates were prepared and subjected to western blot analysis. A 
cotransfection with GFP served as a control for transfection.  
No reduction of protein levels could be observed with the Mission plasmids alone 
(Figure 4.27). This could be due to a low transfection efficiency. To be able to draw a 
sound conclusion, the experiment should be repeated.  
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Figure 4.27. Western blot anaylsis of HDAC2 expression in 293T cells transfected with 
Mission plasmids containing the shRNA sequences generated against HDAC2. Co-
transfection with GFP as trasfection control. No reduction of HDAC2 protein level could be 
observed after 4 days and 6 days of transfection. 
4.1.3.2.2 Knockdown of HDAC2 in cell cultures derived from neurospheres 
In order to determine whether the shRNA oligos generated against HDAC2 were 
reducing HDAC2 expression on the protein level, I carried out immunostainings of 
infected neurosphere cultures plated out for differentiation 4 days after infection and 
determined fluorescence levels of HDAC2 antibody staining in nuclei.  
The cultures were grown and infected on coverslips, then stained and photographed 
using the same exposure time for each image. Those images were then processed in 
Metamorph software. The fluorescence intensity of the nuclear HDAC2 staining was 
determined using Metamorph software. Regions covering the nuclei were determined 
and average fluorescence determined for each nucleus.  
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All nuclei showed HDAC2 expression. Overall, the cultures infected with virus 
supposed to knock down HDAC2 expression antiHDAC2 oligo 3 and antiHDAC2 oligo 
4 did not show less HDAC2 expression than the cultures infected with control virus 
SHC002.  
Furthermore, immunostainings with a TuJ1 antibody revealed no differences in numbers 
of newborn neurons in the cultures where HDAC2 was knocked down compared to 
scrambled-infected controls (Figure 4.28).  
 
Figure 4.28. Immunostaining of striatal neurosphere derived cells on coverslips. Cells 
were infected with lentivirus to knock down HDAC2. Antibodies: Tuj1 (neurons) and 
HDAC2. Scalebar 100 µm. Metamorph Analysis of average HDAC2 immunofluorescence 
in neurospheres infected with lentivirus to knock down HDAC2 expression. No reduction 
in HDAC2 protein levels can be detected. 
4.1.3.2.3 Knockdown of HDAC2 in hippocampal cell cultures  
The same experiment was performed in hippocampal cultures. The cells were infected 
with lentivirus to knock down HDAC2 expression. The cells were fixed and stained 4 
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days after infection. The cells were stained with antibodies to detect HDAC2 and GFP 
to determine the number of infected cells. No reduction in HDAC2 protein levels could 
be observed in infected cells. The staining for GFP revealed that only very few cells 
were infected in the cultures and that HDAC2 fluorescence in nuclei of infected cells 
was not reduced (Figure 4.29).  
 
Figure 4.29. Hippocampal cells (DIV 9) infected with lentivirus carrying shRNAs 
against HDAC2, fixed 4 d after infection. Immunostaining with antibodies against HDAC2 
and GFP, revealing that infected cells did not show reduced HDAC2 protein levels. 
Scalebar 100 µm 
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4.1.3.2.4 Immunostaining to reveal the progeny of infected precursors 
In order to analyze whether infected cells develop specifically to either neurons or 
astrocytes immunostainings were carried out with antibodies staining the EGFP serving 
as a reporter of virusinfected cells, TuJ1 to stain for newborn neurons or GFAP to stain 
astrocytes. The neurosphere cultures were plated out to differentiate, infected and then 
cultured for 7 days to allow for differentiation to occur.  
No neurons could be detected to express GFP, but even only few cells were shown to 
express both GFP and GFAP. In general, the rate of infected cells in the culture was 
very low (Figure 4.30).  
4  Results   Kathrin Weißmüller, 2013 
148 
 
 
Figure 4.30. Neurosphere cultures infected with lentivirus containing shRNA to knock 
down HDAC2 were allowed to differentiate for 7 days, then fixed and stained for GFP to 
detect infected cells and either TuJ1 or GFAP to determine their progeny 
None of the neurons seemed to be an infected cell according to the immunostaining 
against GFP. This could hint to a role of HDAC2 in neurogenesis, but has to be 
investigated further.  
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4.1.3.3 Analysis of the outcome of differentiation in cultures infected 
with lentivirus to knock down HDAC2 
4.1.3.3.1 Differentiation of precursor cells 4 days after infection with lentivirus  
4 days after infection with virus to knock down HDAC2, neurosphere cultures were 
fixed and stained with antibodies against TuJ1 to determine the number of neurons or 
GFAP to investigate the number of astrocytes in the cultures. No change could be 
detected in the numbers of neurons generated in the cultures (Figure 4.31). However, 
this could be expected because the expression of the shRNA and subsequent knock-
down takes some time to occur and might not have exceeded any effect on the cellular 
composition of the cultures.  
 
Figure 4.31. Neurosphere cultures infected with lentivirus containing shRNA to knock 
down HDAC2 were allowed to differentiate for 4 days, then fixed and stained for TuJ1 or 
GFAP to determine the ratio of neuro-and astrogliogenesis in the cultures. Quantification of 
the number of neurons in cultures infected with control (SHC002) or shRNA against 
HDAC2. Scalebar 100 µm 
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4.1.3.3.2 Differentiation of precursor cells after 7 days of shRNA knockdown of 
HDAC2 
7 days after infection with virus to knock down HDAC2, neurosphere cultures were 
fixed and stained with antibodies against TuJ1 to determine the number of neurons or 
GFAP to investigate the number of astrocytes in the cultures. No change could be 
observed in the cellular composition of the culture (Figure 4.32). This could either be 
because HDAC2 does not influence neuro- or gliogenesis or because infection rates 
were so low, that eventual, subtle changes in the cellular composition could not be 
measured.  
 
Figure 4.32. Neurosphere cultures infected with lentivirus containing shRNA to knock 
down HDAC2 were allowed to differentiate for 7 days, then fixed and stained for TuJ1 or 
GFAP to determine the ratio of neuro-and astrogliogenesis in the cultures. Quantification of 
the number of neurons in cultures infected with control (SHC002) or shRNA against 
HDAC2. Scalebar 100 µm 
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4.2 Developmental phenotype of the CNS of 
HDAC4 and HDAC5 transgenic mice 
4.2.1 Expression analysis of HDAC4 and HDAC5 in embryonic 
brain  
4.2.1.1 In situ hybridization to reveal HDAC4 and HDAC5 expression 
patterns 
4.2.1.1.1 Expression of Ngn2 and Dlx2 in embryonic mouse brain 
Expression of all HDACs in embryonic brain tissue had been examined via a 
quantitative real time RT-PCR analysis. Expression of HDAC4 and HDAC5 was also 
examined via in situ hybridization. To test the protocol, probes for Ngn2 and Dlx2 were 
used which were known to function well with the protocol applied.  
The in situ hybridization was carried out on coronal sections of E15.5 mouse brain 
which had been embedded in paraffin. Both Dlx2 and Ngn2 probes gave a distinct and 
specific staining, showing that the experimental procedure worked (Figure 4.33). To 
test the specificity of the HDAC4 and -5 antisense probes, the corresponding sense 
probes were also generated. Those should not bind to the tissue specifically and can 
therefore be used to determine whether the staining seen with antisense probes is 
specific or due to unspecific background staining.  
Both probes showed an intense staining in the appropriate brain areas. Ngn2 is highly 
expressed in embryonic cortex; the transcription factor shows a clear expression pattern 
in embryonic cortical ventricular zone. Dlx2 is a marker expressed in the ventral 
forebrain; it is expressed as expected in the VZ and SVZ of the ganglionic eminences 
(Figure 4.33).  
I therefore conclude that the in situ protocol works well and that results I obtain with the 
newly generated probes for HDAC4 and HDAC5 probably show the true distribution of 
the RNA in embryonic brain.  
4  Results   Kathrin Weißmüller, 2013 
152 
 
 
Figure 4.33. In situ hybridization on E 15.5 coronal brain sections. Ngn2 and Dlx2 
probes were chosen to confirm the protocol functioning properly 
4.2.1.1.2 HDAC4 is present in neurogenic regions of the developing brain (In situ 
hybridization of HDAC4) 
The HDAC4 sense probe showed a weak overall staining, which can be interpreted as 
an overall background signal on the sections. The HDAC4 antisense probe led also to a 
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staining on the entire section; however, several areas were stained more intensely. The 
cortical plate and the ventricular zone and subventricular zone of the cortex were 
stained by the HDAC4 antisense probe, as well as ventricular zone and subventricular 
zone of the lateral and medial ganglionic eminences (LGE and MGE). This can hint to a 
stronger expression of HDAC4 in those neurogenic areas, but might also be due to the 
fact that there are more cell bodies in those areas and the staining in the grey matter 
appears weaker because there are less cell bodies present (Figure 4.34).  
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Figure 4.34. In situ hybridization of HDAC4 on E 15.5 coronal brain sections. Sections 
from anterior (a, b) to more posterior (g, h) brain areas. a and b, c and d, e and f and g and h 
are sections corresponding in anterior-posterior position. 
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4.2.1.1.3 HDAC 5 is present in areas important for cortical layering and 
neurogenesis in the embryonic mouse brain (In situ hybridization of 
HDAC5) 
The HDAC5 sense probe resulted in barely any staining at all on all examined slides, 
the background signal was very low. The HDAC5 antisense probe treated brain sections 
showed an overall staining, just like with HDAC4 antisense, but in some areas the 
staining was also distinctively stronger. The cortical plate showed a strong staining, 
subplate and white matter a less intensive expression and the subventricular zone (SVZ) 
of the cortex again a strong staining. The ventricular zone (VZ) was stained less than 
the SVZ, indicating a stronger expression of HDAC5 in the SVZ. In the case of 
HDAC4, both VZ and SVZ showed the same strong level of staining, which shows the 
different expression patterns of HDAC4 and -5. In the SVZ and VZ of both LGE and 
MGE, I could also observe a very strong staining with HDAC5 antisense.  
Again, the stronger staining for HDAC5 corresponds partly with areas with a high 
density of cell bodies, however, the difference in staining levels in VZ and SVZ of the 
cortex shows that there is a difference in the expression pattern which cannot be caused 
only by differences in cell density (Figure 4.35) 
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Figure 4.35. In situ hybridization of HDAC5 on E 15.5 coronal brain sections. Sections 
from  anterior (a, b) to more posterior (g, h) brain areas. a and b, c and d, e and f and g and 
h are sections corresponding in anterior-posterior position. 
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4.2.1.2 Analysis of HDAC 4 and -5 expression pattern using X-Gal staining 
To determine the expression pattern of HDAC4 and -5 in embryonic brain, I also used 
mutant mice deficient in those genes (Chang 2004, Vega et al 2004b). In both cases a 
LacZ cassette was knocked into the gene sequence, thereby providing a transgene as a 
marker for the expression of the individual HDAC.  
The bacterial enzyme β-galactosidase (gene LacZ) is an enzyme which catalyzes the 
hydrolysis of ß-galactosides into monosaccharides. The enzyme is knocked into the 
gene locus of the respective HDACs and is then expressed under the control of the 
promoter of the individual HDAC. When the enzyme cleaves the artificial substrate X-
gal, it turns blue and thereby one can identify areas of tissue where the HDACs would 
be expressed by a blue stain. 
I examined brains of mutant embryos at 13.5 dpc and 15.5 dpc. The heads were 
dissected, fixed in 0.2% glutaraldehyde, embedded in tissue freezing medium and 
sectioned. 7 µm thin coronal sections were prepared and used for the staining procedure.  
4.2.1.2.1 Expression of HDAC4 in embryonic brain 
At 13.5 dpc I observed a weak overall staining of HDAC4 throughout the brain. In 
posterior sections, a stronger staining could be observed in the hippocampus (Figure 
4.36c,c’).  The   trigeminus  ganglion   showed  a  particularly strong staining at E13.5 dpc 
(Figure 4.36c’).  
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Figure 4.36. LacZ staining on E13.5 coronal brain sections of a HDAC4 mutant 
embryo to determine the subcellular localization of HDAC4 expression in embryonic 
brain. Scalebar 500 µm 
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Brains of 15.5 dpc embryos showed a weak staining in the anterior sections, with some 
cells being stained in the olfactory bulb area in the glomerular layer (Figure 4.37a’).  I  
also observed staining in the cortical plate and frontal part of the corpus callosum 
(Figure 4.37b’, a’,   b’,   c’   and   d’   are   enlargements   of   a,   b,   c   and   d   respectively).  The  
more posterior sections showed a strong staining in the lateral ventricular zone and 
subventricular zone of the cortex (Figure 4.37c,d). However, also the region of the 
cortical plate showed a stronger staining than the underlying layers of the cortex. The 
ventricular zone of the LGE and MGE was also stained, as well as the lateral and medial 
septal nucleus (Figure 4.37c’,d’).  
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Figure 4.37. LacZ staining on E15.5 coronal brain sections of a HDAC4 mutant 
embryo to determine the subcellular localization of HDAC4 expression in embryonic 
brain. Scalebar 500 µm 
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4.2.1.2.2 Expression of HDAC5 in embryonic brain 
X-Gal staining was also performed on coronal sections of HDAC5 mutant mice. The 
experiment was performed with brain of developmental stage E13.5 and E15.5.  
At E13.5 the embryonic brains showed a distinct staining in the cortical plate which also 
remains at E15.5. (Figure 4.38) The cortical plate is the only region of the brain which 
is stained at this age. At E15.5 I could observe staining in the cortical plate and the 
subplate (Figure 4.39). Because the cortical plate is known to be crucial in the control 
of the correct development of cortical layers, I decided to investigate whether there were 
differences in cortical layering in HDAC5 mutant mice.  
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Figure 4.38. LacZ staining on E13.5 coronal brain sections of a HDAC5 mutant 
embryo to determine the subcellular localization of HDAC5 expression in embryonic 
brain. Scalebar 500 µm 
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Figure 4.39. LacZ staining on E15.5 coronal brain sections of a HDAC5 mutant 
embryo to determine the subcellular localization of HDAC5 expression in embryonic 
brain. Scalebar 500 µm 
Comparing both analyses to each other (in situ hybridization and X-Gal staining), 
overall the same expression pattern for HDAC4 emerges. At E15.5, neurogenic regions 
of the embryonic brain express HDAC4, the ventricular and subventricular zones of the 
cortex and the striatum. HDAC4 is also expressed in the cortical plate which might hint 
to a role in layer formation  
Comparing in situ hybridization and X-Gal staining for HDAC5 expression, both 
methods show a strong expression of HDAC5 in the cortical plate, both at E 13.5 and 
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E15.5. This hints to a role of HDAC5 in cortical layer formation or perhaps cell 
migration during layer formation.  
4.2.2 Generation and analysis of conditional mutant animals 
for HDAC4 
HDAC4 null mice die within two weeks after birth, they show several changes in their 
CNS compared to wildtype animals, a reduced brain size and a degeneration of Purkinje 
neurons to name a few. However, since they show severe malformations of the skeleton 
and the skull, which could also influence the development of the brain, we decided to 
generate mice in which HDAC4 is specifically removed from the CNS. We therefore 
bred HDAC4 flox mice (Potthoff et al 2007) with mice expressing Cre through a nestin 
promoter (Tronche et al 1999). This should lead to a deletion of HDAC4 in neural 
progenitor cells and their lineage (neurons and microglia).  
Surprisingly, the conditional knock-out animals survived normally and did not show 
any aberrant behaviour as far as we could observe without applying behavioural tests. 
They also bred normally.  
4.2.2.1 HDAC4 immunoblot to confirm absence of HDAC4 protein in 
mutant embryonic CNS 
To determine to what extent the HDAC4 or -5 protein expression was diminished in 
transgenic animals already in embryonic stages, immunoblot experiments were carried 
out with E13.5 or E15.5 dpc brain and spinal cord tissue.  
4.2.2.1.1 HDAC4 protein level is decreased in embryonic brain of HDAC4 conditional 
knockout animals at E 13.5 
At 13.5 dpc HDAC4 protein was still detectable brains of conditional HDAC4 mutant 
embryos, however, the protein levels were drastically reduced compared to 
heterozygous or wildtype littermates (Figure 4.40). The reduction of HDAC4 protein 
was found to be dose-dependent, a stronger reduction could be seen in homozygous 
animals with two conditionally deleted alleles compared to heterozygotes with only one 
Kathrin Weißmüller, 2013   4  Results 
165 
 
allele. In heterozygous animals, the amount was reduced to about half of the one of 
wildtype, in homozygous mutants the protein amount was only 2% of wildtype.  
 
 
Figure 4.40. HDAC4 immunoblot of E13.5 brain tissue of the CIMH4 mouse line. 
Antibodies: HDAC4 (Santa Cruz), ß-Actin (Sigma). Quantification of immunoblot results 
through pixel density. 
4.2.2.1.1 Strong reduction of HDAC4 protein levels in embryonic brain and 
spinal cord of HDAC4 conditional knock-out animals at E 15.5 
In E 15.5 animals, both in spinal cord and brain, the amount of HDAC4 protein was 
clearly reduced in conditional mutant animals in a dose-dependent fashion. 
Unfortunately there were no wildtype littermates to compare the mutant animals to, but 
4  Results   Kathrin Weißmüller, 2013 
166 
 
the reduction in a full mutant to a wildtype is still obvious. The amount of protein is less 
drastically reduced than in E13.5 brain (Figure 4.41), but this can be due to dissecting 
differences between brain and spinal cord. If there was more meningeal tissue left on 
the dissected spinal cord, this could already explain the higher content of HDAC4 
protein compared to brain.  
 
 
Figure 4.41. HDAC4 immunoblot of E15.5 spinal cord tissue of the CIMH4 mouse 
line. Antibodies: HDAC4 (Santa Cruz), ß-Actin (Sigma). Quantification of immunoblot 
results through pixel density. 
A clear reduction of HDAC4 protein levels could also be observed in brains of E 15.5 
mutant animals, compared to wildtypes (Figure 4.42). The quantification of the blot 
seems to reveal elevated protein levels in heterozygous embryos, this is however an 
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artefact due to a very weak actin staining in two of the heterozygous samples, which can 
be caused for instance by an inhomogeneous distribution of antibody of ECL detection 
solution. 
 
 
Figure 4.42. HDAC4 immunoblot of E15.5 brain tissue of the CIMH4 mouse line. 
Antibodies: HDAC4 (Santa Cruz), ß-Actin (Sigma). Quantification of immunoblot results 
through pixel density. 
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4.2.2.2 Effect of HDAC4 knock out on proliferation in the ventricular zone 
of the cortex 
Since the expression analysis of HDAC4 in embryonic brain revealed that HDAC4 is 
present mainly in neurogenic regions of the forebrain, I decided to investigate the effect 
on cell proliferation in mutant embryos. To investigate this, cryo-sections derived from 
wildtype and knock-out embryos for HDAC4 were immunostained with an antibody for 
the mitosis marker pH3 and the subsequent counting of cells in the cortical ventricular 
zone (Figure 4.43).  
 
Figure 4.43. Immunostaining for PH3 positive cells on coronal hemisections of 
HDAC4 mutant mice and wt littermates at E 15.5. Mitotically active cells line the 
ventricle. Small orientational image from (Ohtsuka et al 2001). Scalebar 100 µm 
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I observed a decrease in PH3 positive cells in the HDAC4 conditional mutant mice in 
the anteriormost region that I examined. The difference cannot be observed in the more 
posterior sections of the brain.  
4.2.2.3 Effect of the HDAC4 conditional knock-out on cell proliferation of 
non-surface dividing cells  
Intermediate progenitor cells of the subventricular zone of the developing cortex are 
progenitors for both neurons and macroglia. They specifically express the transcription 
factor Tbr2. In order to analyse the impact of the conditional knock-out of HDAC4 on 
intermediate progenitor cells, sections of mutant and wildtype brains were stained for 
Tbr2 and ß-tubulin III (TuJ1).  
The results of these stainings are presented in Figure 4.44 to Figure 4.46 which 
represent different coronal planes of examination from rostral (Figure 4.44) to caudal 
(Figure 4.46).  
 
Figure 4.44. Hemicoronal sections of E15.5 HDAC4 wildtype and mutant brain. 
Immunostaining with antibodies for Tbr2 and TuJ1, nuclear stain with DAPI. Scalebar 500 
µm 
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Figure 4.45. Hemicoronal sections of wildtype and HDAC4 mutant brain stained for 
Tbr2 (intermediate progenitors) and TuJ1 (neurons) Scalebar 500 µm 
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Figure 4.46. Hemicoronal sections of wildtype and HDAC4 mutant brain stained for 
Tbr2 (intermediate progenitors) and TuJ1 (neurons). Scalebar 500 µm 
No changes could be observed in expression pattern of Tbr2 or Tuj1 or in the number of 
cells stained. This was however not quantified in any way, which should be done in 
order to get a conclusive result. The location of the staining was equal in both wildtype 
and mutant as well as the amount of cells stained. It seems that there is no difference in 
the pool of basal progenitors in HDAC4 conditional mutants.  
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4.2.3 Analysis of HDAC5 mutant mice 
4.2.3.1 X-Gal staining for HDAC5 to confirm absence of HDAC5 protein in 
mutant embryonic brain 
Absence of HDAC5 in transgenic embryos could not be determined via 
immunoblotting. The LacZ cassette knocked into the HDAC5 locus impairs the 
expression of intact protein, but provides a marker for cells in which the protein would 
normally be expressed. Heterozygote animals show a far less intense staining than 
homozygous mutants. Staining is only shown in the absence of functioning HDAC5 
protein, therefore the staining in HDAC5 null mice is stronger than in heterozygous 
animals with one HDAC5 allele still intact (Figure 4.47). Comparing different coronal 
sections from E 15.5 brains, heterozygous animals show indeed weaker staining than 
mutants. The subcellular distribution of HDAC5 expression has already been discussed 
previously.  
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Figure 4.47. X-Gal staining on coronal brain sections of E 15.5 HDAC5 heterozygote 
(a,c,e) versus mutant (b, d,f) embryos confirms absence of HDAC5 in mutant brains 
Scalebar 500 µm 
4.2.3.2 Investigation of layer formation in HDAC5 mutant mice 
In our expression analysis of the subcellular distribution of HDAC5 expression in 
embryonic brain, the cortical plate showed high expression levels of HDAC5. Therefore 
we were curious whether there were any changes in cortical layering that could be 
observed in mutants of HDAC5. The cortical plate is known for its instructive role for 
the formation of the laminar structure of the cerebral cortex (Frotscher et al 2009, 
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Sekine et al 2011). Therefore we decided to investigate cortical layering early postnatal 
stages of HDAC5 null mice. 
To this end, the brains of early postnatal mice (P8) were sectioned coronally and stained 
with markers for different cortical layers.  
The transcription factor Pax6 is highly expressed in apical progenitors residing in the 
VZ from the earliest stages of corticogenesis. Therefore, its expression can be a marker 
for this layer in developing cortex. Unfortunately the Pax staining has not worked out, 
so that there is only an overall background signal to be observed (Figure 4.48).  
 
Figure 4.48. Immunostaining for Pax6 to reveal the impact of the absence of HDAC5 on 
apical layers of the cortex. Scalebar 100 µm 
The zinc-finger transcription factor Ctip2 is a marker for the outer layers of the cortex. 
It is expressed by subcortically projecting neurons in layer 5. Here, a strong staining 
was only observed in hippocampus. Both heterozygous and mutant brain did not show a 
strong an discrete staining of the outer layers (Figure 4.49). Since no wildtype 
littermate was available for comparison, it is now unclear whether the lack of staining is 
a relevant effect of the absence of HDAC5 or due to experimental conditions. All 
stainings should be repeated with a wildtype brain as control.  
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Figure 4.49. Immunostaining of Ctip2 in coronal hemisections of HDAC5 
heterozygote and mutant mice. Scalebar 500 µm 
SatB2 (Special AT-rich sequence-binding protein 2) is expressed in upper cortical 
layers. The staining for SatB2 did not differ between wildtype and mutant brain (Figure 
4.50).  
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Figure 4.50. Immunostaining of SatB2 in coronal hemisections of HDAC5 heterozygote 
and mutant mice. Scalebar 500 µm 
Reelin is a large secreted glycoprotein of the extracellular matrix. It is secreted by 
Cajal-Retzius cells in hippocampus and developing cortex. In the prenatal and early 
postnatal brain, reelin is expressed in the marginal zone. A staining of the outermost 
layer of the cortex could be observed in both wildtype and mutant. The staining did not 
differ between wildtype and mutant (Figure 4.51).  
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Figure 4.51. Immunostaining of Reelin in coronal hemisections of HDAC5 
heterozygote and mutant mice. Scalebar 500 µm 
Taken together, the immunostainings on early postnatal brain sections of HDAC5 
mutant mice did not reveal any difference in layer formation between mutant and 
wildtype mice. This could be due to the bad quality of the stainings and images or 
barely to the fact that absence of HDAC5 does not have an impact on cortical layer 
formation.  
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5 Discussion 
5.1 Analysis of the role of class I and II HDACs in 
neuro- and gliogenesis in embryonic mouse 
brain in vitro 
We had previously shown that a large number of HDACs is expressed in neural 
progenitor cultures prepared from E 15.5 GE. However, it was not clear which HDACs 
are expressed in vivo in different brain regions and whether there was any change in 
HDAC expression over time. Therefore, quantitative real time RT-PCR analysis was 
performed on total RNA lysates from embryonic brain regions dissected at two different 
developmental ages to analyze expression of HDAC1, -2, -3, -4, -5, 7a, -8 and -9. 
Expression of all examined HDACs could be confirmed at both E 13.5 and E 15.5, but 
there were obviously differences in expression levels.  
At E 13.5 HDAC2 showed the highest expression in all brain tissues, HDAC3 the 
second highest and HDAC1 the lowest. When comparing the expression level not only 
among the individual HDACs, but also between brain regions, HDAC1 showed to have 
a much higher expression in hippocampus than in cortex and GE. This might hint to a 
specific role of HDAC1 in the hippocampus. Although HDAC1 and -2 show very high 
sequence similarities, they were found to be expressed in different patterns in the brain 
(MacDonald & Roskams 2008).. At the same time, expression of HDAC5 is more than 
3-fold higher in striatum and almost 3-fold higher in the cortex than in the 
hippocampus.  
At E 15.5 HDAC3 showed the highest expression level in cortex and hippocampus, in 
striatum both HDAC2 and -3 were highly expressed. In line with the E 13.5 data, 
HDAC1 and -2 expression was higher in the hippocampus than in cortex and GE. Also, 
HDAC5 expression was higher in the cortex than in the hippocampus. Although the 
standard deviations are high and it is difficult to draw a conclusion, this could also point 
to a role for HDAC5 in cortex and hippocampus.  
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This analysis provides a summary of HDAC expression in different regions of the 
developing brain. Individual differences in expression levels might hint to a specific 
role of the respective enzyme in the area of high expression.  
5.2 Inhibition of HDACs in vitro to determine their 
role in neuro- and gliogenesis 
5.2.1  Reduction of neurogenesis in culture upon HDAC 
inhibition wih TSA 
Neurosphere cultures from the developing mammalian forebrain provide a relatively 
uniform population of neural precursor cells, from which both neurons and microglia 
can be derived. Here, neurosphere cultures generated from the medial and lateral 
ganglionic eminences of E15.5 C57BL/6 mice were used to study the effect of HDAC 
inhibition on neurogenesis in vitro. The cultures were plated out to differentiate and 
treated with 10 nM or 50 nM trichostatin A for different time intervals (3 – 24 h) before 
collection of RNA or protein or fixing the cells for immunocytochemistry or FACS. 
TSA belongs to the hydroxamic acid group of HDAC inhibitors and inhibits all class I 
and II HDACs by binding reversibly to their deacetylase domain. . 
When cells were treated with TSA for 12 h (DIV 1.5 to 2.5) and left to differentiate for 
other 5 days, neurogenesis was reduced to less than 50% of the control. This 
corresponds to our previous findings both in vitro and in vivo. TSA had the same effect 
on embryonic neurogenesis in vivo when it was injected in pregnant females from E13.5 
to E14.5. Along with the reduction of neurogenesis in the GE, also the number of 
GABA-positive cells derived from GE and undergoing tangential migration in the 
cortex was reduced (Shaked et al 2008). In previous in vitro-experiments, neurogenesis 
in GE was shown to be drastically reduced; possibly, the smaller extent of reduction 
shown here is due to experimental variation. However, the reduction could be verified 
in vitro.  
The increase in astrogliogenesis we reported previously could not be observed in these 
experiments although it showed to be a very robust and reproducible effect (Shaked et 
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al. 2008). This also speaks for an unexpected variation in these experiments and that 
they should be repeated. 
5.2.2 Quantification of neurogenesis in adherent neurosphere 
cultures by FACS analysis 
In order to quantify neurogenesis more efficiently and in an unbiased manner, a FACS 
protocol for fixed cells was established. The protocol allows for culturing neural 
progenitors in adherent cultures, then detaching them from the surface, fixing and 
staining them with a ß-tubulin III antibody. The protocol proved to be very robust and 
reliable in quantifying neurogenesis in differentiated neuroshere cultures. It confirmed 
the results of the conventional immunostainings and subsequent counting of stained 
cells on coverslips. Also with FACS, a dose-dependent effect of TSA treatment on 
neurogenesis could be observed. It is a novelty to quantify neurogenesis with an internal 
antibody staining in fixed cells by FACS; usually surface epitopes are chosen as 
markers and live cells are used for cytometry. The FACS protocol provides an efficient 
tool to analyze neurogenesis in our culture system and could perhaps also be applied for 
other experimental questions and markers.  
5.2.3 HDACs influence neurogenesis on a transcriptional level 
In order to elucidate by which signaling mechanism HDACs influence the generation of 
neurons and glia in the embryonic brain, we investigated signaling pathways known to 
be involved in these processes. Since we expected HDACs to influence neuro- and 
gliogenesis on a transcriptional level, real time RT-analysis was performed to examine 
transcription of genes known to be involved in neuro- and astrogliogenic developmental 
programs. BMPs had been shown to promote astroglial lineage commitment in vitro 
(Gross et al 1996) and in vivo (Bonaguidi et al 2005); therefore I measured gene 
expression of a number of genes involved in this pathway in TSA-treated neurosphere 
cultures. Also, we saw previously that adding inhibitors of BMP2/4 signaling (Noggin 
and Alk3-ECD) to differentiating neurosphere cultures, did not show any effect on 
neurogenesis. However, in the TSA treated cultures, these inhibitors restored normal 
levels of neuro- and astrogliogenesis (Shaked et al 2008). 
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Upon inhibition of HDACs Bmp2 was transcriptionally upregulated, especially after 6 h 
of treatment, while Bmp4 showed a downregulation. No changes could be observed in 
the transcription levels of Bmp receptors 1a, 1b and 2. Smad7, however, which 
negatively regulates Bmp2/4 signaling, showed a drastic downregulation. Both the 
upregulation of Bmp2 and the downregulation of Smad7 point to the possibility that 
inhibition of BMP signaling is released by TSA. I could also observe a robust 
upregulation of the transcription of Stat1 and Stat3, which was more prominent at later 
time points of observation (12 h treatment). Stat3 is an upstream regulator of Bmp 
expression (Fukuda et al 2007) and co-regulates astrocyte-specific genes through the 
formation of a STAT3-p300-Smad complex (Nakashima et al 1999). The increase in 
Stat3 expression therefore corresponds to our observation of an increase in premature 
astrogliogenesis in TSA-treated cultures along with the decrease in neurogenesis. 
Expression of Ngn1 is also upregulated up to 3-fold upon HDAC inhibition. Ngn1 is 
known to promote cortical neurogenesis.  
Neurosphere cultures were also treated with 10 ng/ml BMP2, to determine the effect of 
BMP2 on transcription levels. BMP2 did not increase its own expression, but decreased 
the one of Bmp4 as TSA did. In contrast to TSA which was downregulating Smad7 
expression, BMP2 strongly upregulates the negative regulator of BMP2/4 signaling. 
Stat3 was upregulated with TSA and BMP2 treatment at all observed time points. This 
effect could also be observed in luciferase assays. A Smad binding motif drives the 
expressiong of firefly luciferase. BMP2 treatment led to a strong luciferase signal 
reflecting a strong upregulation of BMP2/4 signaling. TSA however first decreased the 
activity and subsequently upregulated it. The response to BMP2 treatment also occurred 
much earlier than the one of TSA, suggesting an indirect effect of HDACs on BMP2/4 
signaling.  
We could show that different levels of acetylation upon HDAC inhibition can promote 
different transcriptional outcomes. 
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5.2.4 Protein translation is necessary to upregulate BMP2 
expression upon TSA treatment 
To   elucidate   which   genes’   expression   levels   are   directly   or   indirectly   regulated   by  
HDACs, additionally to the differentiation protocol and treatment with TSA, protein 
translation was blocked in neurosphere cultures and the expression of Bmp2, Bmp4 and 
Stat3 determined again through real time RT-PCR after 3 h of treatment with TSA. 
Cycloheximide (5 µg/ml) was used to block translation and added 1 h before TSA 
treatment was started. Bmp2 expression was not upregulated as strongly in the presence 
of cycloheximide (CHX). This implies that HDACs influence transcription of Bmp2 via 
a factor which has to be transcribed in order to act upon Bmp2 expression. Also the 
downregulation of Bmp4 did not occur as observed before without inhibition of 
translation, so the same holds true for Bmp4 expression. Interestingly, CHX did not 
inhibit the upregulation of Stat3 expression upon HDAC inhibition. Probably the 
expression of Stat3 is regulated by HDACs directly on the chromatin level; perhaps 
Stat3 expression is repressed through deacetylation of the Stat3 promoter. It could be 
that Stat3 is upstream of Bmp2 in mediating the effect of HDACs on neurogenesis.  
5.2.5 Microarray analysis of pathways potentially involved in 
HDAC influence on neurogenesis 
To elucidate the signalling involved between HDACs and neurogenesis, we have 
performed microarray expression profiling on BMP2- and TSA-treated cultures, 
followed by validation of the findings with quantitative RT-PCR and protein analysis. 
Since this work was done in collaboration with Dr. Catharina Scholl and she performed 
much of the data analysis, I will not discuss the findings in detail (Scholl, Weissmuller 
et al. 2012).  
TSA- and BMP-treated cultures showed different transcriptional responses, which 
would also be expected. However, we observed an overlap in genes regulated by the 
treatments, especially when comparing not the same treatment intervals but BMP2 6h 
and 24 h with TSA 24 h for example. Many genes involved in Bmp2/4 signaling could 
be observed at this intersection (e.g. Bmp4, Smad7, Follistatin and Bambi). BMP2 and 
TSA treatment resulted in independent gene expression profiles, the downregulation of 
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genes seems to reflect the similar phenotype seen after both treatments. Only few 
primary target genes of TSA and BMP2 clustered together, but many genes involved in 
neural development were present.  
We assume that genes regulated after 6 h of treatment directly reflected the well-
established activity of HDAC inhibition on gene regulation, but that after 24 h already a 
secondary biological effect might have been observed. The stronger correlation in the 
24 h gene expression data set between TSA- and BMP2-treated cultures reveals that 
even if the early gene expression response to the treatment differs dramatically, similar 
downstream processes are involved which lead to a similar change in the cell fate of 
treated cells. As observed in real time RT-PCR previously, an upregulation of Stat3 and 
its active, phosphorylated form could be observed at the protein level. This corresponds 
to the increase in astrogliogenesis observed in our experiments as well.  
5.3 RNA interference to dissect which HDAC 
family member(s) influence neuro- and 
astrogliogenesis 
5.3.1 Real time RT-PCR analysis of shRNA-mediated knockdown 
of HDAC1, -2, -4, and -5 
RNA interference was used to dissect which of the class I and II HDAC family 
members inhibited by TSA mediate the effect on neuro- and astrogliogenesis. For 
HDAC 1, -2, -4, and -5 five shRNA oligos were bought from Sigma Aldrich to knock 
down expression of the individual enzymes. Effective knockdown of the expression of 
HDACs 1, 2, 4 and 5 was observed at the mRNA level; however, all examined oligos 
against the HDACs also influence expression of other non-target HDACs. This is 
obviously not a good starting point to examine the role one individual enzyme plays. It 
is still unclear why the shRNA oligos directed against one HDAC showed a broad and 
rather unspecific effect also on other family members. It would have perhaps been not 
surprising if HDACs with high sequence similarities and which might have similar 
redundant roles in the CNS were influenced by each other’s knockdown. Here, all 
shRNA oligos generated against one HDAC also up- or downregulated more than one 
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other, not always closely related HDAC. It is known that siRNAs can have off-target 
effects totally unrelated to their actual target mRNA (Scacheri et a. 2004). Those off-
target effects are speculated to be due to partial sequence matches to other sequences 
and a microRNA-like regulation (Scacheri et al. 2004). There are also many sensor 
motifs recognizing foreign RNA molecules in cells which could initiate subsequent off-
target effects (Olejniczak et al. 2010). In this case, I believe that the changes could also 
be explained by unfavorable conditions in the cells due to the viral infection. Many 
improvements to the protocol were made in order to reduce unfavorable conditions as 
much as possible, but with very limited success. The cells usually displayed a different 
morphology compared to untreated cultures and had an unhealthy appearance. 
Purification of the virus preparation with a sucrose pellet, using an endotoxin-free 
plasmid preparation kit did not seem to have a large impact on the cells. Coating of the 
culture dishes with poly-L-lysine reduced detachment of cells after the first round of 
virus harvesting.  
5.3.2 Confirming HDAC2 knockdown on the protein and the 
cellular level 
For further investigations, HDAC2 was chosen as a candidate gene because of its high 
expression levels in embryonic brain, especially in GE and cortex, and because it was 
shown to play a role in several brain functions. HDAC2 negatively regulates memory 
formation (Guan et al 2009)  and is found at higher expression levels in the brain and 
spinal cord of patients suffering from amyotrophic lateral sclerosis (ALS) (Janssen et al. 
2010).  
We analyzed knockdown of HDAC2 because we knew HDAC2 to be ubiquitously 
expressed in brain, especially in GE and cortex, and since it was shown to play a role in 
several brain functions. It negatively regulates memory formation (Guan et al 2009) and 
can be found in higher levels in the brain and spinal cord of patients suffering from 
amyotrophic lateral sclerosis (ALS) (Janssen et al 2010).  
5  Discussion   Kathrin Weißmüller, 2013 
186 
 
5.3.2.1 Knockdown of endogenous HDAC2 in neurospheres –immunoblot 
analysis 4 days after infection 
Knockdown of HDAC2 was assessed in neurosphere cultures and in a permanent cell 
line (293T) to determine the efficiency of the shRNA oligos for knocking down 
HDAC2. Neurosphere cultures were infected with lentivirus carrying shRNA against 
HDAC2 and cell lysates prepared 4 days or 7 days after infection. The protein was 
separated by PAGE and subsequently analyzed though western blotting.  
HDAC2 protein levels were decreased in infected cultures in a dose-dependent manner 
both after 4 and 7 days. However, in cultures infected with scrambled shRNA virus, 
HDAC2 protein level was also decreased compared to uninfected cultures. According to 
this result, knockdown of HDAC2 in neurosphere cultures leads to a reduction of 
protein levels to 50% or even 30% of control; at the same time the viral infection itself 
already decreases the expression of the protein, probably because the cell is in a 
stressed, unfavorable state.  
5.3.2.2 Knockdown of endogenous HDAC2 in 293T cells 
In order to control the knockdown capacity of the lentivirus generated, I went back to 
the original pLKO.1-puro plasmids purchased from Sigma. These were transfected into 
HEK293T cells which were cultured for 4 or 6 days. Lysates were prepared and 
subjected to western blot analysis. A co-transfection with GFP served as a control for 
transfection. In this experiment no reduction of HDAC2 protein could be observed. This 
could be due to low transfection efficiency and a therefore not detectable change in 
protein levels. According to GFP fluorescence in the cultures, the transfection efficiency 
did not seem to be low. To be able to draw a sound conclusion, the experiment should 
be repeated. 
5.3.2.3 Knockdown of HDAC2 in neurosphere-derived cultures 
To determine knockdown of HDAC2 on protein level, immunocytochemistry was 
applied. Neurosphere cultures were plated out for differentiation and infected with 
lentivirus. Cells were fixed and stained 4 days after infection, photographs taken and the 
fluorescence intensity of HDAC2 in nuclei measured with Metamorph software.  
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Although all nuclei were positive for HDAC2, no reduction in HDAC2 fluorescence 
intensity could be observed in infected cultures with shRNA against HDAC2 compared 
to control. However, since I measured the overall HDAC2 fluorescence in all nuclei in 
the cultures, this could dilute a knockdown effect seen on the individual cell level. In 
order to determine the knockdown on the cellular level only cells which are actually 
infected should be analyzed. Therefore, the experiment should be repeated using a 
reporter for infected cells and the degree of knockdown determined only in those.  
The amount of neurons in the cultures did not change between HDAC2 knockdown and 
controls. This would also be expected because no difference in HDAC2 protein levels 
could be observed.  
5.3.2.4 Knockdown of HDAC2 in hippocampal cell cultures  
Knockdown of HDAC2 was also assessed in hippocampal cultures. The cells were 
infected, then fixed and stained 4 days after infection. Immunocytochemistry was 
performed using antibodies to detect HDAC2 and GFP to determine the number of 
infected cells. HDAC2 fluorescence levels were measured with Metamorph. Just as in 
neurospheres, no reduction in HDAC2 protein levels could be observed in the cultures. 
Since the GFP staining revealed that only very few cells were infected in the cultures, 
this is not surprising and also supports the assumption that in the neurosphere 
experiment the same was true and very few cells were infected.  
5.3.3 Immunostaining to reveal the progeny of infected 
precursors 
I wanted to assess whether the reduction in HDAC2 protein level had a consequence on 
the cellular composition of the cultures after differentiation. If HDAC2 knockdown led 
to a change in neuro- and gliogenesis, the cellular composition of the culture should 
reflect this difference. Immunocytochemistry stainings were performed with antibodies 
against EGFP to detect infected cells, TuJ1 to stain for newborn neurons or GFAP to 
stain astrocytes. The neurospheres were cultured for 4 days or 7 days to allow for 
differentiation to occur.  
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The infection rate in the cultures was very low also in this experiment. Very few 
infected cells were co-stained for GFAP, none of the infected cells was positive for 
TuJ1. This could suggest that HDAC2, in infected cells, shifts the developmental 
outcome towards glia instead of neurons. However, since the infection rate was so low, 
it is difficult to draw any conclusion and further experiments should be carried out.  
At both time points, 4 days and 7 days after transfection, no change could be observed 
in the cellular composition of the cultures compared to controls. This could either be 
because HDAC2 does not influence neuro- or gliogenesis or because infection rates 
were so low, that eventual, subtle changes in the cellular composition could not be 
measured. 
To conclude the HDAC2 knockdown experiments it can be said that shRNA against 
HDAC2 led to a knockdown both on transcriptional and protein level. On protein level, 
the knockdown was shown to be dose-dependent. The highest concentration of 
lentivirus led to a reduction of HDAC2 protein to about 30% of controls. On the RNA 
level an unspecific influence on the expression of non-target HDACs was observed. It is 
not clear whether this is the result of off-target effects of the shRNA sequence or, what 
is perhaps more probable, that virus infection leads to detrimental effects on the cells 
thus leading to the observed variability in the expression of non-target family members.  
On a cellular level, it was observed that none of the infected cells co-stained for TuJ1, 
but some were positive both for EGFP and GFAP. This could suggest that inhibition of 
HDACs prevents the cells from becoming neurons. This would be corresponding to the 
finding of MacDonald et al. that HDAC2 expression is initiated in a subset of mitotic 
stem/progenitor cells and appears to be up-regulated as the progenitors commit to a 
neuronal lineage. HDAC2 expression could not be detected, however, in the majority of 
glia (MacDonald and Roskams 2008). This could suggest a role of HDAC2 in the fate 
decision of progenitor cells towards neurogenesis. However, assessment of the progeny 
of infected precursor cells did not reveal any change in cell fate decision. This could be 
due to the low infection rate which might prevent subtle changes from being detected, 
but it also could just be due to the fact that reduction of HDAC2 protein levels does not 
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have an influence on the decision of a progenitor cell to become a neuron or an 
astrocyte. 
5.4 Developmental phenotype of the CNS of 
HDAC4 and HDAC5 transgenic mice 
The recent generation of knockout models for different HDACs has opened up new 
possibilities to investigate their function in vivo. Transgenic mice provide a powerful 
tool to study the role of the enzymes in the organism and at different developmental 
stages.  
The class II family members HDAC4 and HDAC5 were found to be highly expressed in 
brain (Grozinger at al. 1999, Majdzadeh et al. 2008). As opposed to class I HDACs, 
class II HDACs are expressed in more restricted patterns. They are assumed to 
influence protein deacetylation by binding to class I HDACs. HDAC4- and -5 null mice 
were recently generated in the group of Eric N. Olson and extensive analyses of the 
postnatal phenotype carried out. Majdzadeh and colleagues found that the brains of 
HDAC4 null mice were 40% smaller than the ones of wildtype littermates. The cortical 
hemispheres as well as the cerebellum were reduced in size (Majdzadeh et al. 2008).  
HDAC4 was found to protect cerebellar granule neurons against low potassium-induced 
apoptosis and to particularly protect cortical neurons from 6-hydroxydopamine-induced 
neurotoxicity. The neuroprotective effect is independent of the deacetylase activity of 
the enzyme (Majdzadeh et al 2008).  
Since the Hdac4 null mice displayed severe malformations of skeleton and skull, the 
changes in brain morphology could also result from the premature ossification of the 
skull which does not allow the brain to develop normally. For this reason, we generated 
conditonal mutants where HDAC4 is only lacking in the CNS by crossing Hdac4 flox/flox 
mice with a nestin::Cre line.  
HDAC5 null mice are viable in contrast to HDAC4 mutants which die within 2 weeks 
of birth. Since Hdac5 was knocked out by inducing a LacZ expression cassette into the 
gene, mutant mice could be observed for onset and localization of HDAC5 expression 
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in embryos. Already at E10.5, HDAC5 was observed to be strongly expressed in the 
CNS (Chang et al. 2004). 
5.4.1 Embryonic brain phenotype of HDAC4 mutant mice 
5.4.1.1 HDAC4 is expressed in neurogenic regions of the embryonic brain 
Before analyzing the expression pattern in embryonic brains of mutant mice, the 
expression was determined on coronal sections through in situ hybridization and LacZ 
staining.  
In situ hybridization was performed on coronal sections of E15.5 mouse brains which 
had been embedded in paraffin. To test the specificity of the newly generated HDAC4 
antisense probe, the corresponding sense probes were used. The Sense probe did not 
produce but a faint background staining and therefore proved the specificity of the 
staining.  
The HDAC4 sense probe showed a weak overall staining, which can be interpreted as 
an overall background signal on the sections. The HDAC4 antisense probe led also to a 
staining on the entire section; however, several areas were stained more intensely. The 
cortical plate, the ventricular zone and subventricular zone of the cortex were 
specifically stained by the HDAC4 antisense probe, as well as the ventricular zone and 
subventricular zone of the lateral and medial ganglionic eminences (LGE and MGE). 
The stronger expression of the protein in neurogenic areas of the brain might suggest a 
role of the protein in those areas and perhaps in neurogenesis.  
The expression data collected with in situ hybridization was further confirmed through 
X-Gal staining. E 13.5 and E 15.5 coronal sections of mutant and heterozygous brain 
were subjected to X-Gal staining. At 13.5 an overall staining of the sections could be 
observed. Areas with stronger signal were the hippocampus and the trigeminus 
ganglion. At E15.5 the cortical plate and frontal part of corpus callosum were stained, as 
well as the ventricular zone and subventricular zone of the cortex and GE.  
Both in situ hybridization and X-Gal staining showed the same expression pattern of 
HDAC4 which I therefore believe to be specific. E15.5 embryonic brains reveal 
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HDAC4 to be localized to the VZ and SVZ of cortex and GE. Moreover, a strong 
expression could also been observed in cortical plate, which suggests a role in neuronal 
migration and layer formation.  
5.4.1.2 Generation and analysis of conditional mutant animals for HDAC4 
Hdac4 null mice show several changes in their CNS compared to wildtype animals, a 
reduced brain size and a degeneration of Purkinje neurons, to name a few. However, the 
brain phenotype might also derive from the fact that the prematurely ossified skull is 
smaller in size and prevents normal brain development. Therefore a conditional 
knockout line was generated by breeding Hdac4 flox/flox mice (Potthoff et al 2007) with 
mice expressing Cre through a nestin promoter (Tronche et al 1999). This removes 
HDAC4 selectively from neural progenitor cells and their lineage (neurons and 
microglia).  
Western blot confirmed the absence of HDAC4 protein from embryonic spinal cord and 
brain at E13.5 and E15.5. At both embryonal ages, the protein amount in mutant 
animals corresponded to 2 – 3% of the one in wildtypes.  
The nestin::Cre mouse line was generated by oocyte injection. Therefore neither the 
copy number nor the location of the insertion site of the transgene in the genome are 
known. It cannot be excluded that Cre copy number variations led to differences in the 
extent of Hdac4 knockdown. However, the Cre copy number does not necessarily 
reflect the recombinase activity of the transgene (O'Gorman et al., 1997).  
Since neurogenic regions of the developing forebrain showed high expression levels of 
HDAC4, proliferation in the VZ of the cortex was examined. The VZ is the main source 
of excitatory cortical neurons. Coronal sections of wildtype and mutant brains of E15.5 
mice were stained for phospho-histone H3 (PH3). Sections of corresponding position 
along the rostro-caudal axis of the embryo were compared to each other. In the 
anteriormost sections, a decrease in PH3 positive cells could be detected in mutant 
animals. This finding corresponds with the previous one that when all class I and II 
HDACs were inhibited in the embryonic brain, an increase in cell proliferation was 
detected in the ganglionic eminences, but not in the cortex (Shaked et al 2008). The 
5  Discussion   Kathrin Weißmüller, 2013 
192 
 
detailed analysis in this study revealed a slight change in proliferation in rostral 
telencephalon. Here, the absence of HDAC4 seems to reduce mitotic activity. A 
mechanism which is believed to have an important function in the context of cell 
proliferation is the ability of HDAC4 to repress CDK1 activity, thereby suppressing cell 
cycle progression (Majdzadeh et al 2008) 
When non-surface dividing cells, basal progenitors in the subventricular zone, were 
examined through immunohistochemistry for their marker Tbr2 and costaining for TuJ1 
to visualize newborn neurons, no differences in Tbr2 expressing cells or newborn 
neurons could be observed in mutant animals compared to wildtypes at E15.5. The pool 
of basal progenitors in the mutants does not seem to be different in HDAC4 conditional 
mutants. It must, however, be kept in mind that this analysis was by no means 
quantitative and that a quantitative analysis will be indispensable to draw a sound 
conclusion on the basal progenitor population.  
This study confirms the conditional knockout of HDAC4 specifically in embryonic 
brain and spinal cord. Expression analysis reveals localization of in all embryonic brain 
regions, but especially in VZ and SVZ of the cortex and basal ganglia. The preliminary 
experiment to investigate the basal progenitor pool in mutant brains did not show any 
changes, but should be repeated in a quantitative fashion. Also gliogenesis should be 
examined further, possibly by immunohistochmistry to detect GFAP. Since HDAC4 
was also localized to the cortical plate, changes in cell migration or layer formation 
would not be surprising.  
Interestingly, Price and colleagues recently published a study in which the same 
conditional knock-out mice were generated crossing the Hdac4 flox/flox line (Potthoff et 
al. 2007) with mice expressing Cre recombinase through a nestin promoter. Their 
experiments revealed no gross abnormalities that could be detected based on basic 
histological and immunohistological analyses in conditional knock out mice of HDAC4. 
They also carried out locomotor tests which did not reveal any abnormalities (Price et 
al. 2013). This would support the finding in this study that the conditional knockout 
animals were viable, behaved and bred normally and did not show any obvious changes 
in either VZ proliferation or basal progenitors.  
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5.4.2 Embryonic brain phenotype of HDAC5 mutant mice 
5.4.2.1 HDAC 5 is present in areas important for cortical layering and 
neurogenesis in the embryonic mouse brain  
In situ hybridization of HDAC5 revealed that the enzyme is present ubiquitously in the 
embryonic brain. However, the cortical plate and the subventricular zone of the cortex 
showed a more intense staining. Since the cortical plate is important for cortical layer 
formation, the presence of HDAC5 in the structure could suggest a role in the formation 
of layers or neuronal migration. In the basal ganglia, both VZ and SVZ showed strong 
HDAC5 expression.  
X-Gal staining of HDAC5 mutant mice could confirm the absence of HDAC5 from 
mutant tissue. A dose-dependent effect could be seen, since heterozygotes showed a 
weaker X-Gal staining than homozygous mutants in which X-Gal is expressed from 
both Hdac5 alleles. Mutant and heterozygous brains of E13.5 and E15.5 embryos were 
cut coronally and subjected to LacZ staining.  
At E13.5 and E15.5 cortical plate showed a strong staining of HDAC5. At E15.5 also 
the subplate was stained. Presence of HDAC5 in these areas suggests a role of the 
enzyme in cortical layer formation. Therefore, I decided to examine cortical layer 
formation in early postnatal animals.  
Comparing in situ hybridization and X-Gal staining for HDAC5 expression, both 
methods show a strong expression of HDAC5 in the cortical plate, both at E13.5 and 
E15.5. This hints to a role of HDAC5 in cortical layer formation or perhaps cell 
migration during cortical layer formation.  
In order to access potential changes in cortical layer formation in HDAC5 mutant mice 
compared to wildtypes, coronal sections of early postnatal brains (P8) were subjected to 
immunohistochemistry for different cortical layer markers.  
To this end, the brains of early postnatal mice (P8) were sectioned coronally and stained 
with markers for different cortical layers. The following markers were examined: Pax6 
as a marker for apical progenitors in the VZ, Ctip2 and SatB2 as markers for outer 
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cortical layers, and Reelin as a marker of the marginal zone. Pax6 staining has not 
functioned properly, but also stainings for the other markers did not reveal distinct 
changes between wildtype and HDAC5 mutants.  
The fact that no changes could be observed most probably reflects the insufficient 
quality of the staining, but could in principle also be due to the fact that HDAC5 does 
not have an impact on cortical layer formation. 
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6 Outlook 
To complement the studies on signalling pathways mediating the influence of histone 
deacetlyases on neuro- and gliogenesis, chromatin immunoprecipitation should be 
carried out to reveal changes in chromatin structure upon HDAC inhibition and identify 
direct targets of histone deacetylases. We could show that the change in expression of 
Stat3 upon HDAC inhibition was not dependent on translational activity. Therefore, the 
promoter of Stat3 could be a direct target of acetylation. To generate a broader range of 
information on HDAC targets, a genome-wide approach would be appropriate. ChIP-
sequencing might be a sensitive approach to identify putative target sequences.  
Given that transgenic animals for HDACs are available, I would not consider continuing 
the RNA interference studies to analyze the effect of individual HDACs on neuro- and 
gliogenesis. The off-target effects were considerable and the in vitro system also does 
not reflect the situation in vivo.  
The analysis of the brain phenotype of embryonic mutants of HDAC4 and HDAC5 is 
very preliminary in this study. Many aspects of brain development still need to be 
addressed, especially since HDAC4 and -5 have been implicated in several changes in 
brain function, for instance the function of HDAC4 as a neuroprotective agent.  
It should be determined at which developmental stage the conditional knock-out of 
HDAC4 can be first observed; western blot would be a feasible approach to look into 
this. Cre is known to be expressed in mouse embryos as early as 10.5 dpc, therefore it 
should be tested at what age HDAC4 is found to be absent.  
Initial experiments concerning proliferation in the cortical VZ should be repeated and 
also other areas, like the GE, should be investigated, where HDAC4 was also shown to 
be expressed.  
To further investigate the developmental switch from neuro- to astrogliogenesis, basal 
progenitors should be examined also in immunohistochemistry for Pax6 and Tbr1 
(Englund et al. 2005).  
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Astrogliogenesis needs to be examined more closely, especially since HDACs have 
been shown to influence BMP2/4 signaling which in turn in known to induce astrocytic 
differentiation in vitro (Fukuda and Taga 2005).  
It would also be very interesting to investigate HDAC4/5 double knockouts for changes 
in brain architecture and development. Although HDAC4 and -5 have a very high 
sequence similarity, they seem to be expressed differentially and play different roles in 
the CNS.  
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7 Appendix 
7.1 Plasmid maps 
 
pLKO.1-puro 
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pSHC002 
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pLentiLox3.6 
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7.2 Immunocytochemistry of neurosphere cross-
sections 
 
Neurospheres cultured for 7 days in suspension, 10 µm cryosections. Scalebar 100 µm 
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Neurospheres cultured for 7 days in suspension, 10 µm cryosections. Scalebar 100 µm 
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